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Abstract 
Asymmetric Alkenyl Zirconocene/Zinc Additions to Aldehydes and 
Synthetic Efforts Toward Pseudotrienic Acid A 
 
Nilukshi Renuka Jayasuriya, PhD 
University of Pittsburgh, 2007
 
The in situ hydrozirconation-transmetalation-aldehyde addition process is a convenient 
method for the generation of allylic alcohols.  Ongoing research has focused on enhancing the 
enantioselectivity and substrate scope of this process and will be the focus of Chapter 1.  
Investigations have shown that both amino alcohols and amino thiols show moderate to high 
enantioselectivity.  Non-linear effects were analyzed in order to gain mechanistic insight into the 
asymmetric addition process.  Additionaly, analogues of both classes of ligands have been 
synthesized and evaluated.   Amino thiol ligands tend to show the highest enantioselectivities 
due to the higher affinity of sulfur for zinc over zirconium.  A new class of valine-based ligands 
was identified to be quite effective, in terms of ligand loading and % ee in the formation of 
allylic alcohols.  
In Chapter 2, progess toward pseudotrienic acid A is discussed.  The goal of this project 
was the synthesis of pseudotrienic acid A utilizing alkenylzirconium/zinc methodology 
cultivated in the Wipf group and to elucidate the absolute configuration at C(20) of the target 
molecule.  A brief summary of the only reported synthesis of pseudotrienic acid B by Cossy et 
al. is outlined, followed by the retrosynthetic plan and synthesis of the 3 main fragments of this 
molecule.  Lastly, the current progress towards the coupling of these fragments is examined.   
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1.0   Asymmetric Alkenylzirconocene/Zinc Additions To Aldehydes 
1.1 Introduction 
1.1.1 Reactivity of Carbonyl Groups 
The carbonyl group is a key functional group in organic synthesis.  It can act as either an 
electrophile or nucleophile (Figure 1.1).  Electrophilicity is generally expressed at the carbon 
atom whereas its nucleophilic character is most obvious in the enolate form.  When used as an 
electrophile, the carbonyl moiety serves as a precursor to alcohol functionality. Organometallic 
reagents, such as Grignard and alkyllithium reagents add to aldehydes and ketones to produce 
secondary and tertiary alcohols in a 1,2-addition manner. Hydrides can react with carbonyls to 
produce the reduced product, an alcohol.  Electrophilic carbonyl compounds also provide useful 
precursors to amines.  Primary amines react with carbonyls to form imines whereas secondary 
amines condense to form enamines.  Carbonyls exhibit both electrophilic and nucleophilic 
character in aldol condensations, when the enolate is used to produce α,β-unsaturated 
compounds or β-hydroxy ketones and aldehydes.   
 
O
R
O
R
Nuc
E+
E+
 
Figure 1.1.  Sites for electrophilic and nucleophilic attack. 
  1
1.1.2 Asymmetric Additions to Carbonyl Compounds 
A wide variety of reactions mentioned above can now be performed in an asymmetric 
fashion.  The first asymmetric cyanohydrin formation was reported by Reetz et al. in 1986; their 
best result involved using 20 mol% of an (S)-binaphthol-based Ti complex in the addition of 
TMSCN to an aliphatic aldehyde to give the cyanohydrin adduct in 85% yield and 82% ee.1  
Another report by Narasaka et al. showed that by using 1 equivalent of an alkoxy titantium(IV) 
complex, both aromatic and aliphatic aldehydes could be coverted to the corresponding 
cyanohydrins in more than 85% yield and up to 96% ee.2  Hayashi et al. have proposed a 
catalytic asymmetric variant using 20 mol% of complex 1.  The asymmetric addition of TMSCN 
to p-methoxy benzaldehyde resulted in an ee of 91% (Scheme 1.1).3
 
ON
O
i-Pr
Ti(OiPr)2
1MeO
CHO
TMSCN, -80 oC
1 (20 mol%)
MeO
CN
OH
91% ee
 
Scheme 1.1.  Asymmetic cyanohydrin formation using a (S)-binaphthol-based Ti complex. 
 
Noyori et al. have reported an asymmetric variant of a transfer hydrogenation using a 
ruthenium complex as a catalyst (Scheme 1.2).4  In this reaction, a prochiral ketone can be 
converted to a chiral alcohol in the presence of a ruthenium catalyst and potassium hydroxide in 
isopropanol.  This process occurs through six-membered transition state 2, where hydride and 
proton are simultaneously delivered from MH and NH, respectively.   
O
i-PrOH Ru
N Ph
Ph
N Ts
H
2
O
H
H
 KOH
OH
90%; >99% ee
 
Scheme 1.2.  Asymmetric transfer hydrogenation using ruthenium catalysis. 
  2
Mukaiyama et al. have discovered that in the presence of 20 mol% of catalyst 3, different 
aldehydes react with the silyl enol ether of (S)-ethyl propanethiolate to produce aldol adducts 
with excellent relative and absolute stereochemical control (Scheme 1.3).5  These chiral products 
are formed in a procedure that utilizes amine ligand and tin(II) triflate.   
 
H
O
Me
OSiMe3
SEt
Sn(OTf)2 (20 mol%)
CH2Cl2, -78 oC
N
Me HN
(20 mol%)
+ Ph SEt
OH O
+
Ph SEt
OH O
syn anti
93:7; 91% ee
3
 
Scheme 1.3.  Asymmetric Mukaiyama aldol. 
1.1.3 Organozinc Additions to Carbonyl Groups 
Research on asymmetric organozinc additions to carbonyl compounds has expanded 
dramatically in the past 20 years.6  Most of the work in this area has focused on alkylzinc 
additions to aldehydes.  Ordinarily, dialkylzinc compounds are inert to carbonyl substrates, but in 
the presence of certain additives, their reactivity can be enhanced.  The first noteworthy 
observation in this field was that of Oguni and Omi in 1984.7  In the presence of 20 mol% (S)-
leucinol, the reaction of diethylzinc with benzaldehyde provided optically enriched (R)-1-
Phenyl-1-propanol in 49% ee and 96% yield.  This significant discovery led to a rapid growth of 
research in this area.  In 1986, Noyori et al. discovered the first highly efficient ligand for 
enantioselective dialkylzinc additions to aldehydes.8 In the presence of 2 mol% of 4, the reaction 
of diethylzinc with benzaldehyde gave (S)-1-phenylethanol in 98% ee (Scheme 1.4).   
H
O
+ Et2Zn
4 (2 mol%)
Et
97%; 98% ee
NMe2
OH
(-)-DAIB
4
OH
 
Scheme 1.4.  Asymmetric diethylzinc addition catalyzed by (-)-DAIB. 
  3
TADDOL complexes are also effective catalysts for the asymmetric addition of 
organozinc reagents to aldehydes, as reported by Ito et al.9  Enantioselectivities of 95-99% ee 
were obtained using a mixture of 20 mol% of chiral titanium TADDOLate 5 and excess 
Ti(OiPr)4 (Scheme 1.5). 
5
+ Et2Zn
5 (20 mol%)
Et
OH
O
O
Ti(i-PrO)2
Ar
Ar Ar
Ar
H
HO
O
Ar = Ph
O
H
 
Scheme 1.5.  Asymmetric diethylzinc addition catalyzed by TADDOLate 5. 
 
In contrast, it is more challenging to develop an enantioselective arylzinc addition 
because of the fast background reaction even in the absence of catalyst.  The faster background 
reaction produces racemic product, thus lowering the enantioselectivity of the reaction. There are 
only a few enantioselective variants of this reaction.  In 1999, Huang and Pu found that 20 mol% 
binaphthyl ligand 6 was enantioselective for the addition of diphenyl zinc to aldehydes (Scheme 
1.6).10  Initially, low ee’s were obtained due to the competitive background reaction but they 
soon discovered that pretreating 6 with diethylzinc led to ee’s of up to 98%. 
OH
OH
OR
OR
OR
OR
(R)-6
R= n-C6H13
+ Zn
2
 6 (20 mol%)
    Et2ZnMeO MeO
84%, 93% ee
O
H
OH
 
Scheme 1.6.  Asymmetric diphenylzinc addition catalyzed by binaphthyl ligand 6. 
 
Bolm et al. also reported a similar finding in their research of diphenylzinc addition to 
aldehydes (Scheme 1.7).11  Using 10 mol% of ligand 7, diphenylzinc additions proceeded in 3-
75% ee, but with the use of a 1:2 mixture of diphenylzinc and diethylzinc the ee of the product 
was increased to 83-99% ee.  
  4
Ph2Zn/ Et2Zn
 7 (10 mol%)
R R 7
O
H Fe
OH
PhPh
N
O
OH
 
Scheme 1.7.  Asymmetric diphenylzinc addition catalyzed by ferrocenyl 7. 
 
Alkynylzinc additions to aldehydes lead to the formation of propargyl alcohols.  Li et al. 
have described this process in the presence of amino alcohol ligand 8 (Scheme 1.8).  Using 10 
mol% of this ligand and 1.2 equiv. of dimethylzinc, ee of up to 85% and yields in the range of 
65-94% were observed.12  It was also possible to suppress the methyl addition product in this 
reaction by using a mixture of toluene and THF (2.75:1).   
R H
Et2Zn, 8 (10 mol%)
R'CHO
R
R'
OH
N OH
Ph Ph
*
8  
Scheme 1.8.  Asymmetric alkynylzinc addition catalyzed by amino alcohol 8. 
 
Carreira et al. have used 1.2 equivalents of 9 in the presence of Zn(OTf)2 with a variety 
of aromatic and aliphatic aldehydes and observed ee’s ranging from 92-99% (Scheme 1.9).13  An 
interesting aspect of this reaction is that it can be carried out in air using reagent grade solvents 
without loss of enantioselectivity of the propargylic alcohol formed.  
 
R H + R'CHO
Zn(OTf)2, Et3N
R
R'
OH
*
Ph Me
HO NMe2
9
9 (1.2 equiv)
 
Scheme 1.9.  Asymmetric alkynylzinc addition catalyzed by pseudoephederine-derived 9. 
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1.1.4 Non-Linear Effects 
An interesting aspect of a ligand-accelerated catalytic asymmetric process is the 
possibility for non-linear stereoinduction.  The observance of a non-linear effect offers insight 
into the reaction mechanism, specifically relating to species involved in the catalytic cycles and 
species present in solution.  Non-linear effects were first discovered by Kagan and Agami in 
1984.14  The first reactions studied in this context were asymmetric oxidation, asymmetric 
epoxidation and the proline-catalyzed Hajos-Parrish reaction.  All of these processes resulted in a 
substantial departure from the linear correlation of the enantiomeric excess of the ligand and the 
enantiomeric excess of the product.15  This anomaly can arise when more than one chiral ligand 
participates in the stereoselectivity-determining step of the catalytic cycle.  Kagan has developed 
mathematical models to explain this behavior.16  The use of a ligand that shows a (+)-NLE can 
be quite beneficial, as it allows the use of lower ee ligand while still retaining a high 
enantiomeric excess in the product.  Tedious resolutions or absolute control in ligand synthesis 
become unnecessary when a small enantiomeric excess in the ligand is sufficient for a high 
enantiocontrol of the asymmetric transformation.  This benefit, however, comes often at the 
expense of a slower rate of reaction due to the decreased concentration of catalyst available to 
take part in the catalytic cycle.  In 1989, Noyori et al. published a mechanistic study on the 
addition of dialkylzinc reagents to benzaldehyde.17  They demonstrated that diethylzinc additions 
to benzaldehyde in the presence of (-)-DAIB ligand of only 15% ee produced 95% ee of the 
alkylated alcohol product.  This is the most pronounced asymmetric amplification reported to 
date with an asymmetric amplification value (I) of 32 in the presence of 15% ligand ee (Figure 
1.2).  I equals the enantiomeric excess of the observed product divided by the enantiomeric 
excess of the linear product (the expected enantiomeric excess based on a linear relationship with 
ligand ee).   
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HO
+ Et2Zn
(-)-DAIB (15% ee)
8 mol%, toluene
H
OH
97%, 95% ee
NMe2
OH
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Figure 1.2.  Non-linear dependence of product ee vs. ligand ee for the Et2Zn addition to 
benzaldehyde. 
 
Noyori concluded that this strong (+)-NLE was a result of the association between DAIB 
and the organozinc reagent.  In solution, this association leads to the formation of dimeric 
complexes.  When a mixture of (R) and (S)-DAIB was used, two types of dimeric complexes 
were formed: homochiral (R).(R)-11 or (S).(S)-11 and heterochiral (R).(S)-11 (Figure 1.3).18  The 
departure from linearity is due in part to the stability of these complexes.  Noyori did extensive 
work with NMR and X-ray diffraction analysis to determine the stability of the homochiral-11 
vs. heterochiral-11.17  It was concluded that the heterochiral-11 is more stable, thus it is the 
homochiral-11 that dissociates at a faster rate and its monomer is the active catalyst in this 
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reaction.  A (+)-NLE is observed while the minor enantiomer of the ligand is retained in the 
heterochiral-11. 
 
N
O
Zn
Zn
O
Et
N
N
O
Zn
Zn
O
N
Et
Et Et
(S).(S)-11 (R).(R)-11
N
O
Zn Et
N
O
Zn Et
(S)-DAIB-ZnEt (R)-DAIB-ZnEt
N
O
Zn
Zn
O
Et
NEt
(S).(R)-11
homochiral
heterochiral
PhCHO
Me2Zn
PhCHO
Me2Zn
Et
OH
Et
OH
(S)-10 (R)-10
 
Figure 1.3.  Homochiral and heterochiral aggregates formed in the ligand-accelerated 
diethylzinc addition to benzaldehyde. 
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1.1.5 Alkenylmetal Additions to Carbonyl Compounds 
Transition metal-mediated coupling reactions which rely on the addition of an 
alkenylmetal reagent to a carbonyl group represent a popular route for the generation of allylic 
alcohols.  These processes have a strategic advantage because both a new C-C bond and a new 
stereogenic center are formed in one step.  Many of these alkenylmetal reagents are generated in 
situ and then immediately reacted with the corresponding carbonyl compound. 
 In the Nozaki-Hiyama-Kishi reaction, an alkenyl halide or triflate is reacted with a 
carbonyl acceptor in the presence of a nickel catalyst and excess CrCl2, Mn, or Zn to produce an 
allylic alcohol (Scheme 1.10).19  
R
Br + R'CHO
CrCl2, NiBr2
R R'
OH
DMF  
Scheme 1.10.  Nozakai-Hiyama-Kishi reaction. 
 
Kishi et al. has extended this protocol to a stoichiometric asymmetric process by 
employing a chiral sulfonamide ligand (Scheme 1.11).20  Moderate asymmetric induction is 
observed in the presence of ligand 12. 
 
CHO MeI+
OH
Me
CrCl2, NiCl2
12, Et3N, THF
Me
NH
O
N
t-Bu SO2
R,S =12:1
12
 
Scheme 1.11.  Asymmetric Ni(II)/Cr(II)-mediated coupling reaction. 
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Jamison et al. has developed a catalytic intermolecular reductive coupling of alkynes and 
aldehydes to yield di- and trisubstituted allylic alcohols in high stereo- and regioselectivity 
(Scheme 1.12).21  This work has been extended to an asymmetric protocol utilizing a (+)-
(neomenthyl)diphenylphosphine 13 as the chiral phosphine.22  Aliphatic as well as aromatic 
aldehydes show moderate to high enantioselectivity in the coupling process.  Functional groups 
such as protected alcohols, protected amines, and silyl groups are inert to the reaction conditions.  
R1 R2 +
Ni(COD)2 (10 mol%)
Bu3P (20 mol%)
Et3B (200 mol%)
R1 R3
OH
R2
R3CHO
 
Scheme 1.12.  Formation of allylic alcohols via nickel-catalyzed reductive coupling. 
 
Ph Me + H
O Ni(cod)2 (10 mol%)13 (20 mol%)
Et3B (200 mol%)
EtOAc:DMI (1:1)
Ph
OH
Me
Me
PPh2
13
95% yield, 90% ee  
Scheme 1.13.  Asymmetric reductive coupling employing the chiral phosphine ligand 13. 
Related to this method is work reported by Montgomery et al., where a protocol has been 
developed for the nickel-catalyzed cyclization and alkylation of ynals with organozincs to 
produce cyclic allylic alcohols and also effect a three component coupling of alkynes, aldehydes, 
and organozincs to produce acyclic allylic alcohols with complete control of alkene 
stereochemistry.23  This process is envisioned to occur via an oxametallacycle, which in the 
presence of organozinc reagent would produce a common vinyl nickel intermediate for both 
alkylative and reductive cyclization products (Scheme 1.14).  
H
O ZnEt2
Ni(COD)2
HO
H
R1
R1
 
Scheme 1.14.  Nickel-catalyzed cyclization/alkylation of ynals with organozinc reagents. 
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A different approach towards allylic alcohols was taken by Krische et al. in the 
development of an enantioselective reductive coupling of 1,3-enynes to heterocyclic aromatic 
aldehydes and ketones via rhodium catalysis.  In the presence of a chiral phosphoric acid derived 
from BINOL 14, highly optically active products are obtained under standard coupling 
conditions (Scheme 1.15).24   
Ph H
O
N
+
Rh(COD)2OTf (2 mol%)
Ph3CCO2H (2 mol%)
DCE, H2 (1 atm), 40 oC
14 (2 mol%)
Ph
OH
N
91% yield, 92% ee
PTol2
PTol2
14  
Scheme 1.15.  Enantioselective hydrogen-mediated coupling.   
1.1.6 Asymmetric Addition of Alkenylzinc Reagents to Aldehydes 
Allylic alcohols can also be accessed via alkenylzinc additions to aldehydes.   Compared 
to alkylzinc addition, asymmetric alkenyl zinc additions are more challenging and only a few 
reported cases have been published.  Srebnik illustrated the first preparation of bis(alkenyl) zinc 
reagents via hydroboration of an alkyne followed by subsequent transmetalation to form an 
organozinc reagent.25  These reagents were successfully added to aldehydes in the presence of a 
catalytic amount of N-methylpiperdine to afford the allylic alcohols in good yields (Scheme 
1.16).  
1. BH3, THF
2. Et2Zn, hexanes Zn
2
PhCHO
N-methylpiperdine
(5-10 mol%)
Ph
OH
92%  
Scheme 1.16.  Srebnik’s hydroboration followed by transmetalation protocol. 
 
Inter- and intramolecular variants of this reaction as well as a chiral ligand catalyzed 
enantioselective addition have been shown to work successfully.26  In the latter process, 
Oppolzer et al. has taken advantage of Noyori’s (+)-DAIB ligand to promote an enantioselective 
addition with a variety of aldehydes with ee’s in the range of 73-96% using 4.5 mol% of the 
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chiral ligand.27  In recent years, Walsh et al. has shown that 2 mol% of the morpholino analogue 
of the (+)-DAIB ligand, Nugent’s (-)-MIB, also shows promotion of the enantioselective addition 
reaction of a variety of terminal alkynes with ee’s between 88-97% (Scheme 1.17).28
 
1. Cy2BH
2. Et2Zn
R1
ZnEt
15
RCHO R1 R
OH
*
N
OH
O
15
R1 H
 
Scheme 1.17.  Hydroboration/transmetalation protocol.   
 
Bräse et al. has established a successful application of paracyclophane based ketimine 
ligands in the enantioselective alkenylation.29  High enantioselectivities are realized for straight-
chain aliphatic as well as branched aliphatic aldehydes with utilization of 16 (Scheme 1.18).  A 
survey of transmetallating agents for this process was also examined. 
R H
O
+
R"
Zn
16 (2 mol%)
R"R
OH
86 - 98%ee
R'
NOH
16
 
Scheme 1.18.  Asymmetric addition of alkenylzincs catalyzed by chiral paracyclophane 
ketimines. 
 
Chan et al. has also reported an effective aminonaphthol ligand for asymmetric vinylzinc 
addition reactions.30  The ligand is conveniently made in one step from the multicomponent 
reaction of 2-naphthol, benzaldehyde, and (S)-N-α-dimethylbenzylamine 17 to afford the 
optically active tertiary amino naphthol in high purity.  Yields and enantioselectivities are quite 
high for the addition process which works effectively not only with aromatic aldehyde but also 
with aliphatic aldehydes (Scheme 1.19). 
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1. Cy2BH
2. Me2Zn
3. 17 (15  mol%)
4. R'CHO, Toluene
    -30 oC
R'R
OH
90 - 97% ee
17
R
OH
Ph N
Ph
 
Scheme 1.19.  Utilization of chiral aminonaphthol ligand in the asymmetric vinylzinc additions. 
 
A morpholino derivative of a binaphthyl-based N,O-ligand has been disclosed by Ha et 
al.31  Utilization of ligand 18 resulted in moderate enantioselectivity (72-82%) with aromatic 
aldehydes and a decrease in enantioselectivity for aliphatic aldehydes (32-55%) (Scheme 1.20). 
 
1. Cy2BH, rt
    Et2Zn, -78 ºC 
2. 18 (3  mol%)
    PhCHO, 60 ºC
3. 0 ºC, 2 h
PhC4H9
OH
85%; 83% ee
18
C4H9 OH
N
O
 
Scheme 1.20.  Utilization of a morpholino-derived binaphthyl ligand in the asymmetric vinylzinc 
additions. 
 
Recently, Yang et al. have reported a new β–amino thiol scaffold for the enantioselective 
addition of alkenylzinc reagents to aldehydes.32 Using amino thiol ligand 19, high 
enantioselectivities are observed even at 1 mol% loading (Scheme 1.21).   
 
R H
O
+
ZnEt
R'
1. 19 (1 mol%)
2. NaHCO3 RR'
OH
N SH
19
ee's up to >99%  
Scheme 1.21.  Utilization of a chiral β–amino alcohol ligand in the asymmetric vinylzinc 
additions. 
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1.1.7 Allylic Alcohols 
Allylic alcohols represent convenient building blocks for a variety of synthetic 
applications.  These transformations include [3,3] sigmatropic rearrangements,33 enantio- and 
diastereoselective hydroxyl-directed additions to alkenes,34  SN2´-displacements with cuprates,35 
palladium catalyzed π-allyl substitution,36 and cationic cyclizations (Figure 1.4).37   Due to this 
versatility, our lab has also sought efficient ways to synthesize allylic alcohols. 
 
R1 R2
OH
Claisen-
rearrangements
R1 R2
CO2R3
Epoxidations
R1 R2
OH
X
Cationic cyclizations
X+
X = N,O
HO
X
O
 π−allyl Pd-complexes
R1 R2
Nu
Cuprates
R1 R2
Nu
(Cyclopropanations)
X=O, CH2
 
Figure 1.4.  Versatility of allylic alcohols in synthetic methodology. 
1.1.8 Alkenylzirconocene/Zinc Addition to Aldehydes 
The in situ hydrozirconation-transmetalation process pioneered in our labs is another method 
for the convenient generation of allylic alcohols.  In this method, hydrozirconation of an alkyne 
is followed by transmetalation at –65 ºC; upon reaction with an aldehyde the corresponding 
allylic alcohol product is generated in a one-pot reaction and in high yields (Scheme 1.22).38
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Cp2ZrHClR R
ZrCp2Cl Me2Zn
-65 ¼C
R
ZnMe R'CHO
R R'
OH
Me2ZrCp2Cl +
 
 
Scheme 1.22.  The in situ hydrozirconation-transmetalation addition protocol. 
This methodology has been used in the synthesis of a variety of natural products by the 
Wipf as well as other groups.  For example, the syntheses of leucascandrolide A39 and (+)-
curacin A40 by the Wipf group, (+)-halichlorine by the Danishefsky group41, lobatamide C by 
the Porco group42, and (+)-acutiphycin43 by Jamison showcase this methodology (Figure 1.5). 
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OO
O
OMe O O
N
O
NHCO2Me
O
Leucascandrolide A
OMe
S
N
H H
(+)-Curacin A
N
O
O
H
Cl
OH
H
Me
(+)-Halichlorine
N
H
N
O
O
OH
OH
O
O
Me
MeO
O
Me
Lobatamide C
O
OO
n-Bu
Me
OH
Me
O
OH
OH H
(+)-Acutipycin  
Figure 1.5.  Natural products synthesized using alkenylzirconium/zinc methodology. 
 
In order to increase the scope of this reaction, a chiral ligand which provides allylic 
alcohol products in uniformly high ee would be desirable.  This ligand would dictate the specific 
enantiomer of the allylic alcohol that is formed.  Although, countless ligands have shown 
superior enantioselectivity in simple alkylzinc additions to aldehydes, a ligand that affects the in 
situ hydrozirconation-transmetalation-aldehyde addition process with high asymmetric induction 
for all substrates remains to be identified. 
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1.1.9 Previous Wipf Group Work 
Past work in our group has lead to the discovery of a class of thiol-containing ligands that 
show high enantioselectivity in the alkenyl zirconium-zinc addition to most aromatic 
aldehydes.44  Thiols proved to have a higher affinity towards zinc than zirconium.45  This 
selectivity is quite important since in our in situ method both zinc and zirconium are present in 
the reaction medium and differential affinity of the ligand for zinc is desirable.  Thiolates also 
have less of a tendency to lower the Lewis acidity of a metal than alcoholates.  This feature is 
important since the Lewis acidity of the metal activates the carbonyl group towards addition.   
Specifically, the amino thiol 20b has been shown to provide high enantioselectivity in the 
addition of vinylzinc species to electron-poor aromatic aldehydes.46  However, lower ee’s (64-
74%) were found for aliphatic and aromatic aldehydes with electron-donating groups in the 
para- or ortho-positions (Scheme 1.23).  
 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn,Toluene, -65 oC
3. 20b (10 mol%)
4. PhCHO, -30 oC, 15 h
Ph
OH
S
NMe2
Et
SH
20b  
C4H9
OH
83%;
95% ee
C4H9
OH
75%;
63% ee
C4H9
OH
79%;
99% ee
OMe
OMe
C4H9
OH
63%;
74% ee
OH
66%;
99% ee
OH
TIPSO
O 67%;
92% ee
 
Scheme 1.23.  Scope of the alkenylzirconium/zinc addition using ligand 20b. 
 
Proline-based amino alcohols are another class of ligands that have been shown to 
provide satisfactory enantioselectivity in the hydrozirconation-transmetalation addition to 
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aldehydes.  We were able to determine that in the presence of 10-15 mol% of the proline- 
derived amino alcohol 21 the benzaldehyde-derived allylic alcohol was formed in 81% ee 
(Scheme 1.24).44  
 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn,Toluene, -65 oC
3. 21 (15 mol%)
4. PhCHO, -30 oC, 15 h
Ph
OH
S
N
Me
OH
Ph
Ph
21
81% ee
 
Scheme 1.24.  The alkenylzirconium/zinc addition to benzaldehyde using ligand 21. 
 
Thus, we decided that further modifications of these two classes of ligands were 
warranted with the hope of identifying a ligand that shows high asymmetric induction with a 
wide variety of aldehydes and alkynes. 
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1.2 Proline-Based Amino Alcohol Ligands 
1.2.1 Synthesis of Proline-Based Analogues 
Based on the promising preliminary data obtained with the proline-derived amino 
alcohol, substitution of the diphenyl moiety for smaller and larger substituents was further 
explored in hopes of increasing the enantioselectivity above the current maximum of 81% ee 
(Figure 1.6).  
 
N
Me
OH
R
R
R = H, Me. naphthyl 
Figure 1.6.  Modification of the diphenyl moiety of ligand 21 (R = Ph). 
This series of amino alcohols was accessed quite conveniently starting from L-proline 
(Scheme 1.25).  Conversion to the N-carbamate proline methylester 22 using ethyl chloroformate 
in the presence of potassium carbonate and MeOH proceeded in 90% yield.47  Double reduction 
of the carbamate and the methylester using LiAlH4 gave 23 in 72% yield.  Grignard addition of a 
variety of nucleophiles to the methylester 22 afforded the corresponding tertiary alcohols.  
Reduction of the carbamate with LiAlH4 gave the N-methylated amino alcohols 24, 21, and 25 in 
67-87% yield.   
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N
H
ClC(O)OCH2CH3
K2CO3, MeOH
N
O O
1. MeMgBr
2. LiAlH4, reflux
N
CH3
CO2H CO2Me
OH
CH3
CH3
L-Proline
22
24
1. PhMgBr
2. LiAlH4, reflux
1. 2-Naphthyl-MgBr
2. LiAlH4, reflux N
CH3
OH
Ph
Ph
N
CH3
OH
Nap
Nap
21
25
LiAlH4, reflux
N
CH3
OH
23
87%
75%
67%
72%
90%
 
Scheme 1.25.  Synthesis of analogues at the diphenyl moiety of ligand 21. 
 
Amino alcohols 21,23-25 were tested at 10 and 15 mol% loading (Table 1.1).  Ligand 21 
showed the most promise, providing alcohol 27 with 81% ee at 15 mol% loading (Entry 6). A 
possible rationale for the dramatic difference between ligands 23, 24, 21 and 25 is that the side 
chain substituents strongly influence the nature of the dimerization equilibria that lead to 
catalytically active species.  Ligands 23 and 24 might be too small to bias the facial selectivity in 
the alkenyl zinc addition to the aldehyde moiety; on the other hand, the naphthyl substituents on 
25 may also be too bulky to allow tight substrate binding in the transition state, resulting in lower 
facial selectivity.   
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Table 1.1.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 21 and 23-25. 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. L*; 1 h, -65 oC to -30 oC
4. PhCHO, -30 oC, 15 h
Ph
OH2726
 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector, bee given is the average of 2 runs. 
Entry Ligand (L*) 
Ligand loading  
(mol%) 
Yield (%) of 27 ee (%)a of 27 
1 23 10 79 17 
2 23 15 78 18 
3 24 10 85 17 
4 24 15 78 17 
5 21 10 73-77 40 b
6 21 15 74-76 81 b
7 25 10 81 20 
8 25 15 80 20 
 
Due to its relative promise, loading studies of ligand 21 from 5 to 50 mol% were 
performed.  The graph in Figure 1.7 demonstrates that 15 mol% loading is indeed the optimal 
loading for this ligand while lower and higher loadings show a decrease in ee of product 26.   
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Figure 1.7.  Loading effects of ligand 21 on the ee of allylic alcohol 27. 
 
N
R
OH
Ph
Ph
R = Et, Bn  
Figure 1.8.  Modification of substituents at amine site of ligand 21 (R = Me). 
 
Further modifications to proline ligand 21 were examined, targeting modifications at the 
amine site (Figure 1.8).  The synthesis of the analogues commenced with phenyl magnesium 
bromide addition to N-carbamate proline methylester 22 followed by hydrolysis of the ethyl 
carbamate with KOH to give 28 in 63% yield over 2 steps (Scheme 1.26).  Alkylation of the 
amine with either benzyl bromide or ethyl bromide in the presence of Hünig’s base resulted in 
the desired analogues 29 and 30 in 55% and 14% yield, respectively.  Analogously, methyl 
magnesium bromide addition to N-carbamate proline methyl ester 22 and subsequent hydrolysis 
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yielded 31 in 71% yield.  Alkylation of the secondary amine with benzyl bromide in the presence 
Hünig’s base afforded 32 in 59% yield.    
 
N CO2Me
CO2Et
1. PhMgBr
2. KOH, MeOH
63% over 2 steps
N
H
OH
Ph
Ph
EtBr, i-Pr2NEt
110 oC, 24 h
14%
N
OH
Ph
Ph
Et
1. MeMgBr
2. KOH, MeOH
    71% over 2 steps
N
OH
Me
Me
H
22 28 29
31
BnBr, i-Pr2NEt
110 oC, 6 h
59%
N
OH
Me
Me
Bn 32
BnBr, i-Pr2NEt
110 oC, 6 h
55%
N
OH
Ph
Ph
Bn 30
 
Scheme 1.26.  Synthesis of analogues at amine site of ligand 21. 
 
The analogues synthesized were tested at 10 and 15 mol% loading in the 
alkenylzirconocene/zinc addition process (Table 1.2).  Disappointingly, the enantioselectivity 
observed for 29, 30, and 32 was low in all cases (3-20%).  Based on this data, substitution at the 
amine is an important factor in determining enantioselectivity.  Methyl substitution seems to be 
ideal while larger alkyl groups (ethyl and benzyl) at this site decrease the enantioselectivity 
drastically.   
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Table 1.2.  Asymmetric additions of 26 to benzaldehyde in the presence ligands 29, 30, and 32. 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. L*; 1 h, -65 oC to -30 oC
4. PhCHO, -30 oC, 15 h
Ph
OH2726
 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector. 
Entry Ligand (L*) 
Ligand loading  
(mol%) 
Yield (%) of 27 ee (%)a of 27 
1 29 10 82 3 
2 29 15 83 13 
3 30 10 76 4 
4 30 15 78 6 
5 32 5 79 20 
6 32 10 78 4 
 
Proline-derived C2-symmetric bis-β-amino alcohol 33 has been reported by Chan et al. to 
catalyze enantioselective diethylzinc additions to aldehydes.48  The high enantioselectivity 
observed is attributed to the rigid and bulky nature of the ligand.  It was hoped that this sterically 
more demanding ligand would enhance enantioselectivity in our protocol.  C2-symmetrical bis-β-
amino alcohol was conveniently prepared starting from (S)-(+)-diphenyl-pyrrolidin-2-yl-
methanol 28 (Scheme 1.27).  The amine was reacted with phthaloyl dichloride in the presence of 
triethylamine to afford the diamide 33, followed by reduction of the amides using LiAlH4 to 
afford 34 in 62% yield over 2 steps.  Utilization of ligand 34 in the alkenyl zirconium/zinc 
addition protocol resulted in no enantiodifferentiation with an enantiomeric excess of only 2 % at 
5 mol% and 4% at 10 mol%.    
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N
H
OH
Ph
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Et3N, 60%
LiAlH4
62%
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O
N
N
OH
Ph
Ph
HO Ph
Ph
N
N
OH
Ph
Ph
HO Ph
Ph
28 33 34  
Scheme 1.27.  Synthesis of C2-symmetric bis-β-amino alcohol 34. 
 
Shibasaki et al. disclosed a strategy for the development of poly-coordinating ligands for 
the enantioselective dimethylzinc addition to ketoesters.49  This ligand strategy relies on the need 
for both Lewis acid activation of the substrate as well as Lewis base activation of the reagent to 
efficiently promote the reaction (Figure 1.9).  Through dual activation of nucleophilic 
dimethylzinc and a catalytic amount of i-PrOH, high enantioselectivities were afforded.  The 
multicenter approach was appealing and could possibly improve the enantioselectivity of 
alkenylzirconium-zinc addition reaction by providing an extra Lewis basic site.  
 
N
R'
O
O
Zn
Zn
R
O
R
Rs
RL
R
ZnR
Lewis
base
Lewis acid
 
Figure 1.9.  Multicenter approach in activation of substrate and reagent. 
 
Ligand 38 was synthesized as reported by Shibasaki et al.,  2,4-cis-4-hydroxy-D-proline 
was converted to the methylester in the presence of thionyl chloride and MeOH to afford 36, 
which was alkylated with benzyl bromide to give 37 in 62% yield over 2 steps.  Lastly, phenyl 
magnesium bromide addition to the methylester 37 resulted in the formation of 38 in 42% yield.  
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Scheme 1.28.  Synthesis of ligand 38. 
 
The multicentered approach with ligand 38 did not show useful levels of 
enantioselectivity under our reaction conditions (Table 1.3).   
 
Table 1.3.  Asymmetric additions of 26 to benzaldehyde in the presence of ligand 38. 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. 38 (mol%); 1 h, -65 oC to -30 oC
4. PhCHO, -30 oC, 15 h
Ph
OH2726
 
Entry Ligand 
Ligand loading  
(mol%) 
Yield (%) of 27 ee (%)a of 27 
1 38 10 78 9 
2 38 20 85 21 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector. 
 
In the proline-derived scaffold, ligand 21 shows the highest enantioselectivity.  The 
proposed transition state model for this reaction using ligand 21 is shown below (Figure 1.10).  
All analogues synthesized using the proline scaffold afforded a drastic decrease in 
enantioselectivity.  Both the diphenyl moiety and the methyl-substituted amine are vital 
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components of this ligand and any manipulation of these moieties leads to almost no 
enantiodifferentiation and results in low enantioselectivity.   
 
N
O
ZnO Ph
Ph
Zn
Ph
C4H9
H
H
H
 
Figure 1.10.  Possible transition state model for the proline-derived amino alcohol ligand 21 
catalyzed alkenyl zirconocene/zinc addition to benzaldehyde. 
 
1.2.2 Detemination of Non-linear Effect with Ligand 21 
The use of ligand 21 resulted in the highest enantioselectivity of 81% ee at 15 mol% 
loading and thus this ligand was used in the ensuing mechanistic investigation.  In order to gain 
more information about the aggregation state of ligand 21, a study of non-linear effects was 
conducted.  Using the optimal loading of 15 mol%, the reaction with 1-hexyne and benzaldehyde 
was studied while varying the %ee of the ligand.  Each reaction was repeated 2 times and the 
data point shown is the average of the runs.  The ee of the resulting alcohol 27 was measured by 
chiral HPLC50 and plotted against the ligand ee%.   
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Figure 1.11.  Non-linear effect for ligand 21 at 15 mol% loading in the formation of allylic 
alcohol 27. 
 
When the ee of the resulting allylic alcohol was plotted as a function of the %ee of ligand 
21, a linear decrease from 81% to 24% ee of product resulted at 100% to 50% ligand ee (Figure 
1.11).  At 35% ligand ee, a dramatic reversal of enantioselectivity, now favoring the opposite 
enantiomer of the allylic alcohol product, was seen.  This reversal of selectivity diminished with 
20% ligand ee.   
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Figure 1.12.  Formation of homo- and heterochiral metal-ligand complexes that are in 
equilibrium with the catalytically active monomeric complex in the presence of ligand 21.  
 
We interpret this unusual dependence on chiral loading and the switch in the product 
configuration by the participation of both monomeric and aggregated metal-ligand species in the 
catalytic cycle (Figure 1.12).  This complex mechanism could result from the presence of Lewis-
acidic zirconocene coordinating to the alcohol and perturbing the dynamic equilibria of 
aggregates that are formed in solution.  This abnormal behavior is unique for ligand 21 and quite 
in contrast to the non-linear studies performed by Seth Ribe on the methyl amino thiol ligand 20a 
(Figure 1.13).51   
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Figure 1.13.  Positive non-linear effect for ligand 20a at 10 mol% loading in the formation of 
allylic alcohol 27.
 
In the presence of ligand 20a, a positive non-linear effect was observed in agreement 
with Kagan’s ML2 model (Figure 1.14).  This behaviour is indicative of a fast ligand exchange at 
the metal center of a reactive species bearing two chiral ligands.  We postulate that with ligand 
20a, zirconocene byproducts do not affect the aggregates that are formed due to the high affinity 
that sulfur has for zinc.45  Based on the strong asymmetric amplification effect it is reasonable to 
assume that the heterochiral dimer is more stable than the homochiral dimer. The instability of 
the homochiral dimer results in its rapid dissociation into monomeric species, which then take 
part in the catalytic cycle.  Because the homochiral dimer is composed of a single enantiomer of 
the ligand, an asymmetric amplification is observed.   
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Figure 1.14.  Formation of homo- and heterochiral metal-ligand complexes that are in 
equilibrium with the catalytically active monomeric complex in the presence of ligand 20a. 
 
In comparison, the aminoalcohol ligand 21 is inferior to the sulfur containing ligands 20a 
and 20b.  Much of the enhancement of the chiral induction appears to be an effect of the 
presence of a sulfur ligand, and therefore our next avenue of exploration was to convert the 
proline-based amino alcohols into amino thiols in the hope of improving the enantioselectivity of 
the alkenylzinc addition process and decrease chiral ligand loading. 
1.2.3 Synthesis of Thiol Analogues of Proline-based Amino Alcohols 
Amino thiol 42 was synthesized from the common intermediate 22, prepared as part of 
the initial series of proline-based amino alcohols.  The methyl ester 22 was reduced to the 
corresponding alcohol 39 in 78% yield using LiAlH4.  The alcohol was then converted to tosylate 
40 in 52% yield and subsequent displacement with potassium thioacetate furnished thioacetate 
41 in 62% yield.  This reaction was followed by a low yielding double reduction of the acetate as 
well as the carbamate to provide thiol 42.  Using ligand 42, the addition of hexenylzinc to 
benzaldehyde at a loading of 10 mol% gave product of 83% ee; at 15 mol% ligand loading, 
product of 84% ee was obtained.  This was a significant improvement over the enantioselectivity 
(17% ee and 18% ee) observed with the corresponding amino alcohol analogue 23.  
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Scheme 1.29.  Synthesis of ligand 42. 
 
 Encouraged by these results, transformation of diphenylamino alcohol 21 into the 
corresponding thiol 45a was investigated.  Compound 45a was previously synthesized from 21 
by Gibson et al. using Lawesson’s reagent 43 by heating the reaction mixture at reflux for 7 min 
(Scheme 1.30).52  Disappointingly, in our hands these conditions resulted in decomposition of 
the starting material.  
 
N
Me Toluene, reflux, 7 min
decomposition
P S
S P
S
S
H3CO OCH3
Ph
OH
Ph
21
43
 
Scheme 1.30.  Conversion of alcohol 21 to corresponding thioacetate using Lawesson’s reagent.   
 
 An alternative route was also proposed whereby in the presence of zinc iodide and 
thioacetic acid the tertiary alcohol 44 is converted to the corresponding thioacetate. Initially, this 
reaction at room temperature cleanly afforded the acyclic compound 45b as the only product.  
Cooling the reaction to 0 °C for 5 h, afforded the desired product 45a, acyclic product 45b, and 
starting material.  To ensure complete conversion, the reaction mixture was stirred for 24 h at 0 
°C to give 30% of the desired product 45a, 66% of the acyclic product 45b, and a trace of 
starting material.  Further attempts to inhibit the formation of the acyclic product 45b were not 
pursued.  Disappointingly, application of ligand 46 in the alkenylzirconocene/zinc addition led to 
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a low enantioselectivity of 18% ee at 10 mol% loading.  It is unclear at this time what causes the 
dismal enantioselectivity shown by the tertiary thiol ligand 46.   
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Scheme 1.31.  Conversion of alcohol 44 to thioacetate to 45 using an activation/displacement 
protocol.   
1.3 Thiol Benzylamines 
1.3.1 Preparation of 2-(1-dimethylamino-2-methylpropyl)benzenethiol 
SH
R
N
62: R = i-Pr
71: R = i-Bu
SH
Et
N
20b
 
 
Figure 1.15.  Modification to ethyl-substituted aminothiol 20b. 
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After further examination of the data reported by Seth Ribe for the enantioselectivity 
obtained using methyl-(20a) and ethyl-substituted (20b) aminothiols, it was postulated that 
increasing the steric bulk of the R group from an ethyl to an isopropyl substituent would increase 
the enantioselectivity beyond the current maximum of 95% ee (Figure 1.15).  In attempts to 
access this isopropyl amino thiol ligand, we felt that installation of the sulfur moiety at a late 
stage would be beneficial due to the chemical instability of free thiols. Introduction of the sulfur 
moiety would be performed analogously to the synthesis of the methyl- and ethylaminothiol 
ligands (Scheme 1.32).  We felt installation of bromine at the ortho-position would facilitate the 
introduction of the thiol.  Although there are no enantiomerically pure building blocks for this 
synthesis, we were confident that a resolution at some point along the route would be feasible.   
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         83%
H
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Scheme 1.32.  Synthesis of  2-(1-dimethylamino-2-methylpropyl)benzenethiol (52).  
 
Addition of ortho-bromobenzaldehyde to diphenylphosphinamide in the presence of 
TiCl4 and Et3N resulted in an 83% yield of imine 48.  Isopropyl magnesium chloride addition to 
the imine resulted in a 79% yield of 49.  Treatment of 49 with 20% aq. HCl at reflux furnished 
the free amine 50 in 83% yield.  Eschweiler-Clarke methylation of the resulting amine provided 
the dimethylated product 51 in 55% yield.  Finally, halogen-metal exchange using t-BuLi, 
followed by reaction of the aryllithio species with elemental sulfur was expected to furnish the 
ortho-substituted thiol 52.  Unfortunately, this last step proved to be very problematic.  Varying 
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the lithiating agent and also varying reaction times for the halogen-metal exchange still afforded 
no product. This could be due to the added steric bulk of the isopropyl group compared to the 
ethyl and methyl analogues. At this point, an alternate method for conversion of the bromine to 
the thiol was required.  A possible solution was through the use of the air-stable palladium 
catalyst 53, introduced by Li (Scheme 1.33).53
 
POPd 53
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            66%
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Scheme 1.33.  Synthesis of thioethers using POPd (53). 
 
It has been shown that in the presence of a catalytic amount of POPd 53, an aryl halide 
can be coupled to thiophenol to give the thioether in 66% yield.   However, in our substrate no 
reaction resulted (Scheme 1.34).  This lack of reactivity could be partially due to the added steric 
bulk present in 51.  Thus, coupling of the thiol at the ortho-position might present a significant 
challenge.   
Br
NMe2
51
SH
POPd (2.8 mol%)
     Na-O-t-Bu
  Toluene, 110 oC
No Reaction
 
Scheme 1.34.  Conversion of aryl bromide 51 to thioether using POPd 53. 
 
The route was thus modified in order to install the thiol functionality at an earlier stage 
(Scheme 1.35).  The most convenient solution was to start from thiosalicylic acid followed by 
protection of the thiol.  This enabled further elaboration of the ligand while not affecting the thiol 
group.   
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Thiosalicylic acid was treated with LiAlH4 to afford the reduced product 55 in 68% 
yield.82  Protection of thiol 55 with benzylbromide and NaOH gave 56 in 73% yield.  Oxidation 
of the alcohol with barium manganate furnished aldehyde 57 in 86% yield. This aldehyde was 
then reacted with diphenylphosphinamide in the presence of TiCl4 and Et3N to afford imine 58 in 
80% yield.  Isopropyl magnesium chloride addition to the imine afforded the alkylated 59 in 78% 
yield.  Treatment of 59 with 20% aq. HCl at reflux furnished the free amine 60.54  Eschweiler-
Clarke methylation of the amine afforded the dimethylated product 61 in 54% yield over 2 steps.  
Deprotection of the benzyl group with Na/NH3 gave isopropyl aminothiol ligand 62 in 36% 
yield.55  Low yields in the deprotection of 61 were obtained due to the instability of the free thiol 
product 62 upon exposure to air.  After workup, crude NMR analysis revealed <10% disulfide 
formation.  But after purification by column chromatography on SiO2, the amount of disulfide 
formed was increased.  Thus, exposure to air facilitates formation of disulfide 63. 
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Scheme 1.35.  Revised synthesis of  2-(1-dimethylamino-2-methylpropyl)benzenethiol 62. 
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Due to the instability of the free thiol, a more stable analogue was desired.  
Transformation of 62 to the acetate 64 was carried out using acetyl chloride and triethylamine to 
give 64 in 56% yield (Scheme 1.36).  With a viable route to 62 and 64 in hand, separation of 
racemic intermediates was necessary.    
SH
NMe2
AcCl, Et3N
      56%
SAc
NMe2
62 64  
Scheme 1.36.  Conversion of thiol 62 to thioacetate 64. 
 Resolution of racemic amine 60 was explored first.  (R,S)-Tartaric acid, camphorsulfonic 
acid, and (S)-mandelic acid were used as potential resolving agents in the presence of different 
solvents. Recrystallization from CHCl3, EtOH, and 20% Et2O/EtOH was attempted.  However, 
the resolution of the amine failed while a solvent with the ideal properties for resolution was not 
found.  The solvents and salts examined did not differentiate between the enantiomers in order 
for a resolution to be viable.  Next, an enzymatic resolution using Candida antarctica lipase was 
tried.  It has been shown by the group of Wong that primary amines can be resolved quite easily 
using Candida antarctica lipase and dibenzylcarbonate (Scheme 1.37).56  However, the 
resolution via this route was unsuccessful since no enzymatic protection of either enantiomer of 
amine was observed.   
NH2
Candida antarctica lipase
mol. sieves, dibenzyl carbonate
HN O
Bn
O
+
NH2
33% 99% ee  
Scheme 1.37.  Enzymatic resolution of amines. 
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Another technique for separation of enantiomers involves using chiral HPLC.  Using both 
OD and AD-H analytical columns,57 intermediates 59-61 were tested for adequate separation.  It 
was found that intermediate 59 could be separated to baseline resolution using 30% i-
propanol/hexanes at a flow rate of 1 mL/min (Figure 1.16) on the Chiralcel AD-H analytical 
column.  
 
 
Figure 1.16.  HPLC chromatogram of 59.  Rt enantiomer A = 7.01 min and Rt enantiomer B = 
11.77 min. 
  
Separation of racemic-59 on an AD-H Chiralpack Semi-Prep column (2 cm x 25 cm) at a 
flow rate of 10 mL/min with 30% i-propanol/hexanes afforded each enantiomer in >99% ee.58  
The pure enantiomers were then further elaborated to give optically pure 2-(1-dimethylamino-2-
methylpropyl)benzenethiols, (R)- and (S)-62.  The assignment of (R)- and (S)- to this new ligand 
is based on the data for the ethyl analogue 20.  In the case of 20, the (R)-configuration of the 
ligand gave the (S)-configuration of allylic alcohol 27.  Based on the major enantiomer of allylic 
alcohol 27 formed, it was therefore possible to assign the configuration of the ligand (Scheme 
1.38). 
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Scheme 1.38.  Assigment of configuration to enantiomers of 62. 
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Table 1.4.  Asymmetric additions of 26 to benzaldehyde in the presence ligands 62-64. 
Entry Ligand (L*) 
Ligand Loading 
(mol%) 
63:62b
Yield (%) of 
27 
ee (%)a of 27 
1 (S)-62 5 1:4 78 56 
2 (S)-62 10 1:4 74 66 
3 (S)-62b 10 1:10 80 62 
4 (R)-62 5 1:7 70 68 
5 (R)-62 10 1:7 76 96 
6 (R)-62 10 1:15 79 99 
7 (R)-62b 5 1:10 82 87 
8 (R)-62b 10 1:10 80 97 
9 (S)-63 5 1:0 45 26 
10 (S)-63 10 1:0 65 27 
11 (R)-64 5 - 75 11 
12 (R)-64 10 - 79 18 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, 1 mL/min using i-PrOH/hexanes (1:99)) with a PL-
ELS 1000 detector, bligand was used crude, before chromatographic purification, cratio of free thiol to disulfide by 
NMR was determined by measuring doublet at 3.82 ppm (63) and 3.50 ppm (62). 
 
The preliminary data with ligand 62 in the alkenyl zirconocene/zinc addition to aldehydes 
is shown in Table 1.4.  At a ligand loading of 10 mol%, (S)-62 shows enantioselectivities 
between 62-66% for the allylic alcohol (R)-27 (Entry 2, 3).  This is in sharp contrast to 
enantioselectivities between 96-99% observed for (R)-62 (Entry 5,6,8).  This discrepancy is quite 
puzzling since both enantiomers should show similar enantioselectivities in forming allylic 
alcohol 19.  It is unclear at this time if the enantioselectivity of the reaction is perturbed by the 
presence of disulfide.  The disulfide (R)-63 was also tested because of its stability compared to 
the free thiol but showed a low enantioselectivity of ~27% ee (Entry 9, 10).  The thioacetate (R)-
64 showed low enantioselectivities of 11 and 18% ee (Entry 11, 12).  
 
After preliminary data with ligand 62 were obtained, Wipf et al. reported on the inherent 
discrepancy between enantiomeric ratios formulated from ELSD and UV detectors.59  By 
comparing values for enantiomeric excess of a mixture of standards, the UV detector in all cases 
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showed more accurate results.  The ELSD grossly exaggerated the enantiomeric excess of the 
standards.  This difference can potentially be derived from the non-linear response of the ELS 
detector.  
 
In light of this inconsistency, the reactions with isopropyl thiol benzylamine 62 were 
repeated and the enantiomeric excess was determined using both ELSD and UV detectors.  
Disappointingly, the enantiomeric excesses were inflated when ELSD was used as the method of 
detection.  The enantiomeric excess detected by the UV was much lower, 31% ee using (S)-62 
and 84% ee using (R)-62 (Table 1.5).  The divergence in enantioenrichment of product between 
(R)- and (S)-62 are still apparent even with UV detection.  At this time, no clear reason for this 
effect can be given.  The discrepancy can be as a result of varying amounts of disulfide in the 
ligand mixture, which can possibly perturb the asymmetric system.   
 
Table 1.5.  Chiral HPLC analysis of 27 with tandem detection by ELSD and UV. 
Entry Ligand 
Ligand Loading  
(mol%) 
Yield (%) of 
27 
ee (%)a of 27 
ELSD 
ee (%)a of 27 
UV 
1 (S)-62 10 82 76 31 
2 (R)-62 10 80 99 84 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector followed in tandem with PL-ELS 1000 detector. The UV detector was 
connected to the ELSD in a tandem manner.   
 
1.3.2 Preparation of 2-(1-Dimethylamino-2-methylbutyl)benzenethiol 
An isobutyl analogue was synthesized analogously to the isopropyl analogue, 70.  
Aldehyde 57 was improved by employing a copper mediated coupling between ortho-
bromobenzaldehyde and benzylmercaptan to afford 57 in 71% yield.60  This aldehyde was then 
reacted with diphenylphosphinamide in the presence of TiCl4 and Et3N to afford imine 58 in 
80% yield.  Isobutyl magnesium chloride addition to the imine afforded the alkylated product 66 
in 72% yield.  Treatment of 66 with 20% aq. HCl at reflux furnished the free amine 67.61  
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Eschweiler-Clarke methylation of the amine afforded the dimethylated product 68 in 52% yield 
over 2 steps. 
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Scheme 1.39.  Synthesis of benzylamine 68. 
 
Using both OD and AD-H analytical columns, intermediates 66-68 were tested for 
adequate separation.  It was found that intermediate 66 could be separated to baseline resolution 
using 5% i-propanol/hexanes at a flow rate of 1 mL/min (Figure 10) on the Chiralcel OD 
analytical column.  However, transferring these conditions to the semi-preparative AD column 
resulted in no baseline separation. Cbz-protected amine was examined as an alternative 
intermediate to be examined on HPLC.  Inital protection of amine 67 using benzylchlorofomate 
and K2CO3 resulted in 69 in 65% yield (Scheme 1.40).  It was found that intermediate 69 could 
be separated to baseline separation using 5% i-PrOH/hexanes at a flow rate of 1 mL/min on the 
Chiralcel OD analytical column.  Gratifyingly, separation of racemic-69 on an AD-H Chiralpack 
Semi-Prep column (2 cm x 25 cm) at a flow rate of 10 mL/min with 5% i-propanol/hexanes 
afforded each enantiomer in >92% ee.62  
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Scheme 1.40.  Synthesis and separation of Cbz-intermediate 69. 
 
 The pure enantiomers were then further elaborated to give enantiomerically enriched 2-
(1-dimethylamino-3-methylbutyl)-benzenethiol, (R)- and (S)-71 (Scheme 1.41).  The 
configuration of ligand 71 was assigned based on the rationale previously used to assign the 
configuration of ligand 62 (Scheme 1.38).      
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Scheme 1.41.  Synthesis of thiol benzylamine (S)-71. 
 
The preliminary data obtained with both enantiomers of ligand 71 in the alkenyl 
zirconocene/zinc addition to aldehydes is shown in Table 1.6.  At a ligand loading of 10 mol%, 
(S)-71 and (R)-71 show ee’s between 61-69% for the formation of allylic alcohol 27 (Entry 2, 3).   
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 Table 1.6.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 71. 
Entry Ligand 
Ligand Loading 
(mol%) 
Yield (%) of 27 ee (%)a of 27 
1 (S)-71 5 81 44 
2 (S)-71 10 78 61 
3 (R)-71 10 84 69 
4 (R)-71 15 80 70 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes 
(1:99)) with a Dynamax UV-1 absorbance detector. 
 
Unfortunately, increasing the steric bulk of the R group to isopropyl and isobutyl showed 
no further increase in enantioselectivity.  The proposed transition state model for using this 
ligand scaffold is shown in Figure 1.17.  The increase in added steric bulk of the R group must 
inhibit to some degree the formation of this transition state.  This could possibly arise from steric 
crowding of the R group with the amine substituents and thus disrupting the rigidity of the 
transition state.   
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Figure 1.17.  Possible transition state model for the thiol benzylamine catalyzed alkenyl 
zirconocene/zinc addition to benzaldehyde. 
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1.4 Alternative Ligand Scaffolds 
1.4.1 Alternate Ligand Survey 
Alternate ligands surveyed in the alkenylzirconocene/zinc addition to aldehydes are 
shown in Tables 1.7, 1.8, and 1.9.  Norephedrine-based amino alcohols and thiocarboxylates 
ligands have shown promise in diethylzinc addition to aldehydes with ee’s of up to 99%.63  The 
data shown below indicates little selectivity with this ligand scaffold although an increase in 
enantioselectivity was observed between the alcohol 72 and thioacetate 73 (entry 1).  This slight 
increase might again be due to the higher affinity of zinc for thiolates as compared to the 
corresponding alcoholates.  Anderson et al. have demonstrated the importance of the substituents 
on nitrogen in chiral amino thiol ligands for the asymmetric addition of diethylzinc to aromatic 
aldehydes.64  These valine-based ligands, 77-79, were tested in our methodology and showed 
very little selectivity (entry 3).  Aziridine-based β-amino alcohols also have proven to be 
successful in the enantioselective addition of diethylzinc to aromatic aldehydes.65  Ligands of 
this type also posses the diphenylalcohol moiety that was so effective in the proline-based 
ligands.  However, as shown below, no significant enantioselectivity in the alkenyl 
zirconocene/zinc addition to benzaldehyde was observed with ligands 83, 85, and 86 (entry 4).  
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Table 1.7.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 72-86.  
Entry Ligand Ligand Loading (mol%) Yield (%) of 27 
 
ee (%)a of 27 
 
72, R = OH; 10 85 19 
1 
 
N R
Me Ph
 
73, R = SAc; 15 81 46 
2 
 
N OH
Me Ph
O  
74; 10 80 20 
77, R = OH; 10 74 10 
78, R = SAc; 15 75 16 3 
 
N RPh
Me  
79, R = SH; 15 80 17 
83, R = Trt; 15 85 8 
85, R = Bn; 15 74 12 4 
N
R
Ph
OH
Ph
 86, R = Dpm; 10 80 48 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector. 
 
In 2003, Chan et al. reported on the alkenylations of aldehydes using aminonaphthol 87.  
This ligand was easily prepared via a one step procedure and used in Oppolzers’ hydroboration-
transmetalation to zinc followed by addition to aldehyde that resulted in high ee’s of up to 
99%.30  This methodology is quite similar to ours and thus this ligand was considered as a viable 
candidate for further exploration. Unfortunately, these ligands did not provide significant 
stereoinduction in our methodology (Table 1.8, entries 1 and 2).  Possibly, B-Zn and Zr-Zn 
allylic alcohol formations occur via different mechanisms and the presence of zirconocene 
byproducts plays a crucial role in the overall control of the catalytic asymmetric process.  A 
binaphthyl backbone was also considered as a viable option since ligands of this type have 
shown moderated enantioselectivity in asymmetric alkenylzinc addition to aldehydes.31  
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Unfortunately, racemic 27 was afforded with ligand 92 (entry 3).  Dahmen has used 
paracyclophanes-based ketimine ligands in asymmetric alkylzinc additions as well as alkenylzinc 
additions.29  In our reaction manifold, a low enantioselectivity of 6% was observed with ligand 
96 (entry 4). 
 
Table 1.8.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 87-89, 92, 
and 96. 
Entry Ligand 
Ligand loading 
(mol%) 
Yield (%) of 27 ee (%)a of 27 
87, R = OH; 15 76 2 
1 R
Ph N Ph
 88, R = SH; 15 81 28 
2 
 
OH
Ph
H
N Ph
 
89; 15 79 17 
3 
 
OH
N
O
 
92; 10 76 1 
4 
 
HON
 
96; 10 60 6 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)) 
with a Dynamax UV-1 absorbance detector. 
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Oxazolines have shown good stereochemical control properties in metal-mediated 
catalysis.66  Ligands of this type, 97 and 98, also contain a second donor group in the form of a 
thiophene.  Incorporation of sulfur via a thiophene moiety might induce some extra rigidity 
which may have positive effects on the enantioselective addition of alkenylzinc reagents.  Ligand 
97 proved to be slightly more enantioselective in the alkenyl zirconocene/zinc addition to 
benzaldehyde than ligand 98, but neither showed the desired level of enantioselectivity (Table 
1.9, entries 1 and 2).  
 
Table 1.9.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 97 and 98. 
 
Entry Ligand 
Ligand Loading 
(mol%) 
Yield (%) of 27 
 
ee (%)a of 27 
 
1 
 
S
N
O Ph
Me  
97; 15 83 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes(1:99)) 
with a Dynamax UV-1 absorbance detector. 
 
1.4.2 Synthesis and Evaluation of β−Amino Thiol Ligands 
21 
2 
 
S
N
O
 
98; 15 79 7 
In an effort to investigate alternate ligand scaffolds, conformationally relatively restricted 
compounds containing the amino and thiol moieties in a 1,2-relationship were considered. The 
desired analogues were synthesized starting from (L)-valine and (S)-t-leucinol (Scheme 1.42).  
(L)-Valine was reduced using Meyer’s reduction protocol to afford (L)-valinol 100a in 77% 
yield.67  Dialkylation of the amine employing 1,4-dibromobutane and 1,5-dibromopentane in the 
presence of K2CO3 resulted in the formation of 101a and 101b in 86% and 76% yield, 
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respectively.  Conversion of the hydroxy moiety to the thioacetate utilizing Mitsunobu reaction 
conditions followed by LiAlH4 reduction afforded the desired ligands 103a and 103b.68  
Analogously, ligand 103c was synthesized starting from (S)-t-leucinol in the manner described 
above.   
 
H2N OH
O
H2N OH
NaBH4, I2
KOH
Br(CH3)4Br or Br(CH3)5Br
PPh3, DIAD LiAlH4N OH
n
101a, R = H, n = 1; 86%
101b, R = H, n = 2; 76%
101c, R = Me, n = 2; 75%
N SAc
n
N SH
n
100a, R = H; 77%
100b, R = Me
R R
R R R
99a, R = H
103a, R = H, n = 1; 72%
103b, R = H, n = 2; 63%
103c, R = Me, n = 2; 73%
K2CO3, CH3CN
102a, R = H, n = 1; 66%
102b, R = H, n = 2; 56%
102c, R = Me, n = 2; 63%
HSAc
 
 
Scheme 1.42.  Synthesis of β-amino alcohol and thiol ligands. 
 
The β-amino thiol ligands 103a, 103b, and 103c were screened in the alkenyl 
zirconium/zinc addition.  Initial results showed good yields (80-81%) and moderate 
enantioselectivities (71-77%) in the presence of ligands 103b and 103c at 15 mol% ligand 
loading (Table 1.10).  Thiol 103a was rather ineffective (22% ee). Not unexpectedly, the 
corresponding β-amino alcohol ligands also showed a dramatic decrease in enantioselectivity (2-
3%).  The latter effect can be attributed to the characteristics of sulfur atoms and the presence of 
at least two metal complexes as previously mentioned.   
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Table 1.10.  Asymmetric addition of 26 to benzaldehyde in the presence of ligands 103a-103c. 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. L*; 1 h, -65 oC to -30 oC
4. PhCHO, -30 oC, 15 h
Ph
OH2726
 
Entry Ligand (L*) 
Ligand Loading 
(mol%) 
Yield (%) ee (%)a of 27 
1 103a 10 69 22 
2 103b 10 75 64 
3 103b 15 82 77 
4 103b 20 79 76 
5 103c 10 75 61 
6 103c 15 81 71 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)). 
 
Our preliminary results with these rather simple β−amino thiol ligands prompted a further 
exploration of the β−amino alcohol scaffold.  In the hope of increasing the enantioselectivity to 
appreciable levels, steric bulk was introduced at the α−carbon next to the thiol.  Ligands with 
this specific substitution pattern have previously been reported by Yang et al. for the 
alkenylboron/zinc addition to aldehydes.32  High enantioselectivity was observed by Yang when 
employing β−amino alcohol 112.   
β−Amino alcohol 112 was synthesized and examined in the alkenylzirconocene/zinc 
addition protocol.  The amino thiol ligand was synthesized from readily available (L)-valine 
(Scheme 1.43).  Using benzyl chloride in the presence of NaOH gave the N,N-dibenzylamino 
benzyl ester 104 in 79% yield.  Reduction of the benzyl ester using LiAlH4 afforded the resulting 
alcohol, which was further oxidized to the corresponding aldehyde 106 using Swern oxidation 
conditions in 96% yield.  Isopropylmagnesium bromide addition to the aldehyde resulted in the 
bis-isopropyl amino alcohol 107 with high diastereoselectivity in 27% yield.  A major byproduct 
of the Grignard reaction was the reduced alcohol 108.  Cleavage of the benzyl group employing 
hydrogenolysis conditions using Pd(OH)2 afforded the free amine 109 in 97% yield.  Alkylation 
of the amine using 1,4-dibrombutane resulted in the formation of the pyrrolidine alcohol 110 in 
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75% yield.  In order to install the thiolacetate, the alcohol 110 was converted to the mesylate 
followed by displacement with thiolacetic acid.  This process occurs via initial displacement of 
the mesylate by the tertiary amine to form the intermediate aziridine.  The aziridine undergoes 
facile ring opening in the presence of thiolacetate to give the corresponding thiolacetate.  Finally, 
LiAlH4 reduction results in the amino thiol ligand 112 in 96% yield. 
 
H2N OH
O BnBr, K2CO3
Bn2N OBn
O
Bn2N OH
N OH
N SH
79% 84%
Bn2N OH
41%
+
Bn2N OH
1.1 1.0:
Pd(OH)2, H2
97% H2N OH
1,4-dibromobutane
K2CO3
75%
N SAc 96%
99a 104 105
107 108
109 110
111 112
Bn2N O
(COCl)2, DMSO
Et3N
96%(crude) 106
H
MsCl, Et3N
AcSH, Et3N
50%
i-PrMgCl
LiAlH4
LiAlH4
 
Scheme 1.43.  Synthesis of β−amino alcohol 112. 
 
 In our standard reaction, β−amino thiol 112 showed the highest enantioselectivity at 94% 
ee at a ligand loading of 10 mol% (Table 1.11, entry 6). A high enantioselectivity for the 
formation of 27 could be retained even at 2.5 mol% loading. In comparison to the corresponding 
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amino alcohol ligand 110, the amino thioacetate and amino thiol ligands both showed higher 
enantioselectivities (entries 1,2, and 6).  
 
Table 1.11.  Asymmetric additions of 26 to benzaldehyde in the presence of ligands 110-112. 
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. L*; 1 h, -65 oC to -30 oC
4. PhCHO, -30 oC, 15 h
Ph
OH2726
 
Entry Ligand (L*) 
Loading Loading 
(mol%) 
Yield (%) ee (%)a of 27 
1 110 10 81 7 
2 111 10 77 84 
3 112 1 75 66 
4 112 2.5 82 90 
5 112 5 79 93 
6 112 10 81 94 
7 112 15 76 94 
aee’s were determined by chiral HPLC analysis (Chiralcel OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)). 
 
The scope of the alkenylzirconocen/zinc addition process in the presence of the β-
aminothiol ligand 112 is further illustrated in Table 1.12.  It was observed that amino thiol 112 
catalyzed reactions resulted in moderate enantioselectivity for aliphatic aldehydes (73-79% ee, 
entries 1 and 8).  A decrease in enantioselectivity was found for the electron rich p-anisaldehyde 
(entry 3). Attempts at optimizing this reaction resulted in no appreciable increase in 
enantioselectivity (entries 4-6).  The reaction scope was further investigated using internal 
alkynes. Promising results were obtained in the reaction of 3-hexyne with benzaldehyde, which 
resulted in an 89% yield and 90% ee for the corresponding allylic alcohol 118 (entry 10).  The 
analogous reaction with p-anisaldehyde resulted in 87% ee, although at a lower yield of 63% 
(entry 12).  Utilization of a silyl ester functionalized alkyne provided the substituted allylic 
alcohol 122 in 72% yield with an enantioselectivity of 71% (entry 13). 
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Table 1.12.  Asymmetric addition in the presence of ligand 112. 
R'
R
1. Cp2Zr(H)Cl, CH2Cl2, rt.
2. Me2Zn, Toluene, -65 oC
3. 112; 1 h, -65 oC to -30 oC
4. R"CHO, -30 oC, 15 h
R" R"
OH
114
R'
113  
Entry 
Alkyne 
(R, R’) 
Aldehyde 
(R”) 
Ligand 
Loading 
(mol%) 
Product 
Yield 
(%) 
ee (%)e 
of 114 
1 n-C4H9, H Ph CH2CH2 5 115 78 79 
2 n-C4H9, H (p-OMe)C6H4 5 116 72 36 
3 n-C4H9, H (p-OMe)C6H4 10 116 65 42 
4a n-C4H9, H (p-OMe)C6H4 10 116 60 14 
5b n-C4H9, H (p-OMe)C6H4 10 116 62 5 
6c n-C4H9, H (p-OMe)C6H4 10 116 15 10 
7 n-C4H9, H C6H11 5 117 65 72f
8 n-C4H9, H C6H11 10 117 70 73f
9d n-C4H9, H C6H11 10 117 23 24f
10 CH3CH2, CH3CH2 Ph 10 118 89 90g
11 CH3CH2, CH3CH2 Ph CH2CH2 10 119 65 53g
12 CH3CH2, CH3CH2 (p-OMe)C6H4 10 120 63 87g
13 TIPSOC(O)CH2CH2, H Ph 10 122 72 71h
ano premixing of ligand, breaction mixture was stirred at –50 °C for 15 h, creaction mixture was stirred for 1 h, 
dligand was premixed at 0 °C and stirred at 0 °C for 15 h, eee’s were determined by chiral HPLC analysis (Chiralcel 
OD, flow rate 1 mL/min using i-PrOH/hexanes (1:99)), fee’s were determined by 1H NMR analysis of the 
derivatized product using Mosher’s ester, gee’s were determined by chiral HPLC analysis (Chiralcel AD-H, flow 
rate 1 mL/min using i-PrOH/hexanes (1:99)), hthe corresponding allylic alcohol was treated with LiAlH4 followed 
by ee determination of the resulting diol by chiral HPLC analysis (Chiralcel AD-H, flow rate 1 mL/min using i-
PrOH/hexanes (5:95)). 
 
The proposed transition state with ligand 112 is shown below in Figure 1.18.  While 
simple β–amino thiol ligands, 103b and 103c, displayed mediocre enantioselectivity, the bis-
isopropyl β-amino thiol ligand afforded the best enantioselectivity.  This is also the first ligand 
that has shown promising results in both our hydrozirconation/transmetalation protocol as well as 
the reported hydroboration/transmetalation protocol.   
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NS
i-Pr
Zn
O
H
Ph
i-Pr
Zn
C4H9  
Figure 1.18.  Possible transition state model for the β–amino thiol 112 catalyzed alkenyl 
zirconocene/zinc addition to benzaldehyde. 
1.5 Conclusions 
Among the ligands surveyed in the alkenyl zirconium-zinc addition to aldehydes, proline-
derived 21, thiol benzylamine 20b, and β-amino thiol 112 show the most promise (Figure 1.19).  
The amino thiol ligand 20b has demonstrated a positive NLE and remains the optimal ligand 
investigated thus far.  The amino alcohol ligand 21 shows an unusual dependence on ligand ee% 
and loading, but it offers an attractive alternative due to its ease of synthesis and inherent 
stability.  Ligand 112 represents a new β-amino thiol scaffold that was found to be effective in 
the alkenylzirconium/zinc addition process. In comparison to thiol benzylamine 20b, β-amino 
thiol 112 shows comparable enantioselectivity at a lower ligand loading of 5 mol%.  Proline-
based 21 and β-amino thiol 112 can potentially increase the asymmetric induction in substrates 
where ligand 20b has been shown to be mediocre.   
 
N SH
112
SH
N
20b
N
OH
Ph
Ph
21  
Figure 1.19.  Ligands effective in the asymmetric alkenylzirconium/zinc addition to aldehydes. 
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1.6 Experimental 
General:  All moisture-sensitive reactions were performed under an atmosphere of N2. 
Glassware was dried in an oven at 140 ºC prior to use.  THF and Et2O were dried by distillation 
over Na/benzophenone.  CH2Cl2 was purified by filtration through activated alumina. Me2Zn was 
purchased from the Aldrich Chemical Company and Cp2ZrHCl was prepared according to a 
modification of a literature protocol.69  Unless otherwise stated, solvents and reagents were used 
as received.  Analytical thin layer choromatography was performed on pre-coated silica gel 60 F-
254 plates (particle size 0.040-0.055 mm, 230-400 mesh) and visualization was accomplished 
with a 254 nm UV light or by staining with an anisaldehyde solution (7.5 mL of p-anisaldehyde, 
25 mL  of concentrated H2SO4 and 7.5 mL  of glacial acetic acid in 675 mL  of 95% ethanol) or a 
KMnO4 solution (1.5 g of KMnO4, 10 g of potassium carbonate and 2.5 mL of 5% aqueous 
NaOH in 150 mL  of H2O).  Flash chromatography on SiO2 was used to separate and purify the 
crude reaction mixtures.  NMR spectra were recorded at 300 MHz/75 MHz (1H NMR/13C NMR) 
at 21 ºC in CDCl3 unless otherwise noted. Chemical shifts (δ) are reported as follows:  chemical 
shift, multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, p=pentet, sx=sextet, sp=septet, 
o=octet, dt=doublet of triplet, dq=doublet of quartet, m=multiplet, b=broad), integration, and 
coupling constants.  Mass spectra were obtained on a double focusing instrument.  Optical 
rotations were measured on a Perkin-Elmer 241 polarimeter at T= 25 ºC.  IR spectra obtained on 
a Nicolet AVATAR 360 FT-IR E.S.P. Spectrometer.  Chiral HPLC analysis was performed on a 
Dynamax SD-200 delivery system in conjunction with a Dynamax UV-1 absorbance detector or 
PL-ELS 1000 detector. A Chiralcel OD (0.46 cm x 2.5 cm) or AD-H ( 0.46 cm x 25 cm) column 
was used for analytical separation, and a Chiralcel AD-H (2 cm x 25 cm) column for semi-
preparative separations.   
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NO O
CO2Me
22  
N-Ethoxycarbonyl-L-proline methyl ester (22).70  To a solution of 2.50 g (21.7 mmol) of L-
proline and 3.00 g (21.7 mmol) of K2CO3 in 40 mL of MeOH at 0 ºC was added 4.48 mL (46.9 
mmol) of ethyl chloroformate over 10 min. The resulting solution was stirred for 15 h at room 
temperature, concentrated in vacuo, diluted with 30 mL of H2O, and extracted with 25 mL of 
CHCl3 (3x). The combined organic layers were dried (MgSO4), filtered, and concentrated in 
vacuo to yield 4.47 g (90%) of 22 as a clear, oily mixture of rotamers (1:1) that was used without 
further purification: [α]D25 -59.1 (c 1.0, CHCl3); lit.70 [α]D25 -60.3 (c 1.3, CHCl3); 1H NMR δ 
4.36-4.26 (m, 1 H), 4.21-3.99 (m, 2 H), 3.72 (s, 1.5 H), 3.70 (s, 1.5 H), 3.62-3.52 (m, 1 H), 3.52-
3.40 (m, 1 H), 2.26-2.11 (m, 1 H), 2.04-1.80 (m, 3 H), 1.25 (t, 1.5 H, J = 7.1 Hz), 1.18 (t, 1.5 H, 
J = 7.1 Hz); MS (EI) m/z (rel intensity) 201 (M+, 19), 142 (100), 128 (20), 114 (13). 
 
N
CH3
OH
23  
(S)-1-Methyl-2-pyrrolidinemethanol (23). To a solution of 2.00 g (9.94 mmol) of 22 in 20 mL 
of THF at 0 ºC was added 1.13 g (29.8 mmol) of LiAlH4. The reaction mixture was heated at 
reflux for 4 h, cooled to 0 ºC, quenched with H2O, acidified to pH 3 with 1 N HCl, diluted with 
Et2O, and filtered through a plug of celite. The celite was washed with EtOAc and the organic 
layer was separated. The aqueous layer was re-extracted with CH2Cl2 (3x). The combined 
organic layers were dried (MgSO4), filtered, and concentrated in vacuo.  The crude residue was 
purified by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 1.05 g (72%) of 23 as a 
colorless oil: [α]D25 -49.0 (c 1.0, CHCl3); lit.70 [α]D25 -49.5 (c 5.0, CH3OH); 1H NMR δ 3.62 (dd, 
1 H, J = 3.5, 10.8 Hz), 3.48-3.39 (m, 1 H), 3.12-3.00 (m, 1 H), 2.30-2.18 (m, 3 H), 2.31 (s, 3 H), 
1.95-1.75 (m, 2 H), 1.74-1.60 (m, 2 H); MS (EI) m/z (rel intensity) 115 (M+, 26), 84 (100). 
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N
CH3
OH
CH3
CH3
24  
(S)-(+)-Dimethyl(1-methylpyrrolidin-2-yl)methanol (24).71 To a solution of 9.71 g (48.3 
mmol) of 22 in 60 mL of THF at 0 ºC was added 64.0 mL (193 mmol) of a 3 M  solution of 
methyl magnesium bromide in THF.  The reaction mixture was stirred for 4 h at 0 ºC, quenched 
with NH4Cl, and extracted with CHCl3 (3x). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo to yield an orange oil.  This oil was used in the subsequent 
step without further purification. A solution of the oil in 75 mL of THF at 0 ºC was treated 
portionwise with 3.60 g (43.9 mmol) of LiAlH4, heated at reflux for 3 h, cooled to 0 ºC, 
quenched with H2O, acidified to pH 3 with 1 N HCl, diluted with Et2O, and filtered through a 
plug of celite. The celite was washed with EtOAc and the organic layer was separated. The 
aqueous layer was re-extracted with CH2Cl2 (3x). The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo.  The resulting crude residue was purified by 
chromatography on SiO2 (20% EtOAc/Hexanes) to yield 4.64 g (67%) of 24 as a slightly orange 
oil: [α]D25 +6.7 (c 0.15, CHCl3); lit.71 [α]D25 -5.8 (R) (c 0.4, CHCl3); 1H NMR δ 3.07-2.99 (m, 1 
H), 2.47 (s, 3 H), 2.45-2.30 (m, 2 H), 1.87 -1.73 (m, 1 H), 1.74-1.62 (m, 3 H), 1.17 (s, 3 H), 1.08 
(s, 3 H); MS (EI) m/z (rel intensity) 145 (M+, 11), 128 (14), 84 (100). 
 
N
CH3
OH
Ph
Ph
21  
(S)-(+)-Diphenyl(1-methylpyrrolidin-2-yl)methanol (21).72 To a solution of 4.47 g (21.9 
mmol) of 22 in 30 mL of THF at 0 ºC was added 87.8 mL (87.8 mmol) of 1 M phenyl 
magnesium bromide in THF. The reaction mixture was stirred for 4 h at 0 ºC, quenched with 
NH4Cl, and extracted with CHCl3 (3x). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo to yield 8.50 g of an orange oil.  This oil was used in the 
subsequent step without further purification.  A solution of the oil in 60 mL of THF at 0 ºC was 
treated portionwise with 1.60 g (43.9 mmol) of LiAlH4, heated at reflux for 3 h, cooled to 0 ºC, 
quenched with H2O, acidified to pH 3 with 1 N HCl, diluted with Et2O, and filtered through a 
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plug of celite.  The celite washed with EtOAc and the organic layer was separated.  The aqueous 
layer was re-extracted with CH2Cl2 (3x). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo. The resulting crude residue was purified by chromatography 
on SiO2 (20% EtOAc/Hexanes), and further purified by Kugelrohr distillation at 180 ºC (0.1 
Torr) to yield 4.40 g (75%) of 21 as a beige solid: Mp 64-66 ºC (EtOAc/Hexanes, lit. 68.5-68.9); 
[α]D25 +53.4 (c 0.9, CHCl3); lit.72 [α]D23 +57.0 (c 1.0, CHCl3); 1H NMR δ 7.80-7.70 (m, 2 H), 
7.62-7.52 (m, 2 H), 7.48-7.30 (m, 4 H), 7.25-7.12 (m, 2 H), 4.88 (bs, 1 H), 3.70 (dd, 1 H, J = 5.2, 
9.5 Hz), 3.22-3.18 (m, 1 H), 2.60-2.45 (m, 1 H), 2.00-1.90 (m, 1 H), 1.91 (s, 3 H), 1.85-1.75 (m, 
1 H); MS (EI) m/z (rel intensity) 268 (M+, 7), 249 (14), 190 (27), 181 (129), 165 (27), 152 (22), 
105 (17). 
 
N
CH3
OH
Nap
Nap
25  
(S)-(+)-Dinaphthyl(1-methylpyrrolidin-2-yl)methanol (25).  To a solution of 1.26 g (6.26 
mmol) of 22 in 35 mL of THF at 0 ºC was added 50.0 mL (25.0 mmol) of a 0.5 M solution of 2-
naphthyl magnesium bromide in THF. The reaction mixture was stirred for 4 h at 0 ºC, quenched 
with NH4Cl, extracted with CHCl3 (3x), dried (MgSO4), filtered, and concentrated in vacuo to 
yield 2.00 g of an orange oil. This oil was used in the subsequent step without further 
purification.  A solution of the oil in 50 mL of THF at 0 ºC was treated portionwise with 0.360 g 
(9.40 mmol) of LiAlH4, heated at reflux for 4 h, cooled to 0 ºC, quenched with H2O, acidified to 
pH 3 with 1 N HCl, diluted with Et2O, and filtered through a plug of celite. The celite was 
washed with EtOAc and the organic layer was separated. The aqueous layer was re-extracted 
with CH2Cl2 (3x). The combined organic layers were dried (MgSO4), filtered, and concentrated 
in vacuo. The crude residue was precipitated from 50% EtOAc/Hexanes to give 2.00 g (87%) of 
off-white solid 25: Mp 202-204 ºC (EtOAc/Hexanes); [α]D25 +65.2 (c 1.0, CHCl3); IR (KBr) 
3525, 3008, 2900, 1210, 1071, 935 cm-1; 1H NMR δ 8.24 (s, 1 H), 8.11 (s, 1 H), 7.82 (td, 2 H, J 
= 1.4, 7.3 Hz), 7.76-7.66 (m, 6 H), 7.46-7.33 (m, 4 H), 3.87 (dd, 1 H, J = 4.4 Hz, 9.2 Hz), 3.19-
3.09 (m, 1 H), 2.47 (td, 1 H, J = 6.8, 9.8 Hz), 2.06-1.92 (m, 1 H), 1.83 (s, 3 H), 1.82-1.59 (m, 3 
H); 13C NMR δ 135.7, 133.3, 132.1, 128.3, 127.7, 127.4, 125.9, 125.6, 124.5, 124.5, 124.3, 
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124.0, 58.9, 43.2, 30.0, 24.1; MS (EI) m/z (rel intensity) 349 ([M-H2O]+, 30), 282 (28), 252 (8), 
155 (20), 127 (21); HRMS (EI) Calcd for C26H23N (M-H2O) 349.1831, found 349.1819. 
 
Ph
OH27  
General Protocol for formation of allylic alcohol, (S)-1-Phenylhept-2-en-1-ol (27) using 15 
mol% of ligand 21.  To a suspension of 500 mg (1.93 mmol) of zirconocene hydrochloride in 4 
mL of CH2Cl2 under N2 was added 175 µL (1.52 mmol) of 1-hexyne at room temperature. After 
5 min, an additional 80 µL (0.70 mmol) of 1-hexyne was added. The reaction mixture was stirred 
for an additional 10 min, and the solution was concentrated in vacuo.  To a solution of the 
resulting orange oil in 4 mL of toluene at -65 ºC was added 650 µL (1.29 mmol) of Me2Zn (2.0 
M solution in toluene). After 10 min, 52 mg (0.19 mmol) of ligand 21 was added. The reaction 
mixture was then warmed to -30 ºC over a period of 1 h, and 134 µL (1.29 mmol) of freshly 
distilled benzaldehyde was added. The solution was stirred for 15 h at -30 ºC, quenched by 
addition of NaHCO3 solution, filtered through a plug of florisil and extracted with EtOAc. The 
organic layers were washed with brine, dried (MgSO4), filtered, and concentrated in vacuo. The 
resulting residue was purified by chromatography on SiO2 (10% EtOAc/Hexanes) to yield 190 
mg (80%) of 27 as a colorless oil.  The enantiomeric excess was determined using chiral HPLC 
(Chiralcel OD) using 1% i-PrOH/hexane at a flow rate of 1 mL/min (Rt minor = 18.1 min, Rt 
major = 26.8 min) with a Dynamax UV-1 absorbance detector: 1H NMR δ 7.37-7.22 (m, 5 H), 
5.70 (dt, 1 H, J = 6.2, 15.3 Hz), 5.61 (dd, 1 H, J = 6.5, 15.4 Hz), 5.13 (d, 1 H, J = 6.3 Hz), 2.10-
2.00 (m, 2 H), 1.83 (bs, 1 H), 1.41-1.24 (m, 4 H), 0.85 (t, 3 H, J = 6.8 Hz).  
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 23.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 15 mg (0.13 mmol) of  ligand 23, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 197 mg (79%) of 27 with an ee 
of 17%.73   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 23.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
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650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 22 mg (0.19 mmol) of  ligand 23, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 195 mg (78%) of 27 with an ee 
of 18%.  
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 24.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 9.2 mg (0.06 mmol) of  ligand 24, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 105 mg (85%) of 27 with an 
ee of 17%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 24.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.09 mmol) of  ligand 24, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 96 mg (78%) of 27 with an ee 
of 17%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 21.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 43 mg (0.13 mmol) of  ligand 21, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 180 mg (73%) of 27 with an ee 
of 46%.  Run 2 was conducted on the same scale to yield 190 mg (77%) of 27 with an ee of 35%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 21.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 63 mg (0.19 mmol) of  ligand 21, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 185 mg (76%) of 27 with an ee 
of 79%. Run 2 was conducted on the same scale to yield 180 mg (74%) of 27 with an ee of 
83%.73   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 25.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
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325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 22 mg (0.06 mmol) of  ligand 25, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 100 mg (81%) of 27 with an 
ee of 20%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 25.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 33 mg (0.09 mmol) of  ligand 25, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (80%) of 27 with an ee 
of 20%.   
 
Chiral loading: (S)-1-Phenylhept-2-en-1-ol (27) using 5 mol% of ligand (S)-21:  According 
to the general protocol, 510 mg (1.98 mmol) of zirconocene hydrochloride, 179 µL (1.55 mmol) 
of 1-hexyne, 660 µL (1.32 mmol) of Me2Zn (2.0 M solution in toluene), 22 mg (0.08 mmol) of 
(S)-21, and 134 µL (1.32 mmol) of freshly distilled benzaldehyde provided 192 mg (75%) of 27 
with an ee of 9%. The numerical value of each data point is listed below (Table 8). 
 
Table 1.13.  Enantioselective formation of 27 using ligand 21. 
ee73 (%) of (S)-27 ligand loading (mol%) of (S)-21 
0 0 
5 9 
10 41a
15 81a
20 60 
30 66 
40 68 
50 53 
a At the specified chiral ligand loading, 2 runs were conducted and the average was reported. 
 
Non-linear effect: (S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand (S)-21 (65% ee):  
According to the general protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 179 µL 
(1.54 mmol) of 1-hexyne, 660 µL (1.31 mmol) of Me2Zn (2.0 M solution in toluene), 52 mg 
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(0.19 mmol) of (S)-21 and 11 mg (0.04 mmol) of  (R)-21, and 134 µL (1.29 mmol) of freshly 
distilled benzaldehyde provided 180 mg (74%) of 27 with an ee of 41%. Data points in Figure 
1.13 are the average of 2 or 3 runs conducted at the specified %ee of ligand.  The numerical 
value of each data point is listed below (Table 9). 
 
Table 1.14.  Enantioselective formation of 27 using ligand 21 at 15 mol% loading. 
ee73 (%) of 27 ee (%) of (S)-21 
100 81 (S) 
80 65 (S) 
65 46 (S) 
50 24 (S) 
35 13 (R) 
20 1.5 (R) 
0 0 
 
 
N
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(S)-2-Hydroxymethylpyrrolidine-1-carboxylic acid ethyl ester (39).74  To a solution of 3.50 g 
(15.2 mmol) of 22 in 100 mL of Et2O at 0 ºC was added portionwise 421 mg (11.1 mmol) of 
LiAlH4.  The resulting slurry was stirred for 5 h at 0 ºC and quenched with EtOAc and 20% 
potassium hydroxide.  The organic layer was extracted with EtOAc (3x).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated in vacuo.  The resulting 2.4 g (78%) of 
clear oil were found to contain a 6:1 mixture of 39 and 22 and used in subsequent steps without 
further purification.  A portion of this crude oil was purified by chromatography on SiO2 (10% 
EtOAc/Hexanes) to yield pure 39 for characterization purposes:  1H NMR δ 4.16 (q, 2 H, J = 7.1 
Hz), 4.05-3.95 (m, 1 H), 3.70-3.56 (m, 2 H), 3.55-3.47 (m, 1 H), 3.41-3.30 (m, 1 H), 2.10-1.98 
(m, 1 H), 1.97-1.73 (m, 2 H), 1.70-1.50 (bs, 1 H), 1.28 (t, 3 H, J = 7.1 Hz); MS (EI) m/z (rel 
intensity) 173 (M+, 2), 142 (88), 128 (12), 114 (14), 98 (38). 
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(S)-2-Toluene-4-sulfonyloxymethylpyrrolidine-1-carboxylic acid ethyl ester (40).52  To a 
solution of 2.40 g (11.9 mmol) of a 6:1 mixture of 39 and 22 in 20 mL of pyridine at room 
temperature was added 3.17 g (16.6 mmol) of p-toluenesulfonyl chloride. The reaction mixture 
was stirred for 4 h, diluted with CH2Cl2, washed with 1 M HCl, NaHCO3, and H2O, dried 
(MgSO4), filtered and concentrated in vacuo. Chromatography of the crude residue on SiO2 
(50% EtOAc/Hexanes) yielded 2.45 g (52%) of a 1:10 mixture of 22 and 40 as a clear oil. This 
mixture was used without further purification in subsequent steps. A sample of this mixture was 
re-purified by chromatography on SiO2 (33% EtOAc/Hexanes) to yield pure 40 as a 1:1 mixture 
of rotamers for characterization purposes: 1H NMR δ 7.77 (d, 2 H, J = 8.2 Hz), 7.38-7.30 (m, 2 
H), 4.20-3.85 (m, 6 H), 3.45-3.25 (m, 2 H), 2.45 (s, 3 H), 2.05-1.86 (m, 3 H), 1.85-1.75 (m, 1 H), 
1.22 (t, 1.5 H, J = 7.1 Hz), 1.13 (t, 1.5 H, J = 6.8 Hz); MS (EI) m/z (rel intensity) 327 (M+, 9), 
297 (17), 155 (12), 142 (100). 
 
N
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(S)-2-Acetylsulfanylmethylpyrrolidine-1-carboxylic acid ethylester (41).  A solution of 2.45 
g (6.79 mmol) of a 10:1 mixture of 40 and 22 in 50 mL of DMF was treated with 3.92 g (34.4 
mmol) of potassium thioacetate. The resulting solution was heated at reflux for 1 h, diluted with 
H2O, and extracted with CH2Cl2 (3x). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo. The resulting residue was purified by chromatography on 
SiO2 (10% EtOAc/Hexanes) to yield 1.07 g (62%) of 41 as an orange, oily 2:1 mixture of 
rotamers: [α]D25 +59.0 (c 0.5, CHCl3); 1H NMR δ 4.25-4.03 (m, 2 H), 3.93 (bs, 1 H), 3.38 (bs, 2 
H), 3.19 (d, 1 H, J = 3.6 Hz), 2.32 (s, 3 H), 1.96-1.67 (m, 5 H), 1.25 (t, 3 H, J = 7.1 Hz); MS (EI) 
m/z (rel intensity) 232 (M+, 7), 224 (43), 188 (27), 155 (25), 142 (100), 114 (14). 
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(S)-(1-Methylpyrrolidin-2-yl)-methanethiol (42). A solution of 1.07 g (4.62 mmol) of 41 in 40 
mL of THF was added dropwise to a slurry of 1.07 g (20.8 mmol) of LiAlH4 in 60 mL of THF. 
The resulting solution was heated at reflux for 8 h, cooled to 0 ºC, quenched with 1.3 mL of H2O 
and 16 mL of 1 M HCl, dried (MgSO4), filtered through celite, and concentrated in vacuo. The 
resulting oil was purified by chromatography on SiO2 (10% EtOAc/Hexanes) to yield 151 mg 
(25%) of 42 as a clear oil: [α]D25 -84.0 (c  0.5, CHCl3); lit.71 [α]D20 -85.7 (c 0.9, CHCl3); 1H NMR 
δ 3.04 (t, 1 H, J = 9.4 Hz), 3.02 (dd, 1 H, J = 3.4, 12.9 Hz), 2.72 (dd, 1 H, J = 8.2, 12.9 Hz), 
2.45-2.37 (m, 1 H), 2.36 (s, 3 H), 2.30-2.21 (m, 1 H), 2.10-1.90 (m, 1 H), 1.85-1.60 (m, 3 H). 
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 42.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 7.9 mg (0.065 mmol) of  ligand 42, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 100 mg (81%) of 27 with an 
ee of 83%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 42.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 12 mg (0.090 mmol) of  ligand 42, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 120 mg (98%) of 27 with an 
ee of 84%.   
 
N
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(S)-2-(Acetylsulfanyldiphenylmethyl)-pyrrolidine-1-carboxylic acid ethyl ester (45a).52  To 
2.00 g (6.13 mmol) of 44 and 2.15 g (6.74 mmol) of ZnI2 at 0 °C in 110 mL of dichloroethane 
was added 0.94 mL (13.3 mmol) of thiolacetic acid.  The resulting reaction was stirred for 26 h, 
diluted with H2O, extracted with CH2Cl2, dried (MgSO4), filtered, and concentrated in vacuo. 
The crude residue was purified by chromatography on SiO2 (100% Hexanes-30% 
EtOAc/Hexanes) to yield 700 mg (30%) of 45a as white solid: Mp 136-140 °C 
(EtoAc/Hexanes); [α]D25 –229.1.0 (c  0.5, CHCl3); lit.52 [α]D25 –231.4 (c 1.0, CHCl3); 1H NMR δ 
7.54 (d, 2 H, J = 7.5 Hz), 7.45-7.19 (m, 8 H), 5.74 (d, 1 H, J = 8.4 Hz), 4.30-3.90 (m, 2 H), 3.58-
3.20 (bs, 1 H), 2.70 (dt, 1 H, J = 3.9, 10.2 Hz), 2.35-2.10 (m, 1 H), 2.14 (s, 3 H), 2.06-1.90 (m, 1 
H), 1.45-1.18 (m, 5 H), 0.3-0.0 (bs, 1 H); MS (EI) m/z (rel intensity) 307 ([M-C2H3OS]+, 15), 
234 (11), 206 (10), 165 (11), 142 (100), 115 (7), 105 (25), 84 (25); HRMS (EI) Calcd for 
C22H25NO3S-C2H3OS 307.1572, found 307.1569. 
 
N
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(S)-(1-Methylpyrrolidin-2-yl)diphenylmethanethiol (46).52 To 225 mg (5.92 mmol) of LiAlH4 
in 14 mL of THF at 0 °C was added 650 mg (1.69 mmol) of 45 in 19 mL of THF.  The reaction 
was heated at reflux for 7 h, cooled, quenched with 9 mL of H2O, 4.5 mL of 1 N HCl, filtered 
through celite, washed with 50 mL of CH2Cl2, dried (MgSO4), and concentrated in vacuo. The 
crude residue was purified by chromatography on neutral alumina (100% Hexanes) to yield 70 
mg (15%) of 46 as a colorless oil: 1H NMR δ 7.60-7.45 (m, 2 H), 7.40-7.30 (m, 2H), 7.29-7.15 
(m, 6 H), 3.54 (dd, 1 H, J = 3.1, 9.1 Hz), 3.09 (t, 1 H, J = 7.5 Hz), 2.45-2.25 (m, 1 H), 2.22-2.05 
(m, 2 H), 1.95-1.59 (m, 2 H), 1.63 (s, 3 H); MS (EI) m/z (rel intensity) 283 (M+, 6), 250 (17), 220 
(10), 198 (64), 182 (30), 165 (100), 152 (12), 121 (85), 115 (20); HRMS (EI) Calcd for 
C18H21NO1S 283.1395, found 283.1388. 
(S)-1-Phenylhept-2-en-1-ol (27) using 5 mol% of ligand 46.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 18 mg (0.065 mmol) of  ligand 46, 
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and 134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 204 mg (83%) of 27 with an 
ee of 5%.  
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 46.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 36 mg (0.13 mmol) of  ligand 46, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 197 mg (83%) of 27 with an ee 
of 18%.  
N
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(S)-(+)-Dimethylpyrrolidin-2-yl-methanol (31).75  To 2.00 g (9.94 mmol) of 22 in 30 mL of 
THF at 0 ºC was added 13.3 mL (39.8 mmol) of 3 M methyl magnesium bromide in Et2O.  The 
resulting reaction was stirred for 6 h at 0 ºC.  The reaction was quenched with NH4Cl, extracted 
with CHCl3, washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 1.5 g 
(68%) of ethyl carbamate as a colorless oil. To 700 mg (3.12 mmol) of the resulting oil in 6.25 
mL of MeOH was added 1.75 g (3.12 mmol) of KOH.  The reaction was heated at reflux for 4 h, 
cooled, and concentrated in vacuo to remove MeOH.  The resulting residue was dissolved in 
H2O, extracted with CHCl3, washed with NaCl, dried (MgSO4), and concentrated in vacuo to 
yield 550 mg (63%) of 31 as an orange oil.  The crude material was used without purification in 
the next step: [α]D25 –14.2 (c 0.5, CHCl3); lit.76 [α]D25 –16.6 (c 0.57, CH2Cl2); 1H NMR δ 3.64 
(dt, 1 H, J = 7.8, 11.1 Hz), 3.51 (dd, 1 H, J = 5.4, 10.5 Hz), 3.19 (ddd, 1 H, J = 3.3, 9.0, 11.4 Hz), 
2.14-2.04 (m, 1 H), 1.95-1.86 (m, 1 H), 1.85-1.74 (m, 1 H), 1.70-1.58 (m, 1 H), 1.55 (s, 3 H), 
1.39 (s, 3 H); MS (EI) m/z (rel intensity) 155 (7), 142 (12), 113 (12), 110(24), 96 (20), 91 (39), 
82 (66), 69 (100), 63 (9), 53 (48). 
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(S)-(+)-2-(1-Benzylpyrrolidin-2-yl)propan-2-ol (32).78 To 550 mg (3.6 mmol) of 31 in 30 mL 
of toluene was added 0.47 mL (4.0 mmol) of diisopropylethylamine and 1.6 mL (9.0 mmol) of 
benzyl bromide.  The solution was heated at 110 ºC for 4 h, cooled, quenched with NaHCO3, 
extracted with EtOAc, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude 
residue was purified by chromatography on SiO2 (75% EtOAc/Hexanes) to yield 450 mg (59 %) 
of 32 as a colorless oil: [α]D25 –39.2 (c 0.5, CHCl3); lit.76 [α]D25 –40.2 (c 2.45, CH2Cl2); 1H NMR 
δ 7.47-7.10 (m, 5 H), 4.15 (d, 1 H, J = 13.9 Hz), 3.60 (d, 1 H, J = 13.9 Hz), 2.94-2.85 (m, 1 H), 
2.80-2.72 (m, 1 H), 2.67 (s, 1 H), 2.48 –2.30 (m, 1 H), 1.97-1.63 (m, 4 H), 1.27 (s, 3 H), 1.18 (s, 
3 H); MS (EI) m/z (rel intensity) 294 (5), 210 (M+, 90), 181 (19), 160 (18), 106 (19), 91 (100). 
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28  
(S)-(+)-Diphenylpyrrolidin-2-yl-methanol (28).77  To 2.00 g (9.94 mmol) of 22 in 25 mL of 
THF at ºC was added 13.3 mL (39.8 mmol) of 3 M phenyl magnesium bromide in Et2O.  The 
reaction mixture was stirred for 3 h at 0 ºC, quenched with NH4Cl, extracted with CHCl3, washed 
with NaCl, dried (MgSO4), filtered, and concentrated in vacuo to yield 2.30 g of ethyl carbamate 
as an off white solid.  The crude material was used without purification in the next step.  To 2.30 
g of crude ethylcarbamate in 20 mL of MeOH was added 5.6 g (10 mmol) of KOH.  The reaction 
was heated at reflux for 4 h, cooled, and concentrated in vacuo to remove MeOH.  The resulting 
residue was dissolved in H2O, extracted with CHCl3, washed with NaCl, dried (MgSO4), and 
concentrated in vacuo to yield 1.60 g (63%) of 28 as off white solid: Mp 75-78 °C (CHCl3); 
[α]D25 –71.0 (c 0.5, CHCl3); lit.77 [α]D25 –68.1 (c 3.17, CH3OH); 1H NMR δ 7.58 (s, 2 H, J = 7.2 
Hz), 7.50 (d, 2 H, J = 7.5 Hz), 7.34-7.20 (m, 4 H), 7.20-7.12 (m, 2 H), 4.27 (t, 1 H, J = 7.8 Hz), 
3.10-3.88 (m, 2 H), 1.81-1.50 (m, 4 H); MS (EI) m/z (rel intensity) 254 (M+, 42), 234 (64), 206 
(61), 191 (11), 165 (15), 152 (7), 105 (17), 77 (20), 70 (100).   
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(S)-(+)-(1-Ethylpyrrolidin-2-yl)-diphenylmethanol (29).48 To 500 mg (1.98 mmol) of 28 in 15 
mL of toluene at rt was added 0.86 mL (4.94 mmol) of diisopropylethylamine and 0.16 mL (2.17 
mmol) of ethylbromide. The solution was heated at 120 ºC for 24 h, cooled, quenched with 
NaHCO3, extracted with EtOAc, dried (MgSO4), and concentrated in vacuo. The resulting crude 
residue was purified by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 80 mg (14%) of 
29 as a white solid: Mp 77-80 °C (EtOAc/Hexanes, lit.48 78-79 °C; [α]D25 +6.1 (c 0.5, CHCl3); 
lit.48 [α]D25 +6.3 (c 0.64, CH2Cl2); 1H NMR δ 7.65-7.59 (m, 2 H), 7.58-7.52 (m, 2 H), 7.32-7.21 
(m, 4 H), 7.20-7.10 (m, 2 H), 5.15-4.80 (bs, 1 H), 3.79 (dd, 1 H, J = 4.2, 9.1 Hz), 3.28-3.20 (m, 1 
H), 2.42-2.34 (m, 1 H), 2.10-1.80 (m, 3 H), 1.80-1.60 (m, 3 H), 0.80 (t, 3 H, J = 7.2 Hz); 13C 
NMR δ 146.6, 128.0, 127.9, 126.1, 125.7, 125.5, 70.7, 54.6, 49.8, 29.7, 24.3, 13.5; MS (EI) m/z 
(rel intensity) 305 (5), 282 (M+, 6), 272 (8), 263 (25), 204 (45), 182 (24), 165 (30), 98 (100); 
HRMS (EI) Calcd for C19H23NO (M-C6H5) 344.2000, found 344.2014. 
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(S)-(+)-(1-Benzylpyrrolidin-2-yl)-diphenylmethanol (30).75  To 400 mg (1.58 mmol) of 28 in 
15 mL of toluene was added 0.69 mL (3.95 mmol) of diisopropylethylamine and 0.21 mL (1.74 
mmol) of benzylbromide.  The solution was heated at 110 ºC for 4 h, cooled, quenched with 
NaHCO3, extracted with EtOAc, dried (MgSO4), filtered, and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 300 
mg (55%) of 30 as a white solid: Mp 120-124 °C (Hexanes, lit.78 120-122 °C); [α]D25 (c 0.5, 
CHCl3); lit.78 [α]D25 (c, CH3OH); 1H NMR δ 7.74 (d, 2 H, J = 8.1 Hz), 7.59 (d, 2 H, J = 7.8 Hz), 
7.36-7.00 (m, 11 H), 4.95 (bs, 1 H), 3.99 (dd, 1 H, J = 4.5, 9.3 Hz), 3.24 (A of AB, 1 H, J = 12.6 
Hz), 3.04 (B of AB, 1 H, J = 12.6 Hz), 2.92 (p, 1 H, J = 4.2 Hz), 2.37 (q, 1 H, J = 9.3 Hz), 2.08-
1.90 (m, 1 H), 1.85-1.70 (m, 1 H), 1.70-1.56 (m, 3 H); 13C NMR δ 148.0, 246.7, 139.7, 128.6, 
128.2, 128.1, 128.1, 126.8, 126.4, 126.2, 125.6, 125.6, 70.7, 60.6, 55.5, 29.8, 24.2; MS (EI) m/z 
(rel intensity) 325 ([M-OH]+, 7), 167 (10), 160 (100), 105 (15), 91 (73); HRMS (EI) Calcd for 
C24H25NO 344.2000, found 344.2014. 
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(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 29.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 18 mg (0.065 mmol) of ligand 29, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 101 mg (82%) of 27 with an 
ee of 3%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 29.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 27 mg (0.098 mmol) of ligand 29, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 102 mg (83%) of 27 with an 
ee of 13%.73
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 30.  According to the general 
protocol, 300 mg (1.16 mmol) of zirconocene hydrochloride, 105 µL (0.78 mmol) of 1-hexyne, 
388 µL (0.78 mmol) of Me2Zn (2.0 M solution in toluene), 27 mg (0.078 mmol) of ligand 30, 
and 79 µL (0.78 mmol) of freshly distilled benzaldehyde provided 114 mg (76%) of 27 with an 
ee of 4%.
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 30.  According to the general 
protocol, 300 mg (1.16 mmol) of zirconocene hydrochloride, 105 µL (0.78 mmol) of 1-hexyne, 
388 µL (0.78 mmol) of Me2Zn (2.0 M solution in toluene), 40 mg (0.116 mmol) of ligand 30, 
and 79 µL (0.78 mmol) of freshly distilled benzaldehyde provided 117 mg (78%) of 27 with an 
ee of 6%.
 
(S)-1-Phenylhept-2-en-1-ol (27) using 5 mol% of ligand 32.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.033 mmol) of ligand 32, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (79%) of 27 with an ee 
of 20%.73
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(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 32.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 27 mg (0.065 mmol) of ligand 32, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 96 mg (78%) of 27 with an ee 
of 4%.   
 
O
O
N
N
OH
Ph
Ph
33
HO PhPh
 
N,N’-Phthaloyl-bis-((S)-2-(1-hydroxy-1,1-diphenylmethyl)pyrolidine) (33).48 To 0.51 mL 
(3.62 mmol) of phthaloyl chloride in 1 mL of benzene was added 360 mg (1.42 mmol) of 28 in 3 
mL of benzene.  The resulting solution was stirred for 4 h at rt, filtered through celite, washed 
with Et2O, NaHCO3, NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The resulting 
crude residue was purified by chromatography on SiO2 (25% EtoAc/Hexanes) to yield 270 mg 
(60%) of 33 as a white solid: Mp 114-117 °C (EtOAc/Hexanes, lit.48 114-116 °C); [α]D25 +12.9 
(c 0.5, CHCl3); lit.48 [α]D25 +13.6 (c 1.00, CH2Cl2); 1H NMR δ 7.62-7.23 (m, 24 H), 6.95 (s, 2 
H), 6.71 (dd, 2 H, J = 3.9, 6.7 Hz), 3.76 (t, 2 H, J = 6.0 Hz), 3.28 (t, 2 H, J = 7.8 Hz), 2.80-2.65 
(m, 2 H), 2.30-2.14 (m, 2 H), 2.04-1.80 (m, 2 H), 1.79-1.46 (m, 2H), 1.45-1.30 (m, 2 H); HRMS 
(EI) Calcd for C42H40N2O4  (M+Na) 659.2886, found 659.2863. 
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34  
N,N’-α,α‘-o-Xylene-bis-((S)-2-(1-hydroxy-1,1-diphenylmethyl)pyrrolidine) (34).48  To 250 
mg (0.39 mmol) of 33 in 9 mL of THF at 0 °C was added 61 mg (1.61 mmol) of LiAlH4 
portionwise.  The gray slurry was heated at reflux for 2 h, quenched with H2O, filtered, filtrate 
washed with EtOAc, washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (25% EtoAc/Hexanes) to yield 
148 mg (62%) of 34 as a white solid: Mp 112-113 °C (EtOAc/Hexanes, lit.48 110-112 °C); [α]D25 
+5.1 (c 0.5, CHCl3); lit.48 [α]D25 +4.5 (c 0.53, CH2Cl2); 1H NMR δ 7.67 (d, 4 H, J = 7.5 Hz), 7.58 
(d, 4 H, J = 7.2 Hz), 7.40-7.05 (m, 10 H), 3.97 (dd, 2 H, J = 4.5, 9.0 Hz), 3.05 (A of AB, 2 H, J = 
13.5 Hz), 2.95 (B of AB, 2 H, J = 13.2 Hz), 2.78-2.68 (m, 2 H), 2.37 (s, 2 H), 2.22 (q, 2 H, J = 
8.4 Hz), 2.07-1.90 (m, 2 H), 1.80-1.45 (m, 4 H); MS (EI) m/z (rel intensity) 711 (23), 609 (M+, 
100), 458 (27), 356 (30), 236 (28), 167 (20). 
 
(S)-1-Phenylhept-2-en-1-ol (27) using 5 mol% of ligand 34.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 19 mg (0.033 mmol) of ligand 34, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 97 mg (78%) of 27 with an ee 
of 2%.73
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 34.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 39 mg (0.065 mmol) of ligand 34, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 91 mg (73%) of 27 with an ee 
of 4%.
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37  
1-Benzyl-4-hydroxypyrrolidine-2-carboxylic acid methyl ester (37).49  To 1.00 g (7.62 mmol) 
of cis-4-hydroxy-D-proline in 7.64 mL of MeOH was added 0.56 mL (7.62 mmol) of thionyl 
chloride at 0 ºC.  The reaction was heated at reflux for 4.5 h, cooled, and concentrated in vacuo 
to yield 1.10 g (100%) of 36 as a white solid. The crude material was used without purification in 
the next step.  To 1.00 g (6.89 mmol) of 36 in 7 mL of toluene was added 3.00 mL (17.2 mmol) 
of diisopropylethylamine and 0.91 mL (7.58 mmol) of benzylbromide.  The solution was heated 
at 110 ºC for 6 h, cooled, quenched with NaHCO3, extracted with EtOAc, dried (MgSO4), 
filtered, and concentrated in vacuo. The resulting crude residue was purified by chromatography 
on SiO2 (50% EtOAc/Hexanes) to yield 1.1 g (62%) of 37 as an orange/brown oil:  [α]D25 +90.0 
(c 0.5, CHCl3); lit. [α]D25 +92.5 ( c 0.5, CHCl3); 1H NMR δ 7.40-7.20 (m, 2 H), 4.32-4.24 (m, 1 
H), 3.91 (A of AB, 1 H, J = 13.1 Hz), 3.75 (B of AB, 1 H, J = 13.1 Hz), 3.65 (s, 3 H), 3.38 (dd, 1 
H, J = 3.9, 10.0 Hz), 3.21 (bd, 1 H, J = 10.1 Hz), 3.06 (d, 1 H, J = 9.9 Hz), 2.67 (dd, 1 H, J = 3.9, 
9.8 Hz), 2.30-2.50 (m, 1 H), 1.93-2.03 (m, 1 H); MS (EI) m/z (rel intensity) 258 (6), 235 (M+, 
45), 215 (47), 176 (85), 91 (99), 65 (19); HRMS (EI) Calcd for C13H17NO3 235.1219, found 
235.1208. 
 
N
HO
OH
Ph
Ph
Bn
38  
1-Benzyl-5-(hydroxydiphenylmethyl)pyrrolidin-3-ol (38).49  1.00 g (4.25 mmol) of 37 in 12 
mL of THF at 0 ºC was added 5.67 mL (17.0 mmol) of a 3 M solution of phenyl magnesium 
bromide in Et2O.  The resulting reaction was stirred for 3 h at 0 ºC, quenched with NaHCO3, 
extracted with EtOAc, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude 
residue was purified by chromatography on SiO2 (100% Hexanes) to yield 700 mg (46%) of 38 
as off white solid: Mp 126-128 °C (Hexanes, lit.79 127-130°C); [α]D25 +128.0 (c 0.5, CHCl3); 1H 
NMR δ 7.74 (d, 2 H, J = 7.5 Hz), 7.56 (d, 2 H, J = 7.5 Hz), 7.40-7.10 (m, 9 H), 7.01 (d, 2 H, J = 
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6.3 Hz), 4.16 (dd, 1 H, J = 3.0, 10.5 Hz), 4.14-4.05 (m, 1 H), 3.27 (A of AB, 1 H, J = 12.6 Hz), 
3.05 (B of AB, 1 H, J = 12.6 Hz), 3.00 (d, 1 H, J = 10.5 Hz), 2.49 (dd, 1 H, J = 3.6, 10.2 Hz), 
2.40 (ddd, 1 H, J = 6.0, 10.5, 16.5 Hz), 1.76 (d, 1 H, J = 15 Hz), 1.57 (bs, 1 H); MS (EI) m/z (rel 
intensity) 358 (M+, 7), 341 (22), 232 (14), 246 (8), 176 (100), 159(12), 105 (26). 
 
 (S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 38.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 46 mg (0.13 mmol) of ligand 38, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 186 mg (76%) of 27 with an ee 
of  9%.
 
(S)-1-Phenylhept-2-en-1-ol (27) using 20 mol% of ligand 38.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 93 mg (0.26 mmol) of ligand 38, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 208 mg (85%) of 27 with an ee 
of  21%.73
Ph2P(O)NH2
P,P-Diphenylphosphinamide.80  A solution of 20.0 g (84.6 mmol) of diphenylphosphinyl 
chloride in 150 mL of CH2Cl2 was cooled to -78 ºC, treated with ~50.0 g (3.0 mmol) of liquid 
ammonia, warmed to room temperature and stirred for 16 h, diluted with CHCl3, filtered, and 
concentrated in vacuo.  The resulting solid residue was recrystalized from toluene to yield 15.5 g 
(84%) of 63 as a white solid: Mp 164-165 ºC (toluene, lit.81 164-166 ºC); 1H NMR δ 8.00-7.80 
(m, 4 H), 7.55-7.35 (m, 6 H), 3.55 (bs, 2 H); MS (EI) m/z (rel intensity) 216 (M+, 100), 199 (82), 
140 (57), 124 (67). 
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48  
2-Bromo-P,P-diphenylphosphinamide (48).  A suspension of 3.00 g (13.9 mmol) of o-
bromobenaldehyde, 2.51 g (21.5 mmol) of P,P-Diphenylphosphinamide, and 5.75 mL (41.3 
mmol) of triethylamine in 50 mL of CH2Cl2 was cooled to 0 ºC, treated dropwise with a solution 
of 832 µL (7.55 mmol) of TiCl4 in 10 mL of CH2Cl2 over 30 min, gradually warmed to room 
temperature and stirred for 8 h. The reaction mixture was poured into 150 mL of Et2O, stirred for 
5 min, filtered through a plug of celite, washed with 300 mL of Et2O, and concentrated in vacuo. 
The resulting residue was purified by chromatography on SiO2 (10% EtOAc/Hexanes) to yield 
3.80 g (83%) of 48 as a yellow solid: Mp 198-200 ºC (EtOAc/Hexanes); IR (KBr) 3431, 3057, 
2360, 1635, 1203, 1123, 1026 cm-1; 1H NMR δ 9.62 (d, 1 H, J = 31.2 Hz), 8.25 (dd, 1 H, J = 2.2, 
7.4 Hz), 8.00-7.84 (m, 3 H), 7.57 (dd, 1 H, J = 1.6, 5.9 Hz) 7.50-7.28 (m, 9 H); 13C NMR δ 
172.5, 134.4, 134.0, 133.7, 133.3, 131.8, 131.4, 129.6, 128.4, 127.9, 127.5; MS (EI) m/z (rel 
intensity) 386 (53), 384 (M+, 55), 348 (8), 306 (4), 201 (100), 183 (7); HRMS (EI) Calcd for 
C19H16NOPBr 384.0153, found 384.0137. 
 
NHP(O)Ph2
Br
49  
1-(2-Bromophenyl)-2-methylpropyl-P,P-diphenylphosphinamide (49).  A solution of 4.00 g 
(4.90 mmol) of 48 in 40 mL of THF was added to 13.0 mL of a 2 M solution of isopropyl 
magnesium chloride in THF at 0 ºC. The resulting reaction mixture was gradually warmed to 
room temperature and stirred for 5 h, cooled to 0 ºC, quenched with NH4Cl, and extracted with 
CH2Cl2 (3x). The combined organic layers were dried (MgSO4), filtered, and concentrated in 
vacuo to yield 3.5 g (79%) of 49 as a white solid that was used without further purification: Mp 
198-200 ºC; IR (KBr) 3057, 2961, 1590, 1359, 1105 cm-1; 1H NMR (CD3OD) δ 7.73-7.66 (m, 2 
H), 7.52-7.42 (m, 4 H), 7.41-7.32 (m, 4 H), 7.31-7.23 (2 H), 7.22-7.15 (m, 1 H), 7.04-6.96 (m, 1 
H), 5.64 (bt, 1 H, J = 10.5 Hz), 4.23 (bq, 1 H, J = 10.8 Hz), 1.98-1.81 (m, 1 H), 1.04 (d, 3 H, J = 
6.7 Hz), 0.71 (d, 3 H, J = 6.8 Hz); 13C NMR δ 144.1, 133.8, 132.7, 132.6, 132.5, 132.3, 131.8, 
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131.7, 131.6, 131.6, 131.4, 130.9, 128.4, 128.2, 128.1, 127.9, 127.1, 34.3, 19.8, 18.2; MS (EI) 
m/z (rel intensity) 430 (3), 428 (M+, 4), 386 (10), 384 (10), 338 (15), 294 (11), 248 (12), 201 
(22), 127 (16), 107 (32), 91 (100); HRMS (EI) Calcd for C22H23NOPBr (M– C3H7) 384.0153, 
found 384.0157. 
 
 
NH2
Br
50  
1-(2-Bromophenyl)-2-methylpropylamine (50).  A solution of 1.00 g (2.34 mmol) of 49 in 10 
mL of 20% aqueous HCl was heated at reflux for 1 h, cooled to 0 ºC, and extracted with Et2O.  
The aqueous layer was basified with NaOH, and extracted with Et2O (3x).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated in vacuo to yield 440 mg (75%) of 
50 as a light yellow oil that was used without further purification: IR (neat) 3251, 3010, 1605, 
1098, 924 cm-1; 1H NMR δ 7.60 (d, 1 H, J = 7.4 Hz), 7.52 (d, 1 H, J = 7.9 Hz), 7.25 (t, 1 H, J = 
3.9 Hz), 7.11 (t, 1 H, J = 7.2 Hz), 4.10 (d, 1 H, J = 7.5 Hz), 1.99-1.92 (m, 1 H), 0.95 (d, 3 H, J = 
6.7 Hz), 0.86 (d, 3 H, J = 6.8 Hz); 13C NMR δ 138.4, 133.2, 129.4, 128.4, 127.9, 124.2, 60.1, 
33.2, 19.4, 18.5; MS (EI) m/z (rel intensity) 226 (M+, 6), 224 (5), 212 (7), 184 (100), 182 (98), 
130 (8), 115 (6), 104 (30); HRMS (EI) Calcd for C10H11NBr 224.0070, found 224.0075. 
  
 
NMe2
Br
51  
1-(2-Bromophenyl)-2-methylpropyldimethylamine (51).  To 150 mg (0.650 mmol) of 50 was 
added 220 µL (2.92 mmol) of a 37% aqueous solution of formaldehyde, 260 µL (6.06 mmol) of 
aqueous 88% formic acid, and 3 mL of H2O.  The reaction mixture was heated at reflux for 16 h, 
cooled to 0 ºC, basified with NaOH, and extracted with Et2O (3x).  The combined organic layers 
were dried with MgSO4, filtered, and concentrated in vacuo to yield 93 mg (55%) of 51 as a clear 
oil: IR (neat) 3054, 2930, 1245, 1120, 654 cm-1; 1H NMR δ 7.53 (d, 1 H, J = 7.9 Hz), 7.31-7.18 
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(m, 2 H), 7.08- 6.98 (m, 1 H), 3.77 (d, 1 H, J = 8.6 Hz), 2.21-2.09 (m, 1 H), 2.15 (s, 6 H), 0.98 
(d, 3 H, J = 6.6 Hz), 0.71 (d, 3 H, J = 6.7 Hz); 13C NMR δ 137.6, 132.9, 129.5, 128.0, 126.9, 
126.5, 72.2, 41.7, 29.7, 20.1, 18.6; MS (EI) m/z (rel intensity) 257 (19), 255 (M+, 21), 214 (98), 
212 (100), 198 (6), 169 (7), 132 (37), 115 (10). 
 
SH
OH
55  
(2-Mercaptophenyl)methanol (55).82  A solution of 10.0 g (64.8 mmol) of thiosalicylic acid in 
50 mL of THF was added portionwise to a slurry of 4.50 g (112 mmol) of LAH in 100 mL of 
THF at 0 ºC.  The reaction mixture was slowly warmed to room temperature, stirred for 15 h, 
cooled to 0 ºC, diluted with 22 mL of EtOAc and 90 mL of H2SO4, filtered through a pad of 
celite, dried (MgSO4), filtered, and concentrated in vacuo.  The resulting residue was purified by 
chromatography on SiO2 (5% EtOAc/Hexanes) to yield 6.20 g (68%) of 55 as a clear oil: 1H 
NMR δ 7.40-7.33 (m, 2 H), 7.30-7.13 (m, 2 H), 5.16 (s, 2 H), 3.47 (s, 1 H), 2.09 (s, 1 H); MS 
(EI) m/z (rel intensity) 122 ([M-H2O]+, 100), 111 (18). 
 
SBn
OH
56  
(2-Benzylsulfanylphenyl)methanol (56).83  A solution of 6.20 g (44.3 mmol) of 55 in 75 mL of 
95% EtOH was added to a solution of 1.86 g (1.05 mmol) of NaOH in 100 mL of 95% EtOH.  
The resulting solution was stirred at room temperature for 45 min, followed by the addition of 
5.27 mL (44.3 mmol) of benzyl bromide in 100 mL of 95% EtOH at 0 ºC.   The reaction mixture 
was heated at reflux for 15 h, cooled to 0 ºC, concentrated in vacuo, diluted with H2O, and 
extracted with Et20 (3x).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo.  The resulting residue was purified by chromatography on SiO2 (20% 
EtOAc/Hexanes) to yield 7.40 g (73%) of 56 as a white solid: Mp 48-49 ºC (EtOAc/Hexanes, lit. 
48-49 ºC); 1H NMR δ 7.42-7.32 (m, 2 H), 7.29-7.13 (m, 7 H),  4.62 (d, 2 H, J = 6.0 Hz), 4.07 (s, 
2 H); MS (EI) m/z (rel intensity) 182 ([M-?]+, 23), 139 (15), 122 (100), 109 (10). 
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57  
2-Benzylsulfanylbenzaldehyde (57).  To 4.50 g (19.5 mmol) of 56 in 200 mL of CH2Cl2 at 0 ºC 
was added portionwise 25.0 g (97.5 mmol) of barium manganate. The resulting black solution 
was stirred for 15 h at room temperature, filtered through a pad of celite, and concentrated in 
vacuo to yield 3.60 g (86%) of 57 as a white solid: Mp 78-79 ºC (CH2Cl2, lit. 78-79 ºC); MS (EI) 
m/z (rel intensity) 230 (M+, 7), 212 (7), 139 (100), 121 (9), 111 (22), 109 (9); 1H NMR δ 10.26 
(s, 1 H); 7.80 (d, 1 H, J = 7.9 Hz); 7.50-7.38 (m, 3 H); 7.37-7.20 (m, 5 H); 4.18 (s, 2 H). 
 
SBn
H
NP(O)Ph2
58  
2-Benzylsulfanyl-P,P-diphenylphosphinamide (58).  A suspension of 3.77 g (16.5 mmol) of 
57, 2.30 g (10.6 mmol) of, and 4.41 mL (31.7 mmol) of triethylamine in 50 mL of CH2Cl2 was 
cooled to 0 ºC, treated dropwise over 20 min with a solution of 640 µL of (5.79 mmol) TiCl4 in 
10 mL of CH2Cl2, gradually warmed to room temperature, and stirred for 8 h.  The reaction 
mixture was poured into 150 mL of Et2O, stirred for 5 min, filtered through a plug of celite, 
washed with 300 mL of Et2O, and concentrated in vacuo. The resulting residue was purified by 
chromatography on SiO2 (10% EtOAc/Hexanes) to yield 3.8 g (83%) of 58 as a yellow solid: Mp 
116-118 ºC (EtOAc/Hexanes); IR (KBr) 3058, 3028, 1690, 1585, 2738, 2359, 1264, 829 cm-1; 1H 
NMR δ 9.69 (d, 1 H, J = 31.9 Hz), 8.13-7.98 (m, 5 H), 7.58-7.43 (m, 8 H), 7.40-7.27 (m, 5 H), 
7.25-7.18 (m, 1 H), 4.18 (s, 2 H); 13C NMR δ 172.0, 141.3, 136.2, 134.6, 134.3, 133.9, 133.0, 
132.2, 131.6, 129.8, 128.9, 128.4, 128.2, 127.3, 126.0, 39.1; MS (EI) m/z (rel intensity) 428 (M+, 
9), 336 (12), 201 (24), 91 (79), 77 (100). 
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59  
1-(2-Benzylsulfanylphenyl)-2-methylpropyl-P,P-diphenylphosphinamide (59).  A solution of 
2.10 g (4.90 mmol) of 58 in 50 mL of THF was added to 6.13 mL of a 2 M solution of isopropyl 
magnesium chloride in THF at 0 ºC. The reaction mixture was gradually warmed to room 
temperature and stirred for 5 h, cooled to 0 ºC, quenched with NH4Cl, and extracted with CH2Cl2 
(3x). The combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo. The 
residue was purified by chromatography on SiO2 (50% EtOAc/Hexanes) to yield 1.80 g (78%) of 
59 as an off white solid.  The enantiomers were separated using Chiral HPLC (Chiralcel AD-H 
semi-prep column) with ~85 mg/injection of 59 and eluting with 30% i-PrOH/Hexanes at a flow 
rate of 10 mL/min. 
 
(S)-59: Mp 133-138 ºC (i-PrOH/Hexanes); Rt = 11.2 min; [α]D25 -31.6 (c 0.5, CHCl3); IR (KBr) 
3050, 2945, 1558, 1248, 1346, 1156 cm-1; 1H NMR (CD3OD) δ 7.74-7.62 (m, 2 H), 7.57-7.28 
(m, 6 H), 7.19-6.97 (m, 11 H), 5.46 (bt, 1 H, J = 10.6 Hz), 4.54 (bs, 1 H), 3.67 (bd, 1 H, J = 11.9 
Hz), 3.50 (m, 1 H), 1.91-1.70 (m, 1 H), 0.96 (d, 3 H, J = 6.7 Hz), 0.66 (d, 3 H, J = 6.4 Hz); 13C 
NMR δ 144.2, 137.0, 132.7, 132.6, 131.9, 131.8, 131.6, 131.4, 129.0, 128.4, 128.1, 127.9, 127.0, 
126.6,  64.2, 39.9, 34.8, 25.4, 20.2;  MS (EI) m/z (rel intensity) 471 (M+, 10), 428 (69), 336 (19), 
306 (77), 270 (42), 201 (100); HRMS (EI) Calcd for C29H30NOPS 471.1785, found 471.1807. 
 
(R)-59:  Mp 132-135 ºC; [α]D25 +45.3 (c 0.8, CHCl3); Rt = 20.2 min; 1H NMR (CD3OD) δ 7.75-
7.65 (m, 2 H); 7.57-7.29 (m, 6 H), 7.23-6.97 (m, 11 H), 5.48 (bt, 1 H, J = 10.7 Hz), 4.53 (bs, 1 
H), 3.70 (bd, 1 H, J = 12.1 Hz), 3.40-3.60 (m, 1 H), 1.90-1.71 (m, 1 H), 0.98 (d, 3 H, J = 6.7 Hz), 
0.68 (d, 3 H, J = 6.5 Hz); 13C NMR δ 144.2, 137.0, 132.6, 132.5, 131.8, 131.6, 131.3, 129.0, 
128.3, 128.0, 127.8, 127.1, 126.9, 126.6, 39.9, 34.7, 22.5, 20.1; MS (EI) m/z (rel intensity) 471 
(M+, 20), 428 (75), 270 (35), 201 (88), 136 (18); HRMS (EI) Calcd for C29H30NOPS 471.1785, 
found 471.1785. 
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60  
1-(2-Benzylsulfanylphenyl)-2-methylpropylamine (60).  A solution of 900 mg (1.91 mmol) of 
59 in 10 mL  of  20% aqueous HCl  was heated at reflux for 45 min, cooled to 0 ºC, diluted with 
Et2O, and  filtered. The filtrate was extracted with Et2O, the aqueous layer was basified with 
NaOH, and extracted with Et2O (3x).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo.  The resulting yellow oil 60 was used without further 
purification.   
 
(S)-60: [α]D25 +52.5 (c 0.3, CHCl3); IR (neat) 3444, 3060, 2361, 1650, 1472, 1361 cm-1; 1H 
NMR δ 7.55-7.42 (m, 2 H), 7.39-7.10 (m, 9 H), 4.19 (d, 1 H, J = 7.4 Hz), 4.16, 4.11 (AB, 2 H, J 
= 12.6 Hz), 1.92 (o, 1 H, J = 6.8 Hz), 1.02 (d, 3 H, J = 6.6 Hz), 0.83 (d, 3 H, J = 6.8 Hz); 13C 
NMR δ 146.6, 137.5, 133.5, 130.9, 128.9, 128.4, 127.2, 127.0, 126.9, 126.6, 57.9, 40.1, 34.5, 
20.1, 18.4; MS (EI) m/z (rel intensity) 271 (M+, 30), 254 (43), 228 (100), 163 (17), 136 (29), 106 
(32); HRMS (EI) Calcd for C17H21NS 271.1380, found 271.1395. 
 
(R)-60: [α]D25 -44.3 (c = 0.6, CHCl3); IR (neat) 3430, 2967, 2122, 1590, 1266, 1190 cm-1; 1H 
NMR δ 7.43-7.37 (m, 2 H), 7.31-7.14 (m, 7 H), 4.16 (d, 1 H, J = 7.4 Hz), 4.09, 4.04 (AB, 2 H, J 
= 12.7 Hz), 1.86 (o, 1 H, J = 6.8 Hz), 0.97 (d, 3 H, J = 6.6 Hz), 0.77 (d, 3 H, J = 6.8 Hz); 13C 
NMR δ 146.4, 137.5, 134.5, 130.9, 128.8, 128.4, 127.1, 126.9, 126.8, 126.6, 57.8, 40.0, 34.5, 
20.1, 18.3; MS (EI) m/z (rel intensity) 270 (M+, 20), 254 (33), 244 (43), 228 (100), 136 (32), 106 
(18). 
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SBn
N
61  
1-(2-Benzylsulfanylphenyl)-2-methylpropyldimethylamine (61).  To 450 mg (1.66 mmol) of 
60 was added 652 µL (7.80 mmol) of a 37% aqueous formaldehyde solution, 752 µL (15.4 
mmol) of 88% aqueous formic acid, and 5 mL of H2O.  The resulting solution was heated at 
reflux for 20 h, cooled to 0 ºC, basified with NaOH, and extracted with CHCl3 (3x). The 
combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo to yield 310 
mg (54%) of 61 over 2 steps as a clear oil.     
 
(S)-61:  [α]D25 +87.0 (c 0.4, CHCl3); IR (neat) 3145, 2899, 2710, 1704, 1211, 754 cm-1; 1H NMR 
δ 7.43-7.36 (m, 1 H), 7.32-7.12 (m, 8 H), 4.07 (s, 2 H), 3.91 (d, 1 H, J = 8.2 Hz), 2.27-2.04 (m, 1 
H), 2.13 (s, 6 H), 0.95 (d, 3 H, J = 6.6 Hz), 0.70 (d, 3 H, J = 6.7 Hz); 13C NMR δ 138.8, 137.4, 
130.3, 128.9, 128.5, 128.4, 127.1, 126.9, 125.6, 69.7, 42.1, 39.9, 29.6, 20.3, 18.5; MS (EI) m/z 
(rel intensity) 299 (M+, 33), 256 (100), 179 (27), 164 (32), 150 (19); HRMS (EI) Calcd for 
C19H25NS 299.1697, found 299.1708. 
 
(R)-61: [α]D25 -30.7 (c 0.3, CHCl3); IR (neat) 3053, 2802, 2705, 1625, 1287 cm-1; 1H NMR δ 
7.43-7.37 (m, 1 H), 7.33-7.11 (m, 8 H), 4.07 (s, 2 H), 3.95 (d, 1 H, J = 8.3 Hz), 2.29-2.05 (m, 1 
H), 2.15 (s, 6 H), 1.00 (d, 3 H, J = 6.6 Hz), 0.74 (d, 3 H, J = 6.7 Hz); 13C NMR δ 138.8, 137.3, 
130.1, 128.8, 128.3, 128.3, 127.0, 126.7, 125.4, 69.6, 42.0, 39.8, 29.6, 20.3, 18.6; MS (EI) m/z 
(rel intensity) 298 (M+, 8), 256 (100), 209 (37), 164 (21). 
 
SH
N
62 
(R)-2-(1-Dimethylamino-2-methylpropyl)benzenethiol (62).  A solution of 140 mg (0.47 
mmol) of 61 in 5 mL of THF at -78 ºC was treated with 27 mL of liquid NH3, followed by 
addition of 432 mg (0.187 mmol) of Na, stirred for 45 min at -78 ºC, and quenched with solid 
NH4Cl.  The resulting solution was evaporated under N2, the residue dissolved in H2O, and 
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extracted with CHCl3 (3x). The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo. The resulting residue was purified by chromatography on SiO2 (25% 
EtOAc/Hexanes) to yield 35 mg (36%) of crude 62 as a clear oil and 10 mg (10%) of disulfide 
compound 63.   
 
(S)-62: 1H NMR δ 7.34 (d, 1 H), 7.10-6.90 (m, 3 H), 3.50 (d, 1 H, J = 6.7 Hz), 2.40 (s, 6 H), 
2.50-2.30 (m, 1 H), 0.99 (d, 3 H, J = 6.7 Hz), 0.87 (d, 3 H, J = 6.7 Hz) 
 
(R)-62: [α]D25 -30.7 (c 0.3, CHCl3); 1H NMR δ 7.34 (d, 1 H, J = 9.4 Hz), 7.11-6.95 (m, 3 H), 
3.50 (d, 1 H, J = 6.7 Hz), 2.40 (s, 6 H), 2.44-2.25 (m, 1 H), 1.00 (d, 3 H, J = 6.7 Hz), 0.87 (d, 3 
H, J = 6.7 Hz); MS (EI) m/z (rel intensity) 208 (M+, 44), 166 (64), 149 (18), 125 (20), 111 (34), 
97 (48); HRMS (EI) Calcd for C12H18NS 208.1155, found 208.1160. 
 
S)2
N
63 
(S)-(1-(2-(2-(1-Dimethylamino-2-methylpropyl)-phenyldisulfanyl)phenyl)-2-methyl-
propyl)dimethylamine) (63).  IR (KBr) 3060, 2955, 2816, 1585, 1459, 1248, 1152, 872, 524 cm 
–1; 1H NMR δ 7.60 (d, 2 H, J = 8.0 Hz), 7.25-7.08 (m, 6 H), 3.82 (d, 2 H, J = 8.8 Hz), 2.30-2.08 
(m, 2 H), 2.16 (s, 12 H), 0.96 (d, 6 H, J = 6.6 Hz), 0.74 (d, 3 H, J = 7.0 Hz), 0.72 (d, 3 H, J = 7.0 
Hz). 
 
SAc
NMe2
64  
2-(1-Dimethylamino-2-methylpropyl)benzenethiolacetate (64).  To 140 mg (0.67 mmol) 61 in 
5 mL of CH3CN was added 0.10 mL (0.74 mmol) of triethylamine.  The resulting solution was 
stirred for 5 min, followed by addition of 47.5 µL (0.679 mmol) of acetyl chloride and continued 
to stir at room temperature for 6 h.  The reaction mixture was diluted with H2O and extracted 
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with CH2Cl2 (3x).  The combined organic layers were dried (MgSO4), filtered, and concentrated 
in vacuo.  The resulting residue was purified by chromatography on SiO2 (5% MeOH/CH2Cl2) to 
yield 95 mg (56%) of 64 as a clear oil: [α]D25 -30.7 (c 0.3, CHCl3); 1H NMR δ 7.45-7.37 (m, 3 
H), 7.33-7.27 (m, 1 H), 3.69 (d, 1 H, J = 8.4 Hz), 2.43 (s, 3 H), 2.27-2.10 (m, 1 H), 2.12 (s, 6 H), 
0.94 (d, 3 H, J = 6.6 Hz), 0.70 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 224 (M+-?, 7), 208 
(39), 166 (42), 91 (34). 
 
 
(R)-1-Phenylhept-2-en-1-ol (27) using ligand (S)-62, (S)-63.  According to the general 
protocol, runs were conducted on a 500 mg or 250 mg scale of Schwartz reagent at both 5 and 10 
mol% chiral ligand loading.   Resulting yields and %ee of 27 are listed in Table 2. 
 
(S)-1-Phenylhept-2-en-1-ol (27) using of ligand (R)-62, (R)-64.  According to the general 
protocol, runs were conducted on a 500 mg or 250 mg scale of Schwartz reagent at both 5 and 10 
mol% chiral ligand loading.   Resulting yields and %ee84 of 27 are listed in Table 2. 
 
SBn
H
O
57  
2-Benzylsulfanylbenzaldehyde (57). A suspension of 9.5 mg (0.5 mmol) of CuI, 0.12 mL (1.0 
mmol) of 2-bromobenzaldehyde (1.00 mmol), and 276 mg (2.0 mmol) of K2CO3 was added to a 
screw-capped sealed tube.  The tube was evacuated and backfilled with nitrogen (3 cycles).  1.0 
mL of i-PrOH, 0.11 mL of ethylene glycol, and 0.12 mL (1.0 mmol) of benzylmercaptan were 
added at rt.  The tube was heated to 80 ºC for 20 h, cooled, filtered through frit, and concentrated 
in vacuo. The resulting crude residue was purified by chromatography on SiO2 (100% hexanes) 
to yield 200 mg (71%) of 57 as a yellow solid: Mp 78-79 ºC (CH2Cl2, lit. 78-79 ºC); MS (EI) m/z 
(rel intensity) 230 (M+, 7), 212 (7), 139 (100), 121 (9), 111 (22), 109 (9); 1H NMR δ 10.26 (s, 1 
H), 7.80 (d, 1 H, J = 7.9 Hz), 7.50-7.38 (m, 3 H), 7.37-7.20 (m, 5 H), 4.18 (s, 2 H). 
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SBn
Ph2(O)PHN
66  
1-(2-Benzylsulfanylphenyl)-3-methylbutyl-P,P-diphenylphosphinamide (66).  A solution of 
2.70 g (6.31 mmol) of 59 in 50 mL of THF was added to 7.90 mL (15.8 mmol) of a 2 M solution 
of isobutyl magnesium chloride in THF at 0 ºC. The reaction mixture was stirred for 5 h at 0 ºC, 
quenched with NH4Cl, and extracted with CH2Cl2 (3x). The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo. The residue was purified by chromatography on 
SiO2 (25% EtOAc/Hexanes) to yield 2.20 g (72%) of 66 as a white foamy solid: Mp 109-111 ºC; 
IR (KBr) 3193, 3056, 2952, 2866, 2360, 1437, 1188, 1122, 722 cm-1; 1H NMR δ 7.92 (dd, 2 H, J 
= 7.8, 11.7 Hz), 7.77 (dd, 2 H, J = 7.8, 11.7 Hz), 7.52-7.31 (m, 5 H), 7.30-7.19 (m, 6 H), 7.18-
7.07 (m, 4 H), 4.79 (bs, 1 H), 3.95-3.70 (m, 3 H), 1.93-1.64 (m, 2 H), 1.64-1.45 (s, 1 H), 0.95 (d, 
3 H, J = 6.0 Hz), 0.87 (d, 3 H, J = 6.3 Hz); 13C NMR δ 145.5, 137.0, 134.0, 133.1, 132.9, 132.40, 
132.3, 131.9, 131.8, 131.7, 131.4, 131.4, 131.2, 131.2, 128.7, 128.5, 128.2, 128.2, 128.0, 128.0, 
127.8, 127.1, 126.9, 51.8, 39.8, 24.7, 22.9, 21.8; MS (EI) m/z (rel intensity) 485 (M+, 20), 428 
(37), 362 (14), 306 (50), 284 (98), 201 (96), 135 (20), 91 (100), 77 (47); HRMS (EI) Calcd for 
C30H32NOPS 485.1942, found 485.1936. 
 
SBn
NH2
67  
1-(2-Benzylsulfanylphenyl)-3-methylbutylamine (67).  A solution of 2.2 g (mmol) of 66 in 20 
mL of  20% aqueous HCl  was heated at reflux for 1 h, cooled to 0 ºC, diluted with Et2O, and  
filtered. The filtrate was extracted with Et2O, the aqueous layer was basified with NaOH, and 
extracted with Et2O (3x).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo.  The resulting yellow oil 67 was used without further purification: IR 
(KBr) 3280, 3124, 2956, 2675, 1280, 567 cm-1; 1H NMR δ 7.58 (d, 1 H, J = 7.2 Hz), 7.40 (d, 1 
H, J = 7.5 Hz), 7.35-7.15 (m, 7 H), 5.54 (bs, 2 H), 4.78 (s, 1 H), 4.10 (dt, 2 H, J = 4.5, 12.6 Hz), 
1.80-1.65 (m, 1 H), 1.66-1.50 (m, 2 H), 0.94 (d, 6 H, J = 3.0 Hz); 13C NMR δ 143.5, 137.4, 
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134.1, 132.3, 128.9, 128.4, 127.8, 127.7, 127.1, 126.4, 50.2, 45.9, 40.4, 24.9, 22.9, 22.1; MS (EI) 
m/z (rel intensity) 286 (M+, 12), 285 (45), 269 (12), 268 (40), 228 (64), 211 (25), 194 (61), 135 
(41), 91 (100); HRMS (EI) Calcd for C18H23NS 285.1551, found 285.1541. 
 
SBn
HN
Cbz
69  
[1-(2-Benzylsulfanylphenyl)-3-methylbutyl]carbamic acid benzyl ester (69).  To 2.2 g (7.72 
mmol) of 67 in 10 mL of THF was added 1.60 g (11.6 mmol) of K2CO3 followed by 1.21 mL 
(8.49 mmol) of benzyl chloroformate.  The resulting reaction was stirred for 15 h at rt, quenched 
with H2O, extracted with Et2O, washed with NaCl, dried (MgSO4), filtered, and concentrated in 
vacuo. The residue was purified by chromatography on SiO2 (50% EtOAc/Hexanes) to yield 
2.10 g (65%) of 67 as an off white solid:  
 
(S)-69: Mp 63-64 °C (EtOAc/Hexanes); [α]D25 +12.2 (c 0.5, CHCl3); 1H NMR δ 7.43-7.12 (m, 
14 H), 5.38-5.25 (m, 1 H), 5.30 (s, 2 H), 5.08 (d, 2 H, J = 5.4 Hz), 4.14 (s, 2 H), 1.70-1.50 (m, 1 
H), 0.97 (d, 3 H, J = 6.0 Hz), 0.92 (d, 3 H, J = 6.0 Hz); 13C NMR δ 155.5, 144.5, 137.4, 136.5, 
133.7, 132.9, 129.0, 128.4, 128.1, 127.5, 127.4, 127.1, 126.5, 66.7, 51.9, 45.9, 40.2, 25.3, 23.1, 
21.9; MS (EI) m/z (rel intensity) 419 (M+, 25), 362 (13), 318 (27), 284 (50), 268 (30), 211 (19), 
179 (20), 150 (41), 123 (30), 91 (100); HRMS (EI) Calcd for C26H29NO2S 419.1919, found 
419.1934. 
 
(R)-69: Mp 61-65 °C; [α]D25 –11.6 (c 0.5, CHCl3); 1H NMR δ 7.40-7.10 (m, 14 H), 5.35-5.15 (m, 
2 H), 5.30 (d, 2 H, J = 5.4 Hz), 4.14 (s, 2 H), 1.60-1.50 (m, 1 H), 0.97 (d, 3 H, J = 6.0 Hz), 0.92 
(d, 3 H, J = 6.3 Hz); 13C NMR δ 155.5, 144.4, 137.4, 136.5, 133.7, 132.9, 129.0, 128.4, 128.1, 
127.5, 127.4, 127.1, 126.5, 66.6, 51.9, 45.9, 40.2, 25.2, 23.1, 21.9; MS (EI) m/z (rel intensity) 
419 (M+, 25), 362 (13), 318 (27), 284 (50), 268 (30), 211 (19), 179 (20), 150 (41), 123 (30), 91 
(100); HRMS (EI) Calcd for C26H29NO2S (M+Na) 442.1817, found 442.1852. 
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 SBn
N
70  
1-(2-Benzylsulfanylphenyl)-3-methylbutyldimethylamine (70).  To 1.00 g (2.38 mmol) of 69 
in 50 mL of CH2Cl2 at –10 ºC was added of 11.9 mL (11.9 mmol) of a 1M solution of BBr3 in 
CH2Cl2.  The resulting reaction was stirred at –10 ºC for 1 h, rt for 15 h, cooled to 0 ºC, 
quenched with H2O, extracted with CH2Cl2, dried (MgSO4), filtered, and concentrated in vacuo.  
The resulting residue was used without further purification.   
To 760 mg (2.67 mmol) of amine was added 1.05 mL (12.6 mmol) of a 37% aqueous 
formaldehyde solution, 1.21 mL (24.8 mmol) of 88% aqueous formic acid, and 10 mL of H2O.  
The resulting solution was heated at reflux for 20 h, cooled to 0 ºC, basified with NaOH, and 
extracted with CHCl3 (3x). The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo to yield 250 mg (33%) of 70 over 2 steps as a clear oil. 
 
(S)-70: [α]D25 +1.7 (c 0.9, CHCl3); IR (neat) 3190, 3145, 2886, 1620, 1301, 760, 642 cm-1; 1H 
NMR δ 7.42-7.15 (m, 9 H), 4.13 (s, 2 H), 4.11 (t, 1 H, J = 7.5 Hz), 2.20 (s, 6 H), 1.68 (t, 2 H, J = 
6.9 Hz), 1.31-1.18 (sp, 1 H, J = 6.3 Hz), 0.89 (d, 3 H, J = 6.6 Hz), 0.83 (d, 3 H, J = 6.6 Hz); 13C 
NMR δ 141.0, 137.4, 137.4, 129.5, 129.0, 128.5, 127.8, 127.2, 127.1, 125.9, 62.8, 42.2, 40.8, 
39.4, 25.2, 23.9, 22.5; MS (EI) m/z (rel intensity) 313 (M+, 25), 256 (67), 222(35), 164 (33), 135 
(54), 91 (90); HRMS (EI) Calcd for C20H27NS 313.1853, found 313.1864. 
 
(R)-70: [α]D25 –7.3 (c 0.02, CHCl3); IR (KBr) 3205, 3156, 2863, 1560, 1309, 927 cm-1; 1H NMR 
δ 7.45-7.10 (m, 9 H), 4.13 (s, 2 H), 4.10 (t, 1 H, J = 9.9 Hz), 2.19 (s, 6 H), 1.67 (t, 2 H, J = 7.5 
Hz), 1.32-1.17 (m, 1 H), 0.89 (d, 3 H, J = 6.3 Hz), 0.83 (d, 3 H, J = 6.6 Hz); 13C NMR δ 140.9, 
137.4, 137.3, 129.4, 129.0, 128.5, 127.7, 127.2, 127.1, 125.8, 62.7, 42.2, 40.8, 39.3, 25.2, 23.9, 
22.5; MS (EI) m/z (rel intensity) 313 (M+, 8), 268 (8), 256 (100), 222 (65), 164 (30), 135 (60), 91 
(95); HRMS (EI) Calcd for C20H27NS 313.1854, found 313.1864. 
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SH
N
71  
2-(1-Dimethylamino-3-methylbutyl)benzenethiol (71).  A solution of 160 mg (0.51 mmol) of 
70 in 5 mL of THF at -78 ºC was treated with 26.0 mL of liquid NH3, followed by addition of 
345 mg (0.15 mmol) of Na, stirred for 45 min at -78 ºC, and quenched with solid NH4Cl.  The 
resulting solution was evaporated under N2, the residue dissolved in H2O, and extracted with 
CHCl3 (3x). The combined organic layers were dried (MgSO4), filtered, and concentrated in 
vacuo. The resulting residue was purified by chromatography on SiO2 (25% EtOAc/Hexanes) to 
yield 120 mg (97%) of crude 71 as a clear oil.   
 
(S)-71: [α]D25 +9.2 (c 0.5, CHCl3); 1H NMR δ 7.75-7.65 (m, 1 H), 7.33-7.10 (m, 3 H). 3.91 (dd, 
1 H, J = 4.2, 6.2 Hz), 2.25 (s, 6 H), 1.83 (qd, 1 H, J = 3.9, 9.9 Hz), 1.67 (qd, 1 H, J = 4.2, 9.3 
Hz), 1.43-1.28 (m, 1 H), 0.94 (d, 3 H, J = 6.6 Hz), 0.89 (d, 3 H, J = 6.6 Hz); 13C NMR δ 140.6, 
138.3, 128.4, 127.6, 127.4, 125.9, 63.9, 41.8, 39.0, 25.3, 24.0, 22.3; MS (EI) m/z (rel intensity) 
233 (5), 222 (48), 190 (10), 177 (24), 166 (70), 149 (58), 135 (100), 123 (42). 
 
(R)-71: [α]D25 –6.2 (c 0.5, CHCl3); 1H NMR δ 7.76-7.64 (m, 1 H), 7.38-7.10 (m, 3 H), 3.91 (dd, 
1 H, J = 4.2, 10.5 Hz), 2.25 (s, 6 H), 1.85 (qd, 1 H, J = 3.9, 9.9 Hz), 1.67 (qd, 1 H, J = 4.2, 9.3 
Hz), 1.45-1.30 (m, 1 H), 0.95 (d, 3 H, J = 6.3 Hz), 0.89 (d, 3 H, J = 6.6 Hz); 13C NMR δ 140.6, 
138.3, 128.4, 127.6, 127.4, 125.9, 63.9, 41.8, 39.0, 25.3, 24.0, 22.3; MS (EI) m/z (rel intensity) 
233 (4), 222 (40), 190 (10), 177 (20), 166 (68), 149 (58), 135 (100), 123 (38). 
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N72
HO
Ph Me
 
(1R,2S)-1-Phenyl-2-(1-pyrrolidinyl)propan-1-ol (72).85 A solution of 500 mg (3.30 mmol) of 
(1R,2S)-(-)-norephedrine, 0.79 mL (6.6 mmol)of 1,4-dibromobutane, and 2.28 g (16.5 mmol) of 
K2CO3 in 5 mL of EtOH was heated at reflux for 24 h.  The resulting heterogeneous solution was 
filtered and 345 mg (52%) of 72 was obtained as a solid: Mp 44-46 ºC (acetonitrile); [α]D25 
+13.0 (c 1.0, CHCl3); lit.85 [α]D25 +13.1 (c 2.0, CHCl3); 1H NMR δ 7.36-7.23 (m, 5 H), 5.08 (d, 1 
H, J = 2.1 Hz), 3.60 (bs, 1 H), 2.91-2.88 (m, 2 H), 2.76-2.73 (m, 2 H), 2.63-2.55 (m, 1 H), 1.92-
1.83 (m, 4 H), 0.85 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 204 (M+, 25), 187 (33), 160 
(14), 105 (21), 98 (100). 
 
N
73
AcS
Ph Me
 
(1R, 2S)-1-Acetylthio-1-phenyl-2-(1-pyrrolidinyl)propane (73).85 To a solution of 250 mg 
(1.22 mmol) of 72 and 0.260 mL (1.83 mmol) of triethylamine in 5 mL of CH2Cl2 at -78 ºC was 
added 0.100 mL (1.35 mmol) of methanesulfonylchloride. The reaction mixture was stirred for 
30 min at -78 ºC, concentrated in vacuo, redissolved in 5 mL of H2O, warmed to room 
temperature, treated with 418 mg (3.66 mmol) of potassium thioacetate, stirred for 2 h at room 
temperature, and extracted with CH2Cl2 (3x). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo. The resulting residue was purified by chromatography on 
SiO2 (20% EtOAc/Hexanes) to yield 0.070 g (21%) of 73 as a clear oil: [α]D25 +29.1 (c 0.5, 
CHCl3); 1H NMR δ 7.30-7.18 (m, 5 H), 4.94 (bs, 1 H), 2.65-2.49 (m, 5 H), 2.21 (s, 3 H), 1.75-
1.55 (m, 4 H), 0.93 (d, 3 H, J = 6.4 Hz). 
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N74
HO
Ph Me
O  
(1R,2S)-1-Phenyl-2-(1-morpholin)propan-1-ol (74).85 A solution of 500 mg (3.30 mmol) of 
(1R,2S)-(-)-norephedrine, 0.420 mL  (3.30 mmol) of 1,4-dibromoethylether, and 456 mg (3.30 
mmol) of K2CO3 in 10 mL  of CH3CN was heated at reflux for 20 h.  The heterogeneous solution 
was filtered and 350 mg (48%) of 74 was obtained as a beige solid: Mp 204-205 ºC (acetonitrile, 
lit.85 198-199);  [α]D25 -30.7 (c 0.3, CHCl3); 1H NMR (CD3OD) δ 7.40-7.25 (m, 4 H), 7.24-7.15 
(m, 1 H), 5.32 (s, 1 H), 4.10-3.85 (m, 2 H), 3.82-3.70 (m, 2 H), 3.65-3.51 (m, 2 H), 3.49-3.30 (m, 
2  H), 3.22-3.11 (m, 1 H), 1.05 (d, 3 H, J = 6.8 Hz); MS (EI) m/z (rel intensity) 220 (M+, 14), 203 
(14), 176 (12), 144 (11), 114 (100), 105 (10). 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 72.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 13 mg (0.060 mmol) of  ligand 72, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 104 mg (85%) of 27 with an 
ee of 19%.   
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 73.  According to the general 
protocol, 125 mg (0.484 mmol) of zirconocene hydrochloride, 44 µL (0.38 mmol) of 1-hexyne, 
0.16 µL (0.32 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.050 mmol) of  ligand 73, 
and 38 µL (0.32 mmol) of freshly distilled benzaldehyde provided 50 mg (81%) of 27 with an ee 
of 46%.  
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 74.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 29 mg (0.13 mmol) of  ligand 74, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 196 mg (80%) of 27 with an ee 
of 20%.73   
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OOCH3
75
HN
Ph  
Methyl-(S)-[N-phenyl-2-amino-3-methyl]butanoate (75). To a solution of 4.00 g (34.1 mmol) 
of L-valine methylester hydrochloride and 3.59 mL (34.1 mmol) of phenylbromide in 60 mL of 
dimethylacetamide was added 0.650 g (3.41 mmol) of copper iodide (I) and 7.07 g (34.1 mmol) 
of potassium carbonate.  The resulting solution was heated at reflux for 60 h, cooled to room 
temperature, diluted with 120 mL of EtOAc and 60 mL  of H2O, and adjusted to pH 3 using 
concentrated HCl. The organic layer was separated and aqueous layer extracted with EtOAc 
(3x).  The combined organic layers were washed with brine, dried (MgSO4), filtered, and 
concentrated in vacuo.  The resulting residue was purified by chromatography on SiO2 (10% 
EtOAc/Hexanes) to yield 7.00 g (99%) of 75 as a gray oil: [α]D25 -94 (c 1.0, CHCl3); lit.86 [α]D22 
-92 (c 0.8, CHCl3); 1H NMR δ 7.25-7.10 (m, 2 H), 6.72 (t, 1 H, J = 8.0 Hz), 6.63 (d, 2 H, J = 9.6 
Hz), 4.11 (bs, 1 H), 3.86 (d, 1 H, J = 5.9 Hz), 3.70 (s, 3 H), 2.29-2.00 (m, 1 H), 1.03 (d, 3 H, J = 
6.8 Hz), 1.01 (d, 3 H, J = 6.8 Hz). 
O
OCH3
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Methyl-(S)-[N-formyl-N-phenyl-2-amino-3-methyl]butanoate (76). To 8.18 mL (86.5 mmol) 
of acetic anhydride was added 4.07 mL of 88% aqueous formic acid at 0 ºC. The resulting 
solution was stirred at 60 ºC for 1 h, treated with a solution of 7.00 g (33.8 mmol) of 75 in 10 mL 
of THF, stirred for 2.5 h at 65 ºC, and concentrated in vacuo.  The resulting residue was purified 
by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 5.40 g (67%) of 76 as an orange oil: 
[α]D25 -80.1 (c 1.0, CHCl3); lit.86 [α]D22 -82.5 (c 2.0, CHCl3); 1H NMR δ 8.28 (s, 1 H), 7.40-7.20 
(m, 5 H), 4.57 (d, 1 H, J = 10.1 Hz), 3.65 (s, 3 H), 2.40-2.20 (m, 1 H), 0.94 (d, 3 H, J = 6.6 Hz), 
0.85 (d, 3 H, J = 6.7 Hz); MS (EI) m/z (rel intensity) 235 (M+, 8), 198 (17), 176 (70), 148 (100), 
104 (81). 
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(S)-N-Methyl-N-phenyl-2-amino-3-methylbutan-1-ol (77).  A solution of 4.00 g (17.0 mmol) 
of 76 in 60 mL of THF was added portionwise to a slurry of 3.22 g (85.1 mmol) of LAH in 60 
mL of THF at 0 ºC.  The resulting suspension was stirred for a further 15 min, quenched at 0 ºC 
with 3 mL of H2O, 3 mL of aqueous NaOH, and 9 mL  of H2O,  filtered through a pad of celite, 
dried (MgSO4), filtered, and concentrated in vacuo. The resulting residue was purified by 
chromatography on SiO2 (5% EtOAc/Hexanes) to yield 6.20 g (68%) of 77 as a yellow solid: Mp 
74-77 ºC (EtOAc/Hexanes, lit. 78-79 ºC); [α]D25 -145.2 (c 0.41, CHCl3); lit.86 [α]D22 -153.8 (c 
2.0, CHCl3); 1H NMR δ 7.33-7.15 (m, 2 H), 6.91 (bd, 2 H, J = 8.0 Hz), 6.77 (bt, 1 H, J = 7.1 
Hz), 3.90-3.72 (m, 1 H), 3.70-3.50 (m, 2 H), 2.79 (s, 3 H), 1.95-1.75 (m, 1 H), 0.94 (d, 3 H, J = 
6.6 Hz ), 0.77 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 193 (M+, 27), 162 (100), 150 (46), 
132 (32), 107 (44). 
SAc
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(S)-N-Methyl-N-phenyl-2-amino-3-methyl-1-thiolacetylbutane (78).  To a solution of 2.19 g 
(8.33 mmol) of triphenylphosphine in 30 mL of THF at 0 ºC was added 1.64 mL (8.33 mmol) of 
diisopropyl azodicarboxylate.  The resulting solution was stirred for 1 h at 0 ºC, followed by 
simultaneous addition of 0.59 mL (8.33 mmol) of thioacetic acid in 5 mL of THF and 800 mg 
(4.17 mmol) of 77 in 3 mL of THF.  The reaction mixture was stirred for 1 h at 0 ºC, 
concentrated in vacuo to 1/3 its’ volume, and washed with sodium bicarbonate.  The organic 
layer was filtered through SiO2 and concentrated in vacuo.  The resulting residue was purified by 
chromatography on SiO2 (5% EtOAc/Hexanes) to yield 548 mg (49%) of 78 as a yellow oil: 1H 
NMR δ 7.22-7.10 (m, 2 H), 6.70 (d, 2 H, J = 8.3 Hz), 6.62 (t, 1 H, J = 7.3 Hz), 3.61 (td, 1 H, J = 
3.8 Hz, 11.0 Hz), 3.47 (dd, 1 H, J = 3.8, 13.7 Hz), 2.96 (dd, 1 H, J = 11.1, 13.7 Hz), 2.69 (s, 3 
H), 2.20 (s, 3 H), 2.20-1.99 (bs, 1 H), 1.98-1.82 (m, 1 H), 1.04 (d, 3 H, J = 6.6 Hz), 0.80 (d, 3 H, 
J = 6.7 Hz). 
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(S)-N-Methyl-N-phenyl-2-amino-3-methylbutan-1-thiol (79).  A solution of 550 mg (2.03 
mmol) of 78 in 21 mL of THF was added portionwise to a slurry of 307 mg (8.11 mmol) of LAH 
in 18 mL of THF at 0 ºC. The suspension was stirred at room temperature for 30 min, cooled to 0 
ºC, quenched with 3 mL of H2O, 3 mL of aqueous NaOH, and 9 mL of H2O,  filtered through a 
pad of celite, dried (MgSO4), filtered, and concentrated in vacuo. The resulting residue was 
purified by chromatography on SiO2 (Hexanes) to yield 297 mg (70%) of 79 as a clear oil: [α]D25 
-89.5 (c 1.2, CHCl3); lit.86 [α]D22 -93.8 (c 0.8, CHCl3); 1H NMR δ 7.21 (t, 2 H, J = 9.3 Hz), 6.84 
(d, 2 H, J = 8.2 Hz), 6.70-6.60 (m, 1H), 3.58 (dt, 1 H, J = 5.0, 9.4 Hz), 2.85-2.77 (m, 2 H), 2.74 
(s, 3 H), 1.92-1.78 (m, 1  H), 1.39 (dd, 1 H, J = 5.4, 8.8 Hz); 0.97 (d, 3 H, J = 6.6 Hz); 0.79 (d, 3 
H, J = 6.7 Hz).  
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 77.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 12 mg (0.060 mmol) of  ligand 77, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 91 mg (74%) of 27 with an ee 
of 10%.   
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 78.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 53 mg (0.19 mmol) of ligand 78, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 183 mg (75%) of 27 with an ee 
of 16%.
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 79.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 19 mg (0.090 mmol) of  ligand 79, 
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and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (80%) of 27 with an ee 
of 17%.   
OH
O
OCH3HCl.H2N
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(L)-Serine methylester hydrochloride (80).87  To a solution of 1.46 mL (20.0 mmol) of thionyl 
chloride in 20 mL of MeOH at 0 ºC was added 2.10 g (20.0 mmol) of L-serine.  The reaction 
mixture was heated at reflux for 1 h and concentrated in vacuo. The resulting solid residue was 
resubjected to 2 M HCl as before, heated at reflux for an additional 1 h, and concentrated in 
vacuo to yield 3.00 g (97%) of 80 as a white solid: Mp 51-56 ºC (MeOH, lit. 163-166 ºC); [α]D25  
+3.7 (c 0.9, MeOH); lit.87 [α]D22 +4.0 (c 4.0, CHCl3); 1H NMR (CD3OD) δ 4.03 (bt, 3 H, J = 4.2 
Hz), 3.90, 3.80 (d of AB, 2 H, J = 4.5, 11.8 Hz), 3.75 (s, 3 H); MS (EI) m/z (rel intensity) 120 
(M+, 38), 88 (61), 74 (17), 60 (100). 
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(L)-Triphenylmethyl serine methylester (81).88  To a solution of 3.00 g (19.5 mmol) of 80 and 
5.43 mL (5.54 mmol) of triethylamine in 10 mL of CHCl3 at 0 ºC was added dropwise a solution 
of 5.43 mL (19.5 mmol) of chlorotriphenylmethane in 10 mL of CHCl3. The resulting solution 
was stirred for 24 h and concentrated in vacuo. The residue was dissolved in EtOAc, washed 
with sodium chloride, 10% citric acid, sodium bicarbonate, and sodium chloride.  The organic 
layer was dried (MgSO4), filtered, and concentrated in vacuo to yield 4.50 g (64%) of 81 as an 
off white solid.  The solid was used in subsequent steps without further purification: 1H NMR δ 
7.55-7.45 (m, 6 H), 7.35-7.20 (m, 6 H), 7.19-7.10 (m, 3 H), 3.71-3.62 (m, 1 H), 3.57-3.47 (m, 2 
H), 3.28 (s, 3 H), 3.10-2.90 (bs, 1 H), 2.2 (bs, 1 H). 
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1-Tritylaziridine-2-carboxylate methyl ester (82).  To a solution of 3.50 g (9.72 mmol) of 81 
and 2.70 mL (21.4 mmol) of triethylamine in 21 mL of THF was added dropwise a solution of 
0.69 mL (19.5 mmol) of methanesulfonyl chloride. The resulting solution was heated at reflux 
for 48 h at room temperature, and concentrated in vacuo.  The residue was dissolved in EtOAc, 
washed with 10% citric acid and sodium bicarbonate solution, dried (MgSO4), filtered, and 
concentrated in vacuo. The resulting residue was purified by titration of the crude residue with 
hexanes, followed by filtration of the precipitate to yield 1.85 g (56%) of 82 as an off-white 
solid: Mp 105-106 ºC (hexanes, lit. 127-129 ºC); [α]D25 -87.0 (c = 0.5, CHCl3); lit.88 [α]D22 -96.8 
(c 1.1, CH3OH); 1H NMR δ 7.60-7.40 (m, 5 H), 7.35-7.10 (m, 10 H), 3.75 (s, 3 H), 2.24 (dd, 1 H, 
J = 1.6, 2.7 Hz), 1.87 (dd, 1 H, J = 2.7, 6.2 Hz), 1.39 (dd, 1 H, J = 1.6, 6.2 Hz); MS (EI) m/z (rel 
intensity) 342 ( M+, 10 ), 302 (31), 266 (34), 243 (100), 165 (49), 115 (5). 
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N-Tritylaziridin-2-yldiphenylmethanol (83).  A solution of 5.83 mL (11.7 mmol) of phenyl 
magnesium bromide in 50 mL of THF was added to 1.00 g (2.92 mmol) of 82 in 50 mL of THF 
at 0 ºC. The reaction mixture was stirred for 15 h at room temperature, quenched at 0 ºC with 
ammonium chloride, and extracted with CH2Cl2 (3x). The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo. The resulting residue was purified by 
chromatography on SiO2 (10% EtOAc/Hexanes) to yield 1.20 g (88%) of 83 as a white solid: Mp 
130-132 ºC (EtOAc/ Hexanes, lit. 133.5-134.5 ºC); [α]D25 -76.5 (c 0.5,CHCl3); lit.88 [α]D22 -78.8 
(c 1.0, CHCl3); 1H NMR δ 7.48-7.42 (m, 2 H), 7.38-7.29 (m, 8 H), 7.25-7.10 (m, 15 H), 4.46 (s, 
1 H), 2.38 (dd, 1 H, J = 3.2, 6.2 Hz), 2.11 (bd, 1 H, J = 2.9 Hz), 1.36 (d, 1 H, J = 6.3 Hz); MS 
(EI) m/z (rel intensity) 390 ([M-C6H5]+, 12), 243 (100), 183 (10), 165 (77), 105 (26). 
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Aziridin-2-yldiphenylmethanol (84).89  A solution of 300 mg (0.64 mmol) of 83 in a mixture of 
CH2Cl2 (1.5 mL) and MeOH (1.5 mL) was treated at 0 ºC with 1.13 mL of trifluoroacetic acid. 
The resulting suspension was concentrated in vacuo, washed with sodium bicarbonate, and 
extracted with CH2Cl2 (3x).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo to yield 140 mg (97%) of 84 as a white solid which was used without 
further purification in the next step: Mp 144-145 ºC (CH2Cl2, lit. 145-147 ºC; [α]D25 -16.1 (c 0.5, 
CHCl3); lit.89 [α]D22 -16.3 (c 0.2, CHCl3); 1H NMR δ 7.45-7.25 (m, 10 H), 3.37 (bt, 1 H, J = 5.9 
Hz), 1.76 (d, 1 H, J = 3.5 Hz), 1.68 (d, 1 H, J = 3.9 Hz); MS (EI) m/z (rel intensity) 260 (M+, 43), 
206 (28), 183 (93), 154 (38), 105 (100). 
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N-Benzylaziridin-2-yldiphenylmethanol (85).  To a solution of 140 mg (0.620 mmol) of 84 
and 172 mg (1.24 mmol) of potassium carbonate in 5.60 mL of THF was added 0.0700 mL 
(0.620 mmol) of benzyl bromide. The reaction mixture was stirred at room temperature for 20 h, 
diluted with H2O and extracted with CH2Cl2 (3x). The combined organic layers were washed 
successively with 1 M HCl and H2O, dried (MgSO4), filtered, and concentrated in vacuo.  The 
resulting solid was purified by chromatography on SiO2 (5% EtOAc/Hexanes) to yield 88 mg 
(45%) of 85 as a white solid: Mp 86-91 ºC (EtOAc/Hexanes, lit. 88-92 ºC); [α]D25 -33.6 (c 0.5, 
CHCl3); lit.89 [α]D22 -35.4 (c 0.5, CH2Cl2); 1H NMR δ 7.60-7.45 (m, 2 H), 7.40-7.26 (m, 15 H), 
3.79 (d, 1 H, J = 13.2 Hz), 3.47 (d, 1 H, J = 13.3 Hz), 2.64-2.56 (m, 1 H), 2.07 (d, 1 H, J = 3.4 
Hz), 1.57 (d, 1 H, J = 6.3 Hz); MS (EI) m/z (rel intensity) 315 (M+, 42), 260 (47), 183 (95), 154 
(37), 132 (34), 105 (100). 
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N-Benzhydrylaziridin-2-yldiphenylmethanol (86).  To a solution of 500 mg (2.20 mmol) of 84 
and 590 mg (5.60 mmol) of potassium carbonate in 15 mL of THF was added 680 mg (3.31 
mmol) of benzhydryl chloride. The reaction mixture was heated at reflux for 5 d, quenched with 
H2O, and extracted with CH2Cl2 (3x). The combined organic layers were washed successively 
with 1 M HCl and H2O, dried (MgSO4), filtered, and concentrated in vacuo.  The resulting solid 
was purified by chromatography on SiO2 (5% EtOAc/Hexanes) to yield 300 mg (34%) of 86 as a 
white solid: Mp 192-193 ºC (CH2Cl2, lit. 192-194 ºC); [α]D25 -36.2 (c 0.5, CH2Cl2); lit.89 [α]D22 -
39.8 (c 0.3, CH2Cl2); 1H NMR δ 7.45-7.33 (m, 5 H), 7.32-7.17 (m, 4 H), 7.15-7.09 (m, 2 H), 
7.08-6.98 (m, 6 H), 6.97-6.89 (m, 3 H), 3.90 (s, 1 H), 3.84 (s, 1 H), 2.72 (dd, 1 H, J = 3.6, 6.4 
Hz), 2.11 (d, 1 H, J = 3.6 Hz), 1.58 (d, 1 H, J = 6.4 Hz); MS (EI) m/z (rel intensity) 391 (M+, 45), 
314 (31), 224 (37), 196 (71), 167 (100), 152 (21), 105 (13). 
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 83.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 45 mg (0.090 mmol) of ligand 83, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 105 mg (85%) of 27 with an 
ee of 8%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 85.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 28 mg (0.090 mmol) of ligand 85, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 91 mg (74%) of 27 with an ee 
of 12%.   
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 86.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 25 mg (0.060 mmol) of ligand 86, 
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and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (80%) of 27 with an ee 
of 48%.   
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1-(S)-Phenyl(((1’S)-1’-phenylethyl)methylamino)methyl)-2-naphthol (87).30 A solution of 
500 mg (3.47 mmol) of 2-naphthol, 0.600 mL (4.13 mmol) of (S)-(-)-N,α-dimethylbenzylamine, 
and 0.440 mL (4.34 mmol) of benzaldehyde was stirred at 95 ºC for 30 h. The reaction mixture 
was treated with 1 mL of MeOH and stirred at room temperature for 15 h.  The precipitated solid 
was washed with methanol and dried under vacuo to yield 360 mg (28%) of 87 as a light yellow 
solid: Mp 80–86 ºC (methanol, lit.90 128-129 ºC); [α]D25 +230 (c 0.22, CHCl3); 1H NMR δ 7.95-
7.75 (m, 1 H), 7.74-7.50 (m, 3 H), 7.45-7.30 (m, 5 H), 7.29-6.95 (m, 7 H), 5.48 (bs, 1 H), 4.36 
(bd, 1 H, J = 5.3 Hz), 2.17 (bs, 3 H), 1.52 (bd, 3 H, J = 5.2 Hz); MS (EI) m/z (rel intensity) 349 
([M-H2O]+, 40), 287 (20), 246 (40), 120 (37). 
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88  
1-(S)-Phenyl(((1’S)-1’-phenylethyl)methylamino)methyl)-2-thionaphthol (88).30 A solution 
of 500 mg (3.12 mmol) of 2-thionaphthol, 0.540 mL (3.71 mmol) of (S)-(-)-N,α-
dimethylbenzylamine, and 0.40 mL (3.90 mmol) of benzaldehyde was stirred at 95 ºC for 30 h. 
The reaction mixture was treated with 1 mL of MeOH and stirred at room temperature for 15 h.  
The precipitated solid was washed with methanol and dried under vacuo to yield 350 mg (30%) 
of 88 as a off white solid: Mp 132-133 ºC (MeOH); [α]D25 +88.3 (c 0.5, CHCl3); 1H NMR δ 
7.90-7.75 (m, 1 H), 7.74-7.45 (m, 3 H), 7.40-7.28 (m, 5 H), 7.27-6.80 (m, 7 H),  5.31 (bs, 1 H), 
4.25-4.05 (m, 1 H), 3.51 (s, 3 H), 2.15 (bs, 3 H), 1.50 (bd, 3 H, J = 5.8 Hz); MS (EI) m/z (rel 
intensity) 231 ([M-N(CH3)CH2(CH3)Ph]+), 100), 202 (25), 120 (51), 164 (21). 
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1-((S)-Propyl-(((1’S)-1’-phenylethyl)amino)methyl)-2-naphthol (89).  To a solution of 0.390 
mL (4.34 mmol) of isobutyraldehyde was added 500 mg (3.47 mmol) of 2-naphthol in 1 mL of 
EtOH followed by addition of 0.600 mL (4.13 mmol) of (S)-(-)-methylbenzylamine at 0 ºC. The 
reaction mixture was stirred at room temperature for 6 d.  The reaction mixture was treated with 
1 mL of MeOH and stirred at room temperature for 15 h. The precipitated solid was washed with 
methanol, and dried under vacuo.  The resulting 350 mg (32%) of off white solid 89 were 
slightly contaminated with residual 2-naphthol and were used without further purification: Mp 
133-134 ºC (MeOH, lit. 134-135 ºC); [α]D25 +1.5  (c 0.8, CHCl3); 1H NMR δ 8.03-7.15 (m, 11 
H), 4.22 (d, 1 H, J = 6.1 Hz), 3.73 (q, 1 H, J = 6.9 Hz), 2.21-2.14 (m, 1 H), 1.51 (d, 3 H, J = 6.7 
Hz), 0.98 (d, 3 H, J = 6.7 Hz), 0.78 (d, 3 H, J = 7.0 Hz); MS (EI) m/z (rel intensity) 319 (M+, 10), 
276 (79), 198 (32), 144 (100), 115 (52), 105 (82). 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 87.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 33 mg (0.09 mmol) of ligand 87, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (76%) of 27 with an ee 
of 2%.   
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 88.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene),  \37 mg (0.09 mmol) of ligand 88, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 101 mg (81%) of 27 with an 
ee of 28%.73   
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(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 89.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 31 mg (0.06 mmol) of ligand 89, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 97 mg (80%) of 27 with an ee 
of 17%.73  
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(R)-2'-Trifluoromethanesulfonyloxy-[1,1']binaphthalenyl-2-carboxylic acid methyl ester 
(90).91 3.6 mL of Methanol and 1.4 mL (mmol) of diisopropylethylamine were added to a 
solution of 1.00 g (1.83 mmol) of (R)-(-)-1,1’-Bis-2-naphthol bis(trifluoromethanesulfonate) in 
10 mL of DMSO.  The resulting solution was degassed by freeze-pump-thaw cycles and 
transferred to a 3-neck round bottom flask containing 61 mg (0.27 mmol) of Pd(OAc)2 and 113 
mg (0.27 mmol) of bisdiphenylphosphinopropane.  The reaction was stirred under a CO 
atmosphere at 80 °C for 72 h.  The resulting reaction mixture was diluted with NaCl, extracted 
with Et2O, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was 
purified by chromatography on SiO2 (10% EtOAc/Hexanes) to yield 350 mg (42%) of 90 as an 
orange solid: [α]D25 (c 0.5, CHCl3); 1H NMR δ 8.24 (d, 1 H, J = 8.7 Hz), 8.10 (d, 1 H, J = 6.2 
Hz), 8.06 (d, 1 H, J = 6.6 Hz), 7.99 (dd, 2 H, J = 2.8, 8.3 Hz), 7.64-6.55 (m, 4 H), 7.40-7.30 (m, 
3 H), 7.17 (d, 1 H, J = 5.5 Hz), 7.14 (d, 1 H, J = 5.8 Hz), 3.56 (s, 3 H); MS (EI) m/z (rel 
intensity) 460 (M+, 17), 327 (14), 311 (80), 268 (100), 239 (31), 119 (7). 
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(R)-Trifluoromethanesulfonic acid 2'-(morpholine-4-carbonyl)-[1,1']binaphthalenyl-2-yl 
ester (91).92  To a solution of 100 mg (1.35 mmol) of Me3Al in 0.67 mL of toluene at 0 °C was 
added 0.12 mL (1.35 mmol) of morpholine in 4 mL of toluene.  The resulting solution was 
stirred at rt for 1 h followed by the addition of 310 mg (0.68 mmol) of 90.   The mixture was 
heated at reflux for 3 h, quenched with 1 N HCl, extracted with EtOAc, washed with NaCl, dried 
(MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was purified by 
chromatography on SiO2 (75% EtOAc/Hexanes) to yield 330 mg (95%) of 91 as a white solid: 
Mp 94-97 °C; [α]D25 –24.1 (c 0.5, CHCl3); lit.93 [α]D25 –25.5 (c 1.0, CHCl3); 1H NMR δ 8.60 (d, 
2 H, J = 8.7 Hz), 7.97 (d, 2 H, J = 8.1 Hz), 7.70-7.50 (m, 4 H), 7.50-7.10 (m, 4 H), 3.80-3.40 (m, 
8 H); MS (EI) m/z (rel intensity) 515 (M+, 35), 429 (21), 382 (100), 366 (30), 297 (22), 239 (26), 
114 (12), 91 (12), 70 (26). 
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(R)-2'-Morpholin-4-ylmethyl-[1,1']binaphthalenyl-2-ol (92).93  To 300 mg (0.58 mmol) of 91 
in 11 mL of THF at 0 °C was added 88 mg (2.33 mmol) of LiAlH4 portionwise.  The solution 
was heated at reflux for 14 h, cooled, diluted with 40 mL of H2O, filtered through celite, 
extracted with EtOAc, washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. 
The resulting crude residue was purified by chromatography on SiO2 (50% EtOAc/Hexanes) to 
yield 60 mg (28%) of 92 as an off-white solid: Mp 102-104 °C, [α]D25 –83.2 (c 0.5, CHCl3); lit.93 
[α]D25 –84.8 (c 1.25, CHCl3); 1H NMR δ 8.00-7.84 (m, 4 H), 7.51 (d, 1 H, J = 8.4 Hz), 7.48-7.40 
(m, 1 H), 7.42 (d, 1 H, J = 8.7 Hz), 7.35-7.25 (m, 3 H), 7.19 (ddd, 1 H, J = 1.2, 6.9, 8.4 Hz), 7.12 
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(ddd, 1 H, J = 1.2, 6.9, 8.4 Hz), 6.99 (d, 1 H, J = 8.4 Hz), 6.72 (d, 1 H, J = 8.4 Hz), 3.85-3.70 (m, 
3 H), 3.70-3.58 (m, 2 H), 3.67 (d, 1 H, J = 12.0 Hz), 3.30 (d, 1 H, J = 12.0 Hz), 2.75-2.63 (m, 2 
H), 2.37 (ddd, 2 H, J = 2.7, 6.3, 9.3 Hz); MS (EI) m/z (rel intensity) 369 (M+, 49), 311 (4), 281 
(43), 222 (100), 162 (55), 155 (76), 145 (88), 91 (61). 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 92.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 24 mg (0.065 mmol) of  ligand 92, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 97 mg (80%) of 27 with an ee 
of 17%.73 
 
Br
93  
4-Bromo[2,2]paracyclophane (93).94  To 0.51 mL (9.9 mmol) of Br2 in 15 mL of CCl4 was 
added 12 mg (0.2 mmol) of Fe powder and stirred for 15 min.  The suspension was diluted with 
45 mL of CH2Cl2 followed by the addition of 2.00g (9.6 mmol) of [2,2]-paracyclophane.  The 
resulting solution was stirred for 2 h, washed with NaHSO3, dried (MgSO4), filtered, and 
concentrated in vacuo to yield 2.8 g (99%) as an off-white solid 93 and was used without further 
purification in the next step: Mp 136-137 °C (CH2Cl2, lit.94 Mp 134 °C); 1H NMR δ 7.17 (d, 1 H, 
J = 6.9 Hz), 6.65-6.40 (m, 6 H), 3.48 (ddd, 1 H, J = 1.8, 10.5, 12.6 Hz), 3.27-3.02 (m, 5 H), 2.75-
3.02 (m, 2 H); MS (EI) m/z (rel intensity) 288 (M+, 10), 182 (12), 115 (6), 104 (100). 
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HO
94  
4-Hydroxy[2,2]paracyclophane (94).95  To 2.7 g (9.4 mmol) of 93 in 118 mL of Et2O at 0 °C 
was added 12.5 mL (18.8 mmol) of n-BuLi.  The resulting reaction was stirred for 20 minutes at 
0 °C followed by addition of 2.10 mL (18.8 mmol) of B(OMe)3.  The reaction was stirred for 1 h 
at rt, 2 mL of 0.5 M NaOH solution was added, 1.5 mL of 30% H2O2, extracted with Et2O, dried 
(MgSO4), filtered, and concentrated in vacuo to yield 1.0 g (48%) of beige solid 94 and was used 
without further purification in the next step: Mp 220-223 °C (Et2O, lit.95 Mp 225 °C); 1H NMR δ 
7.01 (dd, 1 H, J = 6.3 Hz), 6.55 (dd, 1 H, J = 7.8 Hz), 6.45 (dd, 1 H, J = 7.8 Hz), 6.39 (d, 2 H, J = 
8.1), 6.26 (dd, 1 H, J = 1.5, 7.5 Hz), 5.56 (s, 1 H), 3.38-3.26 (m, 1 H), 3.15-3.00 (m, 4 H), 3.00-
2.85 (m, 2 H), 2.75-2.59 (m, 1 H); MS (EI) m/z (rel intensity) 224 (M+, 43), 120 (100), 115 (14), 
109 (17), 105 (23), 104 (56), 103 (15). 
 
HOO
95  
4-Acetyl-5-hydroxy[2.2]paracyclophane (95).96 To 1.00 g (4.46 mmol) of 94 in 50 mL of 
CH2Cl2 at 0 °C was added 0.64 mL (5.80 mmol) of TiCl4 followed by addition of 0.32 mL (4.46 
mmol) of acetyl chloride.  The resulting reaction was stirred at rt for 2 h, cooled to 0 °C, diluted 
with 50 mL of H2O, dried (MgSO4), filtered, and concentrated in vacuo to yield 1.15 g (97%) of 
yellow/brown solid 95 and was used without further purification:  Mp 112-115 °C (CH2Cl2, lit.96 
Mp 115-116 °C); 1H NMR δ 6.98 (dd, 1 H, J = 1.9, 7.8 Hz), 6.63 (dd, 1 H, J = 1.9, 7.8 Hz), 6.54 
(d, 1 H, J = 7.5 Hz), 6.46 (dd, 1 H, J = 1.8, 7.9 Hz), 6.32 (dd, 2 H, J = 2.1, 7.8 Hz), 3.65 (ddd, 1 
H, J = 1.6, 9.6, 11.2 Hz), 3.45 (ddd, 1 H, J = 3.0, 10.1, 13.1 Hz), 3.25-3.10 (m, 2 H), 3.10-2.93 
(m, 2 H), 2.76 (dd, 1 H, J = 7.7, 9.6 Hz), 2.72 (dd, 1 H, J = 7.7, 9.5 Hz), 2.65-2.50 (m, 1 H), 2.59 
(s, 3 H); MS (EI) m/z (rel intensity) 266 (M+, 42), 162 (71), 120 (20), 104 (100), 91 (27), 78 (20). 
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 HON
96
 
(S,S)-4-hydroxy-5-[1-(1-phenylethylamino)ethyl][2,2]paracyclophane.96 To a solution of 1.15 
g (4.3 mmol) of 95 in 100 mL of toluene was added 0.55 mL (4.3 mmol) of (S)-phenyl 
ethylamine and 53 mg (0.22 mmol) of Et2SnCl2.  The resulting solution was heated at reflux for 
28 h and concentrated in vacuo. The resulting crude residue was purified by chromatography on 
SiO2 (40:1 Benzene/EtOH) to yield 450 mg (28%) of 96 as an orange solid: [α]D25 –215 (c 0.5, 
CHCl3); lit.93 [α]D25 –232 (c 0.4, C6H6); Mp 165-168 °C (Benzene/EtOH, lit.96 Mp 165-166°C); 
1H NMR δ 7.53 (d, 2 H, J = 7.6 Hz), 7.45 (t, 2 H, J = 7.3 Hz), 7.39-7.28 (m, 1 H), 7.00 (d, 1 H, J 
= 7.7 Hz), 6.57 (d, 1 H, J = 7.8 Hz), 6.46 (d, 1 H, J = 7.8 Hz), 6.42 (d, 1 H, J = 8.9 Hz), 6.18 (d, 
1 H, J = 7.6 Hz), 6.09 (d, 1 H, J = 7.7 Hz), 4.87 (q, 1 H, J = 6.5 Hz), 3.49-3.38 (m, 1 H), 3.29-
3.13 (m, 2 H), 3.07-2.91 (m, 2 H), 2.90-2.79 (m, 1 H), 2.58-2.46 (m, 1 H), 2.44-2.32 (m, 1 H), 
2.27 (s, 3 H), 1.68 (d, 3 H, J = 6.5 Hz); MS (EI) m/z (rel intensity) 404 (10), 370 (M+, 100), 266 
(25). 
 
(R)-1-Phenylhept-2-en-1-ol (19) using 10 mol% of ligand 96.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 48 mg (0.13 mmol) of  ligand 96, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 194 mg (79%) of 27 with an ee 
of 16%.84
 
S
N
O Ph
CH397  
(4S,5R)-4-Methyl-5-phenyl-2-(2-thienyl)-1,3-oxazoline (97).97  To 473 µL (5.09 mmol) of 2-
thiophene carbonitrile and 1.00 g (6.61 mmol) of (1S,2R)-(+)-norephederine was added a 
solution of 34.7 mg (0.25 mmol) of ZnCl2 in 15 mL of chlorobenzene. The solution was heated 
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at reflux for 48 h, cooled to 0 ºC, concentrated in vacuo, diluted with CH2Cl2, and extracted with 
H2O (3x). The aqueous layer was re-extracted with CH2Cl2. The combined organic layers were 
dried (MgSO4), filtered, and concentrated in vacuo. The resulting residue was purified by 
chromatography on SiO2 (10% EtOAc/Hexanes) to yield 660 mg (53%) of 97 as a yellow oil: 
[α]D25  -456 (c 0.5, CHCl3); lit.97 [α]D22 -553 (c 0.3, CHCl3); 1H NMR δ 7.68 (dd, 1 H, J = 1.2, 
3.6 Hz), 7.48 (dd, 1 H, J = 1.2, 5.0 Hz), 7.39-7.28 (m, 3 H),  7.26-7.18 (m, 2 H), 7.10 (dd, 1 H, J 
= 3.7, 5.0 Hz), 5.74 (d, 1 H, J = 9.7 Hz), 4.70-4.55 (m, 1 H), 0.86 (d, 3 H, J = 7.0 Hz); MS (EI) 
m/z (rel intensity) 243 (M+, 21), 137 (100), 109 (32), 105 (12). 
 
S
N
O
98
 
(4S)-4-Isopropyl-2-(2-thienyl)-1,3-oxazoline (98).  To 695 µL (7.47 mmol) of 2-thiophene 
carbonitrile and 1.00 g (9.71 mmol) of L-valinol was added a solution of 51.0 mg (0.37 mmol) of 
ZnCl2 in 15 mL of chlorobenzene. The reaction was heated at reflux for 48 h, cooled to 0 ºC, 
concentrated in vacuo, diluted with CH2Cl2, and extracted with H2O (3x).  The aqueous layer 
was re-extracted with CH2Cl2. The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo. The resulting residue was purified by chromatography on SiO2 (10% 
EtOAc/Hexanes) to yield 1.40 g (96%) of 98 as a clear oil: [α]D25 -88.2 (c 0.5, CHCl3); lit.97 
[α]D22 -89.3 (c 0.3, CHCl3);  1H NMR δ 7.57 (dd, 1 H, J = 1.2, 3.7Hz), 7.41 (dd, 1 H, J = 1.2, 5.0  
Hz), 7.05 (dd, 1 H, J = 3.7, 5.0 Hz), 4.44-4.31 (m, 1 H), 4.16-4.02 (m, 2 H), 1.93-1.77 (m, 1 H), 
0.99 (d, 3 H, J = 6.8 Hz), 0.89 (d, 3 H, J = 6.8 Hz); MS (EI) m/z (rel intensity) 195 (M+, 9), 152 
(100), 124 (23), 111 (16). 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 97.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 47 mg (0.19 mmol) of ligand 97, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 203 mg (83%) of 27 with an ee 
of 21%.
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(S)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 98.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 37 mg (0.19 mmol) of  ligand 98, and 
134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 193 mg (79%) of 27 with an ee 
of 7%.84
 
H2N OH
99a  
(L)-Valinol (100a).98  To a solution of 2.00 g (17.1 mmol) of (L)-valine in 75 mL of THF at 0 ºC 
was added 1.30 g (34.1 mmol) of LAH over 15 min. The resulting solution was heated at reflux 
for 20 h, cooled to 0 ºC, quenched with 1 mL of H2O, 1 mL of 15% NaOH, and 3 mL of H2O, 
and filtered through celite.  The celite was washed with Et2O, and the combined solutions were 
concentrated in vacuo to yield 1.50 g (86%) of 100a as a clear oil: [α]D25 +12.3 (c  0.5, CHCl3); 
lit.98 [α]D20 +12.4 (c 0.9, MeOH);  1H NMR δ 3.60 (dd, 1 H, J = 4.0, 10.5 Hz), 3.26 (dd, 1 H, J = 
8.8, 10.5 Hz), 2.60-2.45 (m, 1 H), 1.62- 1.43 (m, 1 H), 0.95-0.70 (m, 6 H); MS (EI) m/z (rel 
intensity) 128 ([M-H2O]+, 33), 114 (18). 
 
N OH
101a  
(S)-3-Methyl-2-pyrrolidin-1-yl-butan-1-ol (101a).   To a solution of 2.00 g (19.4 mmol) of (L)-
valinol in 80 mL of CH3CN were added 5.36 g (38.8 mmol) of K2CO3 and 2.54 mL of 1,4-
dibromobutane. The reaction mixture was heated at reflux for 18 h, cooled, filtered, and 
concentrated in vacuo.  The resulting oil was diluted with H2O, extracted with EtOAc, dried 
(MgSO4), and concentrated in vacuo to yield 2.63 g (86%) of 101a as a colorless oil: [α]D25 
+39.2 (c 1.5, CHCl3); IR (KBr) 3406, 2960, 2874, 1463, 1387, 1111, 1010 cm-1; 1H NMR δ 3.63 
(dd, 1 H, J = 4.8, 10.5 Hz), 3.41 (dd, 1 H, J = 6.9, 10.5 Hz), 2.73 (bs, 4 H), 2.34 (q, 1 H, J = 6.3 
Hz), 1.92 (o, 1 H, J = 6.6 Hz), 1.88-1.70 (m, 4 H), 0.99 (d, 3 H, J = 6.9 Hz), 0.91 (d, 3 H, J = 6.6 
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Hz); 13C NMR δ 67.0, 60.0, 49.4, 28.6, 23.7, 21.7, 18.7; MS (EI) m/z (rel intensity) 126 ([M-
CH2OH]+, 100), 114 (98), 96 (19), 84 (40), 70 (53), 55 (32); HRMS (EI) Calcd for C9H19NO 
158.1545, found 158.1540. 
 
 
N SAc
102a  
Thioacetic acid (S)-(3-methyl-2-pyrrolidin-1-yl-butyl) ester (102a).  To a well stirred solution 
of 2.68 g (10.2 mmol) of PPh3 in 75 mL of THF at 0 ºC was added 2.00 mL (10.2 mmol) of 
diisopropylazodicarboxylate.  The resulting solution was stirred for 30 min, followed by 
simultaneous addition of 0.73 mL (10.2 mmol) of thiolacetic acid and 800 mg (5.10 mmol) of 
101a.  The reaction mixture was stirred for 1 h at 0 ºC, 1 h at rt, and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (2% EtOAc/pet. Et2O) to yield 
725 mg (66%) of 102a as an orange oil: [α]D25 +52.6 (c 0.5, CHCl3); 1H NMR δ 3.17 (A of 
ABX, 1 H, J = 4.5, 13.8 Hz), 3.00 (B of ABX, 1 H, J = 5.4, 13.8 Hz), 2.68-2.55 (m, 4 H), 2.32 (s, 
3 H), 2.04-1.88 (m, 1 H), 1.82-1.69 (m, 4 H), 1.34-1.24 (m, 1 H), 0.96 (d, 3 H, J = 7.2 Hz), 0.93 
(d, 3 H, J = 6.9 Hz); 13C NMR δ 196.0, 67.6, 50.7, 30.8, 30.5, 28.3, 23.5, 20.4, 17.8; HRMS (EI) 
Calcd for C11H21NOS 216.1422, found 216.1409. 
 
N SH
103a  
(S)-3-Methyl-2-pyrrolidin-1-yl-butane-1-thiol (103a).  To a suspension of 42 mg (1.1 mmol) 
of LiAlH4 in 4 mL of Et2O at 0 ºC was added 60 mg (0.28 mmol) of 102a in 2 mL of Et2O. The 
resulting slurry was stirred for 45 min at rt, cooled to 0 ºC, and quenched with 1 mL of H2O, 1 
mL of 15% NaOH, 3 mL of H2O, and filtered through celite.  The resulting filtrate was 
concentrated in vacuo to yield 35 mg (72%) of 103a as a colorless oil: [α]D25 +31.8 (c 0.25, 
CHCl3); IR (KBr) 2959, 2872, 2790, 1462, 1365, 1296, 1118 cm-1; 1H NMR δ 2.80-2.55 (m, 4 
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H), 2.33 (q, 1 H, J = 5.4 Hz), 1.96 (o, 1 H, J = 6.0 Hz), 1.82-1.68 (m, 4 H), 1.61 (bs, 1 H), 1.26 
(s, 1 H), 0.96 (d, 3 H, J = 6.3 Hz), 0.94 (d, 3 H, J = 6.3 Hz); 13C NMR δ 69.8, 50.1, 30.3, 24.0, 
23.7, 20.6, 18.5; MS (EI) m/z (rel intensity) 173 (M+, 43), 140 (36), 126 (100), 97 (13), 84 (6), 70 
(17), 55 (8); HRMS (EI) Calcd for C9H19NS 173.1238, found 216.1232. 
 
N OH
101b  
(S)-3-Methyl-2-piperidin-1-yl-butan-1-ol (101b).99 According to the preparation of 101a, 101b 
(76%) was obtained as a colorless oil: [α]D25 +23.3 (c 0.25, CHCl3); 1H NMR δ 3.98 (s, 1 H), 
3.56-3.45 (dd, 1 H, J = 5.4, 10.2 Hz), 3.16 (t, 1 H, J = 10.2 Hz), 2.91-2.78 (m, 2 H), 2.63-2.47 
(m, 2 H), 2.35-2.21 (m, 1 H), 1.92-1.78 (m, 1 H), 1.68-1.42 (m, 6 H), 1.03 (d, 3 H, J = 6.6 Hz), 
0.81 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 154 ([M-OH]+, 13), 140 (60), 128 (20), 98 
(20), 91 (61), 84 (82), 69 (74), 63 (100). 
 
N SAc
102b  
Thioacetic acid (S)-(3-methyl-2-piperidin-1-yl-butyl) ester (102b). According to the 
preparation of 102a, 102b (56%) was obtained as an orange oil: [α]D25 +42.4 (c 1.0, CHCl3); 1H 
NMR δ 3.07 (d, 2 H, J = 5.5 Hz), 2.62-2.53 (m, 2 H), 2.53-2.40 (m, 2 H), 2.32 (s, 3 H), 2.34-2.22 
(m, 1 H), 1.83 (o, 1 H, J = 6.8 Hz), 1.53-1.46 (m, 4 H), 1.46-1.36 (m, 2 H), 0.95 (d, 3 H, J = 6.7 
Hz), 0.92 (d, 3 H, J = 6.7 Hz); MS (EI) m/z (rel intensity) 229 (M+, 31), 210 (80), 186 (93), 144 
(76), 140 (100), 110 (49), 103 (70); HRMS (EI) Calcd for C12H23NOS 229.1500, found 
229.1507. 
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N SH
103b  
(S)-3-Methyl-2-pyrrolidin-1-yl-butane-1-thiol (103b). According to the preparation of 103a, 
103b (63%) was obtained as an orange oil: [α]D25 +72.2 (c 0.6, CHCl3); 1H NMR δ 3.06 (A of 
ABX, 1 H, J = 7.2, 12.6 Hz), 3.04 (B of ABX, 1 H, J = 4.8, 12.9 Hz), 2.65-2.53 (m, 2 H), 2.53-
2.44 (m, 2 H), 1.82 (o, 1 H, J = 6.6 Hz), 1.63-1.48 (m, 4 H), 1.48-1.35 (m, 2 H), 0.95 (d, 3 H, J = 
6.6 Hz), 0.93 (d, 3 H, J = 6.3 Hz); 13C NMR δ 70.7, 50.7, 39.2, 30.2, 26.7, 25.1, 21.2, 20.6; MS 
(EI) m/z (rel intensity) 188 (M+, 7), 186 (10), 140 (100), 111 (16), 98 (6), 84 (18), 69 (7), 55 
(13); HRMS (EI) Calcd for C10H21NS 187.1395, found 187.1397. 
 
N OH
101c  
(S)-3,3-Dimethyl-2-piperidin-1-yl-butan-1-ol (101c). According to the preparation of 101a 
except starting from (S)-tert-leucinol, 101c (75%) was obtained as a white flaky solid: [α]D25 
+31.4 (c 0.5, CHCl3); IR (KBr) 3269, 2931, 2801, 1043, 1041 cm-1;1H NMR δ 3.58-3.40 (m, 2 
H), 3.05-2.95 (m, 2 H), 2.75-2.60 (m, 2 H), 2.42 (dd, 1 H, J = 1.4, 10.8 Hz), 1.52-1.43 (m, 6 H), 
0.97 (s, 9 H); 13C NMR δ 74.8, 57.3, 51.6, 36.8, 29.1, 27.8, 24.9; MS (EI) m/z (rel intensity) 185 
(M+, 23), 170 (70), 154 (72), 128 (100), 98 (60), 83 (57), 68 (48); HRMS (EI) Calcd for 
C11H23NO 185.1779, found 185.1780. 
 
N SAc
102c  
Thioacetic acid (S)-(3,3-dimethyl-2-piperidin-1-yl-butyl) ester (102c). According to the 
preparation of 102a, 102c (63%) was obtained as an orange solid: [α]D25 +114 (c 0.1, CHCl3); IR 
(KBr) 3353, 2935, 2772, 2359, 1687, 1440, 1310, 1166 , 957 cm-1; 1H NMR δ 3.34 (dd, 1 H, J = 
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3.2, 13.6 Hz), 2.96 (dd, 1 H, J = 11.5, 13.6 Hz), 2.85-2.73 (m, 2 H), 2.63-2.52 (m, 2 H), 2.33 (s,  
3 H), 2.28 (dd, 1 H, J = 3.1, 11.6 Hz), 1.57-1.40 (m, 6 H), 0.94 (s, 9 H); 13C NMR δ 196.2, 73.0, 
52.9; 38.0, 30.6, 27.7, 27.6, 27.1, 25.0; MS (EI) m/z (rel intensity) 228 ([M-CH3]+, 33), 200 
(6),154 (15), 28 (144), 110 (9), 84 (100); HRMS (EI) Calcd for C13H26NOS 244.1735, found 
244.1724. 
 
N SH
103c  
(S)-(3,3)-Dimethyl-2-piperidin-1-yl-butane-1-thiol (103c). According to the preparation of 
103a, 103c (73%) was obtained as a colorless oil: [α]D25 +64.6 (c 0.85, CHCl3); IR (KBr) 2934, 
2852, 1476, 1389, 1250, 1002 cm-1; 1H NMR δ 2.91-2.78 (m, 4 H), 2.77 (d, 1 H, J = 5.4 Hz), 
2.69-2.56 (m, 1 H), 2.29 (dd, 1 H, J = 3.0, 11.1 Hz), 1.95 (bs, 1 H), 1.56-1.39 (m, 6 H), 0.91 (s, 9 
H); 13C NMR δ 76.8, 52.4, 38.3, 28.9, 27.4, 25.1, 23.0; MS (EI) m/z (rel intensity) 343 (40), 232 
(5), 200 ([M-CH3]+, 22), 154 (77), 142 (100), 111 (44), 96 (17), 83 (27), 68 (13); HRMS (EI) 
Calcd for C12H27NS-CH3 200.1473, found 200.1478. 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 103a.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 11 mg (0.065 mmol) of ligand 103a, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 86 mg (69%) of 27 with an ee 
of 22%.   
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 103b.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 12 mg (0.065 mmol) of ligand 103b, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 93mg (75%) of 27 with an ee 
of 64%.
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(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 103b.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 17 mg (0.09 mmol) of ligand 103b, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 101 mg (82%) of 27 with an 
ee of 77%.
 
(R)-1-Phenylhept-2-en-1-ol (27) using 20 mol% of ligand 103b.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 24 mg (0.13 mmol) of ligand 103b, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 98 mg (79%) of 27 with an ee 
of 76%.73
 
(S)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 103c.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 13 mg (0.065 mmol) of ligand 103c, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 93 mg (75%) of 103c with an 
ee of 61%.   
 
(R)-1-Phenylhept-2-en-1-ol (27) using 15 mol% of ligand 103c.  According to the general 
protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 87 µL (0.76 mmol) of 1-hexyne, 
325 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 18 mg (0.09 mmol) of  ligand 10, 
and 66 µL (0.65 mmol) of freshly distilled benzaldehyde provided 100 mg (81%) of 27 with an 
ee of 71%.
 
Bn2N OBn
O
104  
(S)-2-Dibenzylamino-3-methylbutyric acid benzyl ester (104).100  A solution of 20.3 mL (171 
mmol) of benzyl bromide in 40 mL of EtOH was slowly added to a solution of 5.00 g (42.7 
mmol) of (L)-Valine and 23.6 g (171 mmol) of K2CO3 in a 5:1 mixture of EtOH-H2O (250 mL).  
The reaction mixture was heated under reflux for 14 h, concentrated in vacuo, and the resulting 
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slurry was extracted with EtOAc (3 x 150 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo.  The resulting crude residue was purified by 
chromatography on SiO2 (2.5% EtOAc/Hexanes) to yield 13.0 g (79%) of 104 as colorless oil: 
1H NMR δ 7.60-7.10 (m, 15 H), 5.31 (A of AB, 1 H, J = 12.0 Hz), 5.17 (B of AB, 1 H, J = 12.3 
Hz), 3.97 (A of AB, 1 H, J = 13.8 Hz), 3.29 (B of AB, 1 H, J = 14.1 Hz), 2.92 (d, 1 H, J = 10.8 
Hz), 2.28-2.12 (m, 1 H), 1.02 (d, 3 H, J = 6.6 Hz), 0.78 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel 
intensity) 388 (M+, 5), 387 (13), 344 (50), 252 (90), 181 (29), 160 (30), 92 (80), 65 (100). 
 
Bn2N OH
105  
(S)-2-Dibenzylamino-3-methyl-butan-1-ol (105).100  To a solution of 1.10 g (29.1 mmol) of 
LiAlH4 in 75 mL of Et2O at 0 ºC was added 1.10 g (24.3 mmol) of 104 in 25 mL of Et2O.  The 
reaction was stirred at rt for 1 h, quenched at 0 ºC with 1.1 mL of H2O, 1.1 mL of NaOH, and 3.4 
mL of H2O.  The resulting slurry was flitered through a plug of celite and washed with EtOAc.  
The filtrate was dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude residue 
was purified by chromatography on SiO2 (5% EtOAc/Hexanes) to yield 5.8 g (84%) of 105 as a 
light yellow oil: [α]D25 +23.1 (c 1.0, CHCl3); lit.101 [α]D25 +24.5 (c 0.8, CHCl3); 1H NMR δ 7.36-
7.15 (m, 10 H), 3.90 (A of AB, 2 H, J = 13.2 Hz), 3.69 (B of AB, 2 H, J = 13.2 Hz), 3.64-3.52 
(m, 1 H), 3.45 (t, 1 H, J = 10.2 Hz), 2.99 (s, 1 H), 2.09 (sp, 1 H, J = 6.9 Hz), 1.16 (d, 3 H, J = 6.7 
Hz), 0.90 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 283 (M+, 12), 280 (10), 265 (56), 252 
(37), 240 (20), 210 (38), 160 (7), 106 (11), 91 (100), 65 (21). 
 
Bn2N O
106
H
 
2-Dibenzylamino-3-methyl-butyraldehyde (106).102 To a solution of 730 μL (8.47 mmol) of 
oxalyl chloride in CH2Cl2 at –60 ºC was added 1.00 mL (14.1 mmol) of DMSO in 10 mL of 
CH2Cl2 dropwise and was stirred for 15 min.  2.00 g (7.07 mmol) of 106 in 15 mL of CH2Cl2 was 
added.  After the mixture was stirred for 30 min, 3.94 mL (28.2 mmol) of Et3N was added.  The 
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reaction was slowly warmed to rt, hydrolyzed by the addition of H2O, and extracted with 
CH2Cl2. The combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo.  
1.90 g (96%) of the resulting yellow oil, 106, was used without further purification in the next 
step: [α]D25 +24.2 (c 0.5, CHCl3); 1H NMR δ 9.87 (d, 1H), 7.50-7.00 (m, 10 H), 4.03 (A of AB, 2 
H, J = 13.8 Hz), 3.72 (B of AB, 2 H, J = 13.8 Hz), 2.73 (dd, 1 H, J = 3.3, 10.2 Hz), 2.25-2.40 (m, 
1 H), 1.09 (d, 3 H, J = 6.6 Hz), 0.88 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 369 (4), 314 
(5), 278 (3), 263 (3), 252 (45), 106 (44), 91 (100). 
 
Bn2N OH107  
(3R,4S)-4-(Dibenzylamino)-2,5-dimethylhexan-3-ol (107).32 To a stirred solution of 2.37 g 
(8.43 mmol) of 106 in 10 mL of THF at 0 ºC was added 8.43 mL (16.8 mmol) of a 2 M solution 
of isopropyl magnesium chloride in THF.  The resulting reaction was stirred for 1 h at 0 ºC and 
warmed to rt.  At rt, the reaction was quenched with NH4Cl and extracted with EtOAc. The 
combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo.  The resulting 
crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 1.12 g (41%) of 
107 as colorless oil: [α]D25 +20.3 (c 0.5, CHCl3); [α]D25 +20.4 (c 5.5, CHCl3); 1H NMR δ 7.40-
7.10 (m, 10 H), 3.74 (A of AB, 2 H, J = 13.8 Hz), 3.73-3.65 (m, 1 H), 3.58 (B of AB, 2 H, J = 
13.8 Hz), 2.39 (dd, 1 H, J = 4.8 Hz), 2.28 (o, 1 H, J = 6.6 Hz), 2.08 (o, 1 H, J = 6.3 Hz), 1.13 (d, 
3 H, J = 6.9 Hz), 1.03 (d, 3 H, J = 6.6 Hz), 0.96 (d, 3 H, J = 6.9 Hz), 0.87 (d, 3 H, J = 6.6 Hz); 
MS (EI) m/z (rel intensity) 324 (M+, 2), 282 (22), 252 (73), 210 (15), 181 (12), 160 (10), 91 
(100), 65 (39). 
 
H2N OH109  
(3R,4S)-4-Amino-2,5-dimethylhexan-3-ol (109).32  To a solution of 580 mg (1.78 mmol) of 108 
in 10 mL of MeOH was added 192 mg of 20% Pd(OH)2.  An atmosphere of H2 was introduced 
via a balloon (1 atm) and stirred for 3 h at rt.  The resulting solution was filtered through celite 
and washed with MeOH.  The filtrate was concentrated in vacuo to yield 250 mg (97%) of 109 
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as a white solid and was used without further purification in the next step: Mp 86-89 °C; lit.32 
Mp 87-88 °C; [α]D25 +6.1 (c 0.5, CHCl3); lit.32 [α]D25 +6.8 (c 2.8, EtOH); 1H NMR δ 3.31 (dd, 1 
H, J = 4.4, 6.9 Hz), 2.63 (dd, 1 H, J = 4.0, 6.9 Hz), 2.06-1.87 (m, 2 H), 1.09 (d, 3 H, J = 6.6 Hz), 
0.88 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 147 (10), 146 (M+), 102 (24), 72 (100), 55 
(30).  
 
N OH
110  
(3R,4S)-2,5-Dimethyl-4-(pyrolidin-1-yl)hexan-3-ol (110).32  To a mixture of 624 mg (4.29 
mmol) of 109 and 1.18 g (8.58 mmol) of potassium carbonate in 40 mL of CH3CN was added 
616 mg (5.15 mmol) of 1,4-dibromobutane.  The reaction was heated at reflux for 16 h and 
filtered, and concentrated in vacuo. The resulting residue was diluted with H2O, extracted with 
EtoAc, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was 
purified by chromatography on SiO2 (25% EtOAc/Hexanes) to yield 650 mg (76%) of 110 as a 
colorless oil. 
 
N SAc
111  
(3R,4S)-2,5-Dimethyl-4-(pyrolidin-1-yl)hexan-3-yl ethanethioate (111).32  To a solution of 
550 mg (2.75 mmol) of 110 and 1.15 mL (8.24 mmol) of Et3N in 20 mL of CH2Cl2 at 0 ºC was 
added 0.426 ml (5.50 mmol) of MsCl.  The resulting solution was stirred for 1 h at 0 ºC and 
concentrated in vacuo.  The resulting residue was dissolved in 20 mL of benzene followed by 
1.15 mL (8.24 mmol) of Et3N and 0.391 mL (5.50 mmol) of thiolacetic acid.  The reaction was 
heated to reflux for 8 h and concentrated in vacuo. The resulting crude residue was purified by 
chromatography on SiO2 (100% EtOAc/Hexanes) to yield 650 mg (76%) of 111 as a colorless 
oil: [α]D25 +52.8 (c 0.5, CHCl3); lit.32 [α]D25 +53.9 (c 1.21, CHCl3); 1H NMR δ 3.80 (t, 1 H, J = 
6.3 Hz), 2.75-2.72 (m, 2H), 2.68 (t, 2 H, J = 6.3 Hz), 2.12-2.00 (m, 1 H), 2.00-1.85 (m, 1 H), 
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1.75-1.55 (m, 4 H), 0.95 (d, 6 H, J = 7.2 Hz), 0.93 (d, 3 H, J = 7.2 Hz), 0.88 (d, 3 H, J = 6.6 Hz). 
MS (EI) m/z (rel intensity) 215 ([M-C2H3O]+,10), 214 (65), 138 (5), 126 (100), 110 (9), 96 (5), 
70 (15). 
 
N SH
112  
(3R,4S)-2,5-Dimethyl-4-(pyrolidin-1-yl)hexan-3-thiol (112). To a suspension of 58 mg (1.5 
mmol) of LiAlH4 in 3 mL of Et2O at 0 ºC was added 200 mg (0.77 mmol) of 111 in 6 mL of 
Et2O.  The resulting slurry was stirred for 1 h, quenched with 2M NaOH, and filtered through a 
pad of celite.  The resulting filtrate was concentrated in vacuo to yield 160 mg (96%) of 112 as a 
yellow oil: [α]D25 +13.0 (c 0.5, CHCl3); lit.32 [α]D25 +13.7 (c 0.99, CHCl3); 1H NMR δ 3.00 (m, 1 
H), 2.80-2.69 (q, 4 H, J = 6.0 Hz), 2.56 (dd, 1 H, J = 4.0, 7.8 Hz), 2.30-2.15 (m, 1 H), 2.07-1.80 
(m, 1 H), 1.75-1.55 (m, 4 H), 1.01 (d, 1H, J = 4.4 Hz); 1.00 (d, 3 H, J = 4.0 Hz); 0.99 (d, 3 H, J = 
3.4 Hz); 0.92 (d, 3 H, J = 6.6 Hz); MS (EI) m/z (rel intensity) 215 (M+, 10), 214 (20), 182 (22), 
170 (48), 126 (95), 110 (55), 86 (83), 70 (90), 61 (100). 
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 110.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 26 mg (0.13 mmol) of ligand 110, 
and 134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 200 mg (81%) of 27 with an 
ee of 7%.  
 
(R)-1-Phenylhept-2-en-1-ol (27) using 10 mol% of ligand 111.  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 33 mg (0.13 mmol) of ligand 111, 
and 134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 190 mg (77%) of 27 with an 
ee of 84%. 
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Chiral loading: (R)-1-Phenylhept-2-en-1-ol (27) using 1 mol% of ligand 112.  According to 
the general protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 
1-hexyne, 650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 2.8 mg (0.013 mmol) of 
ligand 17, and 134 µL (1.29 mmol) of freshly distilled benzaldehyde provided 185 mg (75%) of 
27 with an ee of 66%.  The numerical value of each data point is listed below (Table 1.13). 
 
Table 1.13.  Enantioselective formation of 27 using ligand 112. 
 
 
ee73 (%) of (S)-27 ligand loading (mol%) of (S)-112 
1 66 
2.5 90 
5 93 
10 94 
15 94 
 OH
115
 
 
(R)-1-Phenylnon-4-en-1-ol (115) using 5 mol% of ligand 112.46  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.065 mmol) of ligand 112, 
and 170 µL (1.29 mmol) of freshly distilled hydrocinnamaldehyde provided 220 mg (79%) of 
115 with an ee of 84%: 1H NMR δ 5.70-5.39 (m, 2 H), 3.76 (sx, 1 H, J = 3.4 Hz), 2.04 (q, 2 H, J 
= 6.8 Hz), 1.78-1.76 (m, 1 H), 1.76-1.63 (m, 4 H), 1.45-1.05 (m, 10 H), 1.05-0.80 (m, 2 H), 0.90 
(t, 3 H, J = 6.9 Hz). 
 
OH
116H3CO  
(R)-1-(4-Methoxyphenyl)-pent-2-en-1-ol (116) using 10 mol% of ligand 112.46  According to 
the general protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 
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1-hexyne, 650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 28 mg (0.129 mmol) of 
ligand 112, and 156 µL (1.29 mmol) of freshly distilled p-anisaldehyde provided 185 mg (65%) 
of 116 with an ee of 42%: 1H NMR δ 7.30 (d, 2 H, J = 8.7 Hz), 6.90 (d, 2 H, J = 8.5 Hz), 5.82-
5.60 (m, 2 H), 5.13 (dd, 1 H, J = 3.7, 5.9 Hz), 3.82 (s, 3 H), 2.07 (q, 2 H, J = 6.8 Hz), 1.80 (d, 1 
H, J = 3.5 Hz), 1.45-1.25 (m, 4 H), 0.90 (t, 3 H, J = 7.1 Hz). 
 
OH
117  
(R)-1-Phenylnon-4-en-1-ol (117) using 5 mol% of ligand 112.46  According to the general 
protocol, 500 mg (1.93 mmol) of zirconocene hydrochloride, 175 µL (1.52 mmol) of 1-hexyne, 
650 µL (1.29 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.065 mmol) of ligand 117, 
and 156 µL (1.29 mmol) of freshly distilled cyclohexanecarbaldehyde provided 177 mg (70%) of 
27 with an ee of 73%: 1H NMR δ 7.35-7.15 (m, 5 H), 5.78-5.42 (m, 2 H), 4.15-4.00 (m, 2 H), 
2.80-2.60 (m, 2 H), 2.04 (q, 2 H, J = 6.3 Hz), 1.95-1.70 (m, 2 H), 1.43 (d, 1 H, J = 3.8 Hz), 1.41-
1.25 (m, 3 H), 0.91 (t, 3 H, J = 7.0 Hz). 
 
OH
118  
(R)-2-Ethyl-1-phenylpent-2-en-1-ol (118) using 10 mol% of ligand 112.46  According to the 
general protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 86 µL (0.76 mmol) of 3-
hexyne, 323 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.065 mmol) of 
ligand 112, and 78 µL (0.645 mmol) of freshly distilled benzaldehyde provided 110 mg (89%) of 
118 with an ee of 90%: 1H NMR δ 7.43-7.28 (m, 5 H), 5.60 (t, 1 H, J = 7.8 Hz), 5.18 (s, 1 H), 
2.20-1.96 (m, 4 H), 1.96-1.85 (m, 1 H), 1.78 (bs, 1 H), 1.51 (d, 1 H), 1.03 (t, 3 H, J =7.5 Hz), 
0.84 (t, 3 H, J = 7.5 Hz); 13C NMR δ 142.7, 142.1, 128.6, 128.2, 127.3, 126.5, 78.1,  20.7, 20.5, 
14.4, 14.2; MS (EI) m/z (rel intensity) 190 (M+, 33), 172 (15), 161 (100), 157 (13), 143 (82), 128 
(44), 105 (45). 
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OH
119  
(R)-4-Ethyl-1-phenylhept-4-en-3-ol (119) using 10 mol% of ligand 112.46  According to the 
general protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 86 µL (0.76 mmol) of 3-
hexyne, 323 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg (0.065 mmol) of 
ligand 112, and 95 µL (0.645 mmol) of freshly distilled hydrocinnamaldehyde provided 91 mg 
(65%) of 119 with an ee of 53%: 1H NMR δ 7.34-7.14 (m, 5 H), 5.39 (t, 1 H, J = 7.2 Hz), 4.06 
(ddd, 1 H, J = 2.4, 3.9, 6.3 Hz), 2.81-2.57 (m, 2 H), 2.20-1.98 (m, 4 H), 1.88 (q, 2 H, J = 8.1 Hz), 
1.41 (d, 1 H, J = 3.0 Hz), 1.03 (t, 3 H, J = 7.5 Hz), 1.00 (t, 3 H, J = 7.5 Hz); 13C NMR δ 142.53, 
142.18, 128.54, 128.42, 128.31, 125.71, 76.23, 37.26, 32.30, 20.66, 20.13, 14.64, 14.37; MS (EI) 
m/z (rel intensity) 218 (M+, 56), 200 (45), 189 (74), 171 (47), 126 (62), 113 (83), 109 (100).  
 
OH
120
H3CO
 
(R)-2-Ethyl-1-(4-methoxyphenyl)pent-2-en-1-ol (120) using 10 mol% of ligand 112.46 
According to the general protocol, 250 mg (0.820 mmol) of zirconocene hydrochloride, 86 µL 
(0.76 mmol) of 3-hexyne, 323 µL (0.645 mmol) of Me2Zn (2.0 M solution in toluene), 14 mg 
(0.065 mmol) of ligand 112, and 78 µL (0.645 mmol) of freshly distilled p-anisaldehyde 
provided 90 mg (63%) of 120 with an ee of 87%: 1H NMR δ 7.29 (d, 2 H, J = 9.9 Hz), 6.87 (d, 2 
H, J = 8.7 Hz), 5.59 (t, 1 H, J = 7.2 Hz), 5.12 (d, 1 H, J = 2.4 Hz), 2.11 (p, 2 H, J = 7.5 Hz), 2.02 
(dq, 1 H, J = 7.8 Hz, 15.3 Hz), 1.88 (dq, 1 H, J = 7.5, 15.0 Hz),  1.79 (d, 1 H, J = 3.3 Hz), 1.03 (t, 
3 H, J = 7.5 Hz), 0.85 (t, 3 H, J = 7.5 Hz);  13C NMR δ 158.9, 142.2, 134.9, 127.9, 127.8, 113.6, 
77.4, 55.2, 20.7, 20.7, 14.4, 14.1; MS (EI) m/z (rel intensity) 220 (M+, 20), 202 (47), 191 (65), 
173 (79), 158 (43), 137 (100), 121 (48), 115 (30), 109 (24). 
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O
TIPSO
 
Pent-4-ynoic acid triisopropyl silyl ester (121).46 To a solution of 1.00 g (10.2 mmol) of 4-
pentynoic acid and 2.18 mL (10.2 mmol) of TIPSCl in 60 mL of CH2Cl2 was added 694 mg 
(10.2 mmol) of imidazole.  The reaction was stirred for 5 h, quenched with H2O, extracted with 
CH2Cl2, dried(MgSO4), and concentrated in vacuo. . The resulting crude residue was purified by 
chromatography on SiO2 (25% EtOAc/Hexanes) to yield 2.20 g (85%) of 121 as a colorless oil. 
1H NMR 2.65-2.55 (m, 2 H), 2.54-2.44 (m, 2H), 2.10-1.93 (m, 1 H), 1.30 (sx, 3 H, J = 7.2 Hz), 
1.08 (d, 18 H, J = 7.2 Hz); MS (EI) m/z (rel intensity) 295 (20), 271 (20), 257 (13), 211 ([M-i-
Pr]+, 100), 155 (5), 131 (14), 103 (21), 75 (37), 61 (37). 
 
122
OH
O
OTIPS
 
(S)-6-Hydroxy-6-phenylhex-4-enoic acid triisopropyl silylester (122) using 10 mol% of 
ligand 112.46  According to the general protocol, 250 mg (0.820 mmol) of zirconocene 
hydrochloride, 193 mg (0.76 mmol) of TIPS alkyne, 323 µL (0.645 mmol) of Me2Zn (2.0 M 
solution in toluene), 14 mg (0.065 mmol) of ligand 112, and 65 µL (0.645 mmol) of freshly 
distilled benzaldehyde provided 168 mg (72%) of 122 with an ee of 71%: 1H NMR δ 7.43-7.27 
(m, 5 H), 5.87-5.68 (m, 2 H), 5.17 (t, 1 H, J = 4.8 Hz), 2.51-2.34 (m, 4 H), 1.86 (d, 1 H, J = 3.6 
Hz), 1.27 (sp, 3 H, J = 7.5 Hz), 1.06 (d, 18 h, J = 7.2 Hz); MS (EI) m/z (rel intensity) 344 ([M-
C3H7]+, 65), 317 (68), 301 (100), 157 (7), 141 (5), 131 (11), 103 (14), 75 (20), 61 (11). 
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123
OH
OH
 
(S)-1-Phenylhex-2-ene-1,6-diol (123).  To 80 mg (2.21 mmol) of LiAlH4 in 4 mL of Et2O at 0 
°C was added 80 mg (0.22mmol) of 122 in 2 mL of Et2O.  The resulting reaction was heated at 
reflux for 3 h, quenched with NaSO4•H2O, filtered through celite, and concentrated in vacuo. 
The resulting crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 
36 mg g (86%) of 123 as colorless oil:  1H NMR δ 7.44-7.28 (m, 5 H), 5.86-5.67 (m, 2 H), 5.20 
(dd, 1 H, J = 3.0, 3.6 Hz), 3.66 (q, 2 H, J = 6.3 Hz), 2.17 (q, 2 H, J = 6.9 Hz), 1.90 (d, 1 H, J = 
3.3 Hz), 1.69 (p, 2 H, J = 6.6 Hz), 1.26 (t, 1 H, J = 5.1 Hz); MS (EI) m/z (rel intensity) 174 (M+, 
30), 143 (5), 131 (17), 104 (17), 86 (64), 84 (100). 
 
 
 
 
 
  118
2.0  Pseudotrienic Acid 
2.1 Introduction 
 
 
 
Figure 2.1.  Flowers of Brassica rapa subsp. Rapa L. (Brassicaceae).103
 
Pseudotrienic acids A and B, differing only in the length of their side chains, are 
secondary metabolites isolated in 2005 using bioassay-guided fractionation of a liquid culture 
broth of Pseudomonas sp. isolate MF381-IODS by Pohanka et al.104 The Pseudomonas sp. was 
isolated from the roots of a Brassica rapa subsp. Rapa L. (Brassicaceae) plant specimen 
collected in Switzerland (Figure 2.1).105 Pseudotrienic acids were isolated using a combination 
of solid phase extraction and preparative HPLC. During the chromatography, the activity of the 
fractions was monitored by an in vitro bioassay based on inhibition of growth of cells or spore 
germination of the organisms Fusarium culmorum, Drechslera sorokiniana and Staphylococcus 
aureus.106 Along with pseudotrienic acids A and B, 2,3-deepoxy-2,3-didehydrorhizoxin(DDR) 
and pyrrolnitrin were also isolated from the broth (Figure 2.2). 
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Minimum inhibitory concentrations of the pseudotrienic acids were determined for 
human and agricultural pathogens as well as bacteria. Both acids inhibited the growth of 
Staphylococcus aureus and Pseudomonas syringae pv. Syringae at a MIC of 70 μg/mL and were 
not selective towards the inhibition of Aspergillus fumigatus, and Candida albicans at 
concentrations of up to 100 μg/mL. 
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Figure 2.2.  Antimicrobial compounds isolated from Pseudomonas sp. MF381-IODS. 
 
The structural features of pseudotrienic acids include an (E,E,E)-trienic acid segment and 
a trisubstituted conjugated (E,E)-diene at C(16)-C(19).  The alkene portions of the molecule are 
connected by two amide linkages to a γ-amino-β-hydroxy acid with (11S,12R)-configuration.  
The carbon skeleton of the pseudotrienic acids was assigned based on 1H NMR, 13C NMR, and 
MS.  The trans-configuration of all double bonds was established using NOE experiments and 
determined further by the magnitude of the three bond coupling constants (3JHH = 14.8–16.0 Hz).  
The relative configurations at C(11) and C(12) were assigned using NOE (Figure 2.3).  The 
absolute configuration was determined by a chiral resolution method.  A resolution is achieved 
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by derivatizing a chiral compound of interest with an enantiomerically pure reagent.107  In this 
case, the natural product was degraded through chemical transformations into smaller segments 
that were analyzed using chiral resolution.  The absolute stereochemistry of the γ-amino β-
hydroxy acid was determined to be (11S,12R) in comparison to bistramide A which also contains 
a γ-amino β-hydroxy acid moiety with a (S,R)-configuration.108  The stereochemistry at C(20) 
was concluded to be a 1:1 mixture of epimers after degradation and GC-MS experiments.   
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Figure 2.3.  Elucidation of configuration at C(11) and C(12) of pseudotrienic acids by NOE and 
3JHH analysis. 
 
The biosynthetic origin of the pseudotrienic acids is uncertain.  They may be derived 
from a ring opening of a macrolactone. In the presence of 0.1% TFA, pseudotrienic acids are 
converted readily to the lactone form (Scheme 2.1).  The isolated lactones have the same 
bonding pattern as macrolides FR252922 and FR252921 which were previously described by 
Fujine et al.109 The macrolides were isolated from a Pseudomonas fluorescence strain and 
demonstrate immunosuppressive activity.110  The absolute configurations of the three stereogenic 
carbons in FR2529922 and FR252921 have yet to be assigned.  However, it is suspected that 
FR252922 and FR252921 possess configurations at C(11) and C(12) identical to those present in 
pseudotrienic acids.  Biosynthetically, pseudotrienic acids may be derived from ring opening of 
the lactone by nucleophilic attack of H2O at C(20), leading to a mixture of epimers.  This 
proposed mechanism is in agreement with the formation of epimers at C(20) of the pseudotrienic 
acids.   However, this is contrary to the usually very stereospecific biosynthesis of 
polyketides.111  Thus, the epimerization at the C(20) stereogenic carbon could have occured 
during the isolation of the natural product. 
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Scheme 2.1.  Lactone formation under acidic conditions. 
 
The intrinsic structure as well as the ambiguous biosynthetic pathway makes the 
pseudotrienic acids an attractive synthetic target.  By synthesizing a single enantiomer at C(20), 
the origin of the mixture of diastereomers isolated can be further investigated.  A single 
diastereomer could be resubjected to isolation conditions to determine if epimerization of the 
C(20) center is as a result of isolation conditions.  The synthesis of pseudotrienic acid can also 
provide valuable insights that could be relayed to establish the absolute configurations of 
FR252922 and FR252921 and obtain clues for their biosynthesis.   
2.1.1 Previous Synthesis of Pseudotrienic Acid B 
To date, one total synthesis of pseudotrienic acid B has been reported by Cossy et al., 
affording pseudotrienic acid B as a mixture of epimers at C(20).112 Their retrosynthetic strategy 
is depicted in Scheme 2.2.  The analysis requires a late stage palladium catalyzed Stille coupling 
between a vinyl iodide and vinyl stannane to generate the (E,E)-diene.  The vinyl iodide stems 
from amide formation between a trienic protected amine and carboxylic acid. The trienic ester 
portion was synthesized based on a cross metathesis and a Horner-Wadsworth-Emmons reaction 
sequence.  
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Scheme 2.2.  Cossy’s retrosynthetic analysis of pseudotrienic acid B. 
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The synthesis of the trienic acid segment was initiated by the metathesis of methyl 
sorbate with allyl bromide in the presence of 5 mol% of Grubbs-Hoveyda catalyst113 to afford 
142 in 48% yield with good stereoselectivity (E,E/E,Z > 95:5) (Scheme 2.3).  Phosphonation of 
allylic bromide 142 under Michaelis-Arbuzov conditions employing P(OEt)3 led to the formation 
of 143 in 99% yield.  Diethylphosphonate 143 was coupled with Boc-protected amino aldehyde 
144 in a Horner-Wadsworth-Emmons olefination followed by subsequent deprotection to 
provide the trienic ester fragment 140 in 52% yield over 2 steps and 25% overall yield.    
 
MeO
O
allyl bromide
141a (2 mol%)
48%
MeO
O
Br
141
P(OEt)3, reflux
99%
MeO
O
P
O
OEt
OEt 1. LDA,
O
H NHBoc
2. TFA/CH2Cl2, Na2CO3
52% over 2 steps
MeO
O
143
140
142
NH2
144
NNMes Mes
Ru
Cl
Cl
O
141a
 
Scheme 2.3.  Synthesis of the trienic acid fragment 140. 
 
The contiguous stereocenters of the γ-amino acid segment were installed using Hafner-
Duthaler crotylation methodology.114  Initial reduction of methylester 145 with DIBAL-H 
resulted in the formation of the requisite aldehyde.  The aldehyde underwent reaction with 
crotyltitanocene to afford the homoallylic amino alcohol, 147, in 57% yield with a 
diastereomeric ratio of 95:5 and an enantiometric excess of 95% (Scheme 2.4).  The amino 
alcohol was protected as an N,O-acetonide followed by oxidative cleavage of the terminal alkene 
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under Sharpless conditions, using catalytic RuCl3 and NaIO4, to afford 148 in 75% yield over 2 
steps.    
 
BocHN
OMe
O
Ti
O
O
Ph
Ph
Ph
Ph O
O
(S,S)-146
1. DIBAL-H (1.1 equiv.)
2.
BocHN
OH
57% over 2 steps
145 147
1. 2,2-dimethoxypropane
pTsOH
2.  RuCl3, NaIO4
CCl4/CH3CN/H2O (2:2:3)
75% over 2 steps
BocN
O
O
148
OH
 
Scheme 2.4.  Utililization of crotyltitanocene in the synthesis of fragment 148.   
 
Vinyl iodide fragment 139 was synthesized via stannylcupration of pent-3-yn-1-ol to give 
a mixture of vinyl stannane regioisomers favoring the desired regioisomer (9:1) in a combined 
yield of 74% (Scheme 2.5).  The desired isomer was subject to iododestannylation, resulting in 
iodide 152.  Lastly, oxidation with Jones’ reagent afforded the desired carboxylic acid 139 in 
92% yield.   
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I
OH
149
152
CuCN, n-BuLi, n-BuSnH, MeOH
74%
Bu3Sn
OH
151
OH
SnBu3
+
150
I2, Et2O
CrO3, H2SO4, acetone
92%
I
OH
139 O
151/150 = 9:1
94%
 
 
Scheme 2.5.  Synthesis of vinyl iodide 139. 
 
Vinyl stannane 137 was synthesized from octanal following a synthetic sequence 
beginning with ethynyl magnesium bromide addition to give 154 in 81% yield (Scheme 2.6). 
Conversion of the alkyne to the bromoalkyne in the presence of NBS and AgNO3 resulted in 
93% yield of 155 followed by hydrostannylation to afford the desired (E)-vinyl stannane 137 in 
70% yield. 
4
OH
4
O
H
154
SnBu3
4
OH
137
4
OH
155
Br
HC CMgBr
81%
NBS, AgNO3, acetone
n-Bu3SnH, [PdCl2(PPh3)2]
70%
93%
153
  
 
Scheme 2.6.  Synthesis of vinyl stannane 137. 
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With the desired fragments in hand, elaboration toward pseudotrienic acid B began with a 
standard HOBT-coupling of carboxylic acid 148 with trienic amine 140, affording the desired 
product in 96% yield (Scheme 2.7).  Removal of the the acetonide using TFA, deprotection of 
the t-butyloxycarbonyl group using pTsOH and MeOH, followed by HOBT-coupling of the 
resulting amine with acid 139 afforded the C(1)-C(19) segment of the natural product in 78% 
yield over 2 steps.  The resulting vinyl iodide underwent a [PdCl2(MeCN)2]-catalyzed Stille 
cross-coupling followed by saponification of the methylester to furnish pseudotrienic acid B in 
75% yield. The Cossy synthesis of pseudotrienic acid B is highly convergent with the longest 
linear sequence consisting of 10 steps from methyl sorbate proceeding in 5.8% overall yield. 
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O
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O
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O
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N
H
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O
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N
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N
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O H
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2. TFA, CH2Cl2
3. HOBT, HBTU, 139
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1. 137, [PdCl2(MeCN)2], 51%
2. LiOH, 75%
130  
 
Scheme 2.7.  Coupling of fragments towards the synthesis of pseudotrienic acid B. 
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2.2 Pseudotrienic Acid A: Retrosynthesis 
The unassigned hydroxy-bearing stereogenic carbon C(20) is a salient feature of this 
molecule, which provides an incentive to test the asymmetric alkenylzirconium/zinc 
methodology, utilizing the ligands synthesized in Chapter 1.  Using the asymmetric 
methodology, both enantiomers at C(20) can be synthesized easily by using both enantiomers of 
the ligand.  The retrosynthetic disassembly is depicted in Scheme 2.8.  Pseudotrienic acid A 
originates from three distinct segments.  The trienic acid portion 156 would arise from an alkenyl 
zirconocene/zinc addition to the α,β-unsaturated aldehyde 160 followed by base-induced 1,4- 
elimination.120  Formation of the C(10)-C(14) fragment would arise form desymmetrization of 
cyclic anhydride 161 followed by Frater-Seebach alkylation, providing the desired (S,R)-
configuration at C(11) and C(12).133 As mentioned earlier, the C(20) stereocenter would be 
formed using an asymmetric zirconocene/zinc addition of eneyne 162 to decyl aldehyde.   
 
  128
O N
H
H
N
OH O OH
O
11
121 3 5 7 9
H
SMe
Asymmetric 
Zr/Zn 
methodology
OH
TIPSO
O
+
H
O
OTBS
Zr/Zn methodology
MeO
NHCbz
O OTBS
O NH2
OH
OO O
OTBDPS
+
O OH
16 18 22 24 26 28
159
156
160
161
157 158
162
MeS
SMe
O
+
1
163
HO+
 
 
Scheme 2.8.  Retrosynthetic analysis of pseudotrienic acid A. 
2.3 Synthesis of the Trienic Acid Segment 
Retrosynthetically, the C(1)-C(9) segment 156 was envisioned to arise from intermediate 
164.  Fragment 164 would arise from an alkenylzirconocene/zinc addition followed by base-
induced 1,4-elimination (Scheme 2.9). Fragment 164 can be simplified into α,β-unsaturated 
aldehyde 160 and alkyne 159.  Both of these intermediates conveniently originate from 3-butyn-
1-ol. 
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Scheme 2.9.  Retrosynthetic analysis of trienic acid 164. 
 
The total synthesis of pseudotrienic acid A commenced with the synthesis of trienic acid 
164.  Synthesis of 163 was initiated by TBS protection of 3-butyn-1-ol followed by 
hydroxymethylation of the resulting alkyne to afford propargyl alcohol 167 in 79% yield 
(Scheme 2.10).115 Red-Al reduction of the alkyne generated the desired trans-allylic alcohol in 
75% yield.116  LiAlH4 was also tested in the reduction but resulted in concurrent desilylation of 
the TBS ether along with the desired reduction of the internal alkyne.117   Lastly, oxidation of the 
allylic alcohol using MnO2 gave α,β-unsaturated aldehyde 160 in 73% yield.118 In contrast, use 
of Dess-Martin periodane for the ensuing alcohol to aldehyde conversion resulted in only 50% 
yield of the α,β-unsaturated aldehyde.119  The alkyne partner was synthesized via Jones 
oxdiation of 3-butyn-1-ol followed by TIPS protection of the resultant acid to afford ester 159 in 
53% yield over 2 steps.120   
 
OTBS
OH
HO OTBS
166 167
TBSCl
Imidazole
n-BuLi, (CH2O)n
HO OTBS
168
Red-Al
75%
MnO2
73%
165
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O
160
TIPSO
O
159
HO
1. CrO3, H2SO4, acetone; 53%
2. TIPSCl, imid.; quant.165
79%
99%
 
Scheme 2.10.  Preparation of aldehyde and alkyne for coupling.   
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 With both aldehyde 160 and alkyne 159 in hand, the feasibility of the alkenyl 
zirconium/zinc addition to form the desired bisallylic alcohol was investigated (Table 2.1).121  
Investigation of the desired hydrozirconation of alkyne 159, followed by transmetalation and 
aldehyde addition revealed that 1.1 equivalents of Schwartz reagent122 did not result in full 
conversion of the aldehyde. Increasing the amount of Schwartz reagent to 2 equivalents and also 
employing a different solvent, toluene, in place of dichloromethane after the initial 
hydrozirconation resulted in 100% conversion and 36% yield (entry 2).  In an effort to improve 
the yield, methods employing carbonyl activation utilizing cationic zirconocene were also 
explored.123  Suzuki et al. reported a remarkable rate enhancement by employing a catalytic 
amount of AgClO4 in alkenylzirconium additions to carbonyl compounds. The in situ generated 
cationic species is hypothesized to be responsible for the observed enhancement of rate.124  
Analogously, silver hexafluoroarsenate (AgAsF6) is reported as a safe alternative to AgClO4 and 
works effectively in both alkyl and alkenylzirconocene additions.125  The use of both AgClO4 
and the more reactive AgAsF6 in catalytic amounts resulted in isolation of 37-38% of the desired 
product 169 (entries 3-5). While both alkenyl zirconium/zinc addition and cationic zirconocene 
addition provided similarly low yields, the H NMR spectra of all reaction mixtures were quite 
clean and the mass balance before purification was quite high.  It is conceivable that the 
bisallylic alcohol 169 could be somewhat unstable under the slightly acid chromatography 
conditions and could partly decompose to give lower yields.  To avoid this decomposition 
pathway, the mixture was used without purification and tested in the ensuing activation-
elimination reaction sequence. 
1
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Table 2.1.  Formation of bisallylic alcohol 169.  
TIPSO OTBS
O OHH OTBS
O
TIPSO
O
160
159 169  
 
Entry Conditions 
Conversion 
of 160a
Yield (%) of 169 
1 Cp2ZrHCl (1.1 equiv), Me2Zn, CH2Cl2, rt, 15 h incomplete messy 
2 Cp2ZrHCl (2 equiv), Me2Zn, Toluene, rt, 15 h 100% 36% 
3 Cp2ZrHCl (2 equiv), AgClO4 (5 mol%), 3 h 100% 38% 
4 Cp2ZrHCl (2 equiv), AgClO4 (25 mol%), 30 min 100% 37% 
5 Cp2ZrHCl (1.8 equiv), AgAsF6 (10 mol%), 30 min 100% 38% 
aconversion of 160 measured by 1H NMR. 
 
Initially, trifluoroacetic anhydride was used to activate the alcohol. In the presence of 
diisopropylethyl amine, the resulting trifluoracetate underwent a 1,4-elimination to give the 
desired all-trans trienyl ester 164 as a single stereoisomer in 39% yield over 2 steps (Table 2.2, 
entry 1).126  We were pleased to note that switching to 1-(trifluoroacteyl)imidazole as the 
activating agent resulted in a respectable yield of 60% over 2 steps (entry 3).  When employing 
TFAA, the lower yield could be attributed to the formation of trifluoracetic acid as the 
byproduct, whereas benign imidazole is generated as the byproduct from 1- 
(trifluoroacteyl)imidazole.  We thus obtained the trienic acid fragment 164 in 6 steps and 26% 
overall yield. 
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Table 2.2.  Formation of 164 via a 2-step protocol.   
 
H OTBS
O
TIPSO
O
+
TIPSO OTBS
O OH
TIPSO OTBS
O
(crude)
a
159 160 169
164
b
 
Entry Conditions Yield (%) of 164 
1 
a) Cp2ZrHCl, AgClO4 (5 mol%), 3 h; 
b) i.TFAA, pyridine, ii. i-Pr2NEt 
39% 
2 
a) Cp2ZrHCl, AgClO4 (10 mol%), 30 min; 
b) i.TFAA, pyridine, ii. i-Pr2NEt 
36% 
3 
a) Cp2ZrHCl, AgClO4 (10 mol%), 30 min; 
60% 
b) i.CF3CO-imid., pyridine, ii. i-Pr2NEt 
 
2.4 Synthesis of the γ-Amino-β-Hydroxy Acid Segment 
2.4.1 Desymmetrization/Alkylation Approach  
At the outset, synthesis of the C(10)-C(13) segment was envisioned based on the 
desymmetrization of cyclic anhydride 161 to form the enantiomerically enriched hemiester 170 
(Scheme 2.11). Utilization of a Frater-Seebach alkylation would install the correct configuration 
of the methyl substituent at C(11). 
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Scheme 2.11.  Initial retrosynthesis of the γ-amino-β-hydroxy segment. 
 
The pursuit of this strategy was initiated by silyl protection of diethyl 3-hydroxyglutarate 
followed by ester saponification and dehydration to afford the cyclic anhydride 161 (Scheme 
2.12).127 A catalytic desymmetrization using a modified cinchona alkaloid, (DHQD)2AQN, in 
the presence of methanol produced the optically active methyl ester 170 in 73% yield and in 94% 
ee.128   
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Scheme 2.12.  Synthesis of enantiomerically enriched hemiester 170. 
 
Initial attempts to convert 170 to the Boc-protected amine via a Curtius rearrangment129 
using t-BuOH as the nucleophile afforded dimer 175 as the major product (Table 2.3, entries 1-
3).  The formation of 175 can be attributed to the hydrolysis of the intermediate isocyanate by 
residual water, decarboxylation of the carbamic acid and attack of the resulting amine onto the 
isocyanate.  Alternatively, utilizing the more nucleophilic BnOH (1.5 equiv) to trap the 
intermediate isocyanate resulted in the desired product 174 in 66% yield along with an 
unidentified byproduct (entry 4).130  Gratifyingly, increasing the amount of BnOH to 3 
equivalents resulted in the exclusive formation of 174 in 80% yield (entry 5). 
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Table 2.3.  Curtius rearrangement of 170. 
 
MeO2C CO2H
OTBDPS Conditions
MeO2C NHX
OTBDPS
170
+ MeO2C
H
N
TBDPSO H
N CO2Me
O
OTBDPS
175
173; X = Boc
174; X = Cbz
 
 
Entry Conditions 
Product and 
Isolated Yields 
1 DPPA, Et3N, t-BuOH, 1 h at rt, 18 h, reflux 175 
2 DPPA, Et3N, t-BuOH(distilled), 1 h at  rt, 18 h, reflux 175 
3 DPPA, Et3N, 1 h at rt, 3 h at reflux, t-BuOH (distilled), 18 h, reflux 175 
4 DPPA, Et3N, 1 h at rt, 3 h at reflux, BnOH (1.5 equiv), 18 h, reflux 174; 66% 
5 174; 80%131DPPA, Et3N, 1 h at rt, 3 h at reflux, BnOH (3.0 equiv), 18 h, reflux 
 
A brief survey of deprotection conditions for the removal of the TBDPS group was 
conducted (Table 2.4).132 Optimal yields were obtained with HF-pyridine in THF, affording the 
desired secondary alcohol 176 in 80% yield (entry 1).   
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Table 2.4.  Deprotection of TBDPS ether 174 to afford alcohol 176.  
 
MeO2C NHCbz
OTBDPS Conditions
MeO2C NHCbz
OH
174 176  
Entry Conditions Yield (%) of 176 
1 HF-pyridine/THF, 3 d 80% 
2 TBAF, 3 h 44% 
3 AcCl, MeOH 66% 
 
It was envisioned that α-methylation using Frater-Seebach conditions would lead to the 
desired product 157 in a highly diastereoselective fashion (Table 2.5).133  However, under the 
standard conditions none of the desired product 157 was formed, only cyclic amide 177 could be 
isolated in 46% yield (entry 1).  At elevated temperatures, using 2.3 equiv. of freshly prepared 
LDA and 2.2 equiv. of HMPA, methylation occurred at the amine to give 178 in 55% yield.  This 
result suggested the formation of the dianion at the alcohol and amine sites.  Increasing the 
amount of LDA to 3.3 equivalents in order to facilitate the formation of the trianion afforded 
methylation of the amine as well as the desired C(11), resulting in a 35% yield of 179 (entry 3).  
Switching the base to LHMDS and KHMDS resulted in the alkylation of the amine to afford 
178. According to these results, the least acidic site is C(11) and in theory this should be the site 
of alkylation, but in the majority of these reactions the dianion predominates and alkylation 
occurs at the amine.     
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Table 2.5.  Attempted Frater-Seebach alkylation. 
MeO
NHCbz
OHO
MeO
NHCbz
OHO
Conditions
176 157
CbzN
O
OH
MeO
Cbz
N
OHO
MeO
Cbz
N
OHO
177
179178  
 
Entry Conditions Isolated Yields 
1 LDA (3 equiv); 176, -78 ºC to -20 ºC; 
CH3I, -78 ºC to rt 
177; 46% 
2 LDA (2.3 equiv); 176, -50 ºC; CH3I, HMPA; 
reflux, 45 min 
178; 55% 
3 LDA (3.3 equiv); 176, -50 ºC; CH3I, HMPA; 
reflux, 45 min 
179; 35% 
4 LHMDS (3.3 equiv); 176, -78 ºC; CH3I, HMPA; 
-78 ºC to rt, 1.5 h 
178; 46% 
5 KHMDS (3.3 equiv); 176, -78 ºC; CH3I, HMPA; 178; 32% 
-78 ºC to rt, 1.5 h 
 
To prevent the formation of the anion on the secondary amine, the bis-CBZ protected 
amine 179 was synthesized (Scheme 2.13).  Attempted deprotection of 179 using acetyl 
chloride/MeOH or HF•pyridine was unsuccessful and resulted in migration of the Cbz group to 
the alcohol. 
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LHMDS, HMPA
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 48 h
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OHO
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Scheme 2.13.  Attempted deprotection of TBDPS-ether 179. 
2.4.2 Acyl Halide-Aldehyde Cyclocondensation Approach 
The Acyl Halide-Aldehyde Cyclocondensation (AAC) reaction was also examined as a 
way to gain direct access to this segment.134  The AAC reaction offers a convenient tool by 
which enantioenriched β-lactone can be accessed.  Retrosynthetically, this segment could arise 
from a nucleophilic ring opening of a β-lactone, which in turn could be synthesized under AAC 
reaction conditions (Scheme 2.14).   
 
O
O
N(Boc)2182
MeO
N(Boc)2
O OH
181  
 
Scheme 2.14.  Retrosynthesis of γ-amino-β-hydroxy ester via an AAC reaction. 
 
The aldehyde necessary to probe the feasibility of the AAC reaction was synthesized 
from allyl amine (Scheme 2.15).  Allyl amine was bis-Boc protected followed by ozonolysis to 
give the desired aldehyde 186.  The AAC reaction between acetyl chloride and aldehyde 186 
employing a Lewis base catalyst, TMS-quinidine (TMSQ), and LiClO4 afforded the desired β-
lactone 182 in 66% yield with 98% ee.135  The high enantiomeric excess was encouraging, as 
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aldehyde substrates containing amine functionalities have not been previously reported by the 
Nelson group.  
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Scheme 2.15.  Application of AAC-reaction to the formation of 182. 
 
 With β-lactone 182 in hand, conditions for enolization and subsequent methylation were 
explored.  Seebach et al. disclosed the first example of alkylation at C(3) of a β-lactone to afford 
the trans-3,4-disubstituted lactone 188 in low yield (31%) but with good levels of 
diasteroselectivity (Scheme 2.16).136  Another example has been reported more recently by 
Parsons et al. in the total synthesis of (-)tetrahydrolipstatin.137  In this report, enolization 
utilizing NaHMDS in the presence of the alkylating agent, 1-iodohex-2-ene, resulted in 36% of 
the desired monoalkylated product 190 along with 26% of the dialkylated β-lactone 191.  
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Scheme 2.16.  Previously reported enolization-alkylation reactions of β-lactones. 
 
Attempts at enolization in conjunction with methylation using LDA or NaHMDS as bases 
resulted in no reaction.  Alternatively, the use of LHMDS and KHMDS resulted in the recovery 
of starting material along with an unidentified byproduct.  
2.4.3 Alternate Approaches Towards the Synthesis of the γ-Amino-β–Hydroxy Acid 
Segment 
Alternative routes to the α-amino-β-hydroxy acid segment were subsequently 
investigated.  Standard Brown138 crotylation of 186 gave the desired product 193 in 60% yield 
but with low diastereoselectivity (Scheme 2.17).  Asymmetric aldol139 reactions are convenient 
methods for introducing two-stereocenters in high enantioselectivity.  Retrosynthetically, the 
stereochemistry inherent in the γ-amino-β-hydroxy acid fragment could arise from an anti-aldol.  
Currently, there are very few general approaches for anti-aldol reaction of aliphatic aldehyde 
substrates.  Anti-aldol reactions using chiral auxillaries reported by Ghosh140 and Masamune141 
were considered as viable approached to this fragment, but unfortunately these protocols were 
low yielding.  The chromium-Reformatsky142 reaction was also considered as a possible option, 
but low yield and low diastereoselectivity deterred from further exploration.   
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Scheme 2.17.  Alternative approaches towards the synthesis of the γ-amino-β–hydroxy acid 
segment. 
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2.4.4 Revised Alkylation Approach 
EtO
O
N3
OH
200
HO
O
OH
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O
201  
Scheme 2.18.  Frater-Seebach alkylation of malic acid derivative. 
 
An alternative approach was initiated by a Fischer esterification of  (D)-malic acid to give 
the corresponding ethyl diester 202 in 80% yield (Scheme 2.19).  A diastereoselective 
methylation employing Frater-Seebach conditions gave 203 in 64% yield with a dr of 6:1 
(trans:cis). A combination of BH3•DMS and catalytic NaBH4 affected the chemoselective 
reduction of the vicinal hydroxy-ester to the desired 1,2-diol.143 This selective reduction is 
proposed to occur through a 5-membered boron chelate between the neighboring hydroxy group 
and the ethyl ester.  The resulting crude diol was converted to tosylate 204 employing catalytic 
Bu2SnO-mediated sulfonylation conditions, proceeding via formation of the tin acetal 
intermediate to afford 56% of 204 over 2 steps.144  The tin acetal plays the dual role of activating 
the primary alcohol while temporarily protecting the secondary alcohol.  Lastly, displacement of 
the tosylate by sodium azide gave the desired fragment 200 in 65% yield. 
 
EtO
O
OTs
OH
EtO
O
N3
OH
EtO
O
OEt
OH
O
EtO
O
OEt
OH
O
HO
O
OH
OH
O
HCl, EtOH
80%
LDA, MeI
64%
1. BH3.DMS, NaBH4
2. Bu2SnO, TsCl, Et3N
56%
NaN3, DMF
65%
202
203 204
205
201
 
Scheme 2.19.  Synthesis of the amino acid fragment 200. 
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2.5 Synthesis of the Hydroxy-Diene Segment  
2.5.1 Alkenylzirconium/zinc Addition Approach  
The retrosynthetic disconnection of this fragment at the C(19)-C(20) bond 205 gives 206 
and decylaldehyde as precursors (Scheme 2.20).  Enyne 206 can be conveniently synthesized via 
a palladium coupling.   
 
20
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H
SMe
SMe
SMe TMS H
CO2Et
+
206OH205
OMeO
207
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Scheme 2.20.  Retrosynthetic analysis of the hydroxy diene segment. 
 
Construction of 205 begins with utilization of a palladium-catalyzed cross coupling 
method developed by Trost et al., in which 3-methylbutynoate (the activated internal alkyne 
acceptor) is cross-coupled to TMS-acetylene (donor alkyne) (Scheme 2.21).  The reaction 
proceeded smoothly in the presence of 3% Pd(OAc)2 and 3% tris(2,6-
dimethoxyphenyl)phosphine to afford the cross-coupled product 209 in 77% yield (Scheme 
5).145 The resulting methylester was reduced using DIBAL-H to afford the corresponding alcohol 
210 in 84% yield.  Alcohol 210 was then converted to the mesylate146 followed by displacement 
with the carbanion of tris(methylthio)methane.147  Seebach et al. has widely researched the 
umpolung reactivity of carbonyl compounds through these and other sulfur-containing 
reagents.148  The Umpolung reactivity of tris(methylthio)methane can be harnessed by reaction 
with n-BuLi to affect formation of the carbanion.149 Tris(methylthio)methane is used in synthesis 
as a masked acid derivative.150  It provides essentially a route by which homologation and 
oxidation take place concurrently by introduction of tris(methylthio)methane.  The TMS-group is 
hydrolyzed using K2CO3 and MeOH to provide 206 in 51% yield over 3 steps.151   
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Scheme 2.21.  Synthesis of enyne 210.     
 
Application of the alkenylzirconocene/zinc methodology in the addition of 206 to 
decylaldehyde gave the desired allylic alcohol 211 in an unoptimized yield of 41% (Scheme 
2.22). The asymmetric reaction was also tested briefly using 15 mol% of 21 to produce 27% of 
the allylic alcohol 211 in 15% ee. The reaction conditions were not optimized due to the 
problems encountered in the ensuing step.  Attempted hydrolysis of the trithioorthoester under 
the Stork protocol utilizing PIFA or PIDA was unsuccessful.152 Hydrolysis conditions using 
PIFA and PIDA were also tested on the shorter fragment 206, but these also resulted in no 
product formation.   Not many alternatives exist for the hydrolysis of the trithioorthoester, and 
thus this route was abandoned in favor of an alternate process.   
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Scheme 2.22.  Alkenylzirconocene/zinc addition and subsequent attempted hydrolysis of 
trithioester 206. 
2.5.2 Alternate Alkenylzirconium/zinc Addition Approach 
Retrosynthetic scission of the C(19)-C(20) bond of 205 in hopes of utilizing the 
alkenylzirconocen/zinc methodology furnishes decyl aldehyde and enyne 213 as precursors 
(Scheme 2.23).  Enyne 213 can be readily obtained from 2,3-dihydrofuran by employing a 1,2-
metallate rearrangement. Enyne 213 was used in attempts to avoid the problem encountered with 
deprotection of trithioorthoester 211; the requisite carbons are already contained within this 
alkyne.    
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Scheme 2.23.  Retrosynthetic analysis for the C(14)-C(29) segment. 
 
The vinyl iodide 216 was synthesized in a straightforward manner by utilizing the 1,2-
metallate rearrangment strategy described by Kocienski et al.153 2,3-Dihydrofuran has been 
shown to undergo a facile 1,2 metallate rearrangement in the presence of a higher order cuprate 
to afford upon alkylation of the alkenyl cuprate the trisubstituted alkene 215 (Figure 2.4).  The 
alcohol of the vinyl stannane is readily protected, followed by subsequent iododestannylation to 
afford vinyl iodide 216 in 73% yield over 3 steps (Scheme 2.24).   
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Figure 2.4.  Proposed mechanism for the 1,2-metallate rearrangement. 
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Scheme 2.24.  Synthesis of vinyliodide 216 using a 1,2-metallate rearrangement. 
 
Vinyliodide 216 was coupled with ethynyl magnesium chloride in the presence of 
Pd(Ph3P)4 to furnish 213 in 71% yield. Use of alkenylzirconocene/zinc methodology in the 
addition of 213 to decylaldehyde resulted in formation of the allylic alcohol 217 in 23% yield 
(Scheme 2.25). The major isolated byproduct was the reduced alkyne.  Deuterium studies 
revealed that the low yield was due to protonation of the alkenylzirconium intermediate prior to 
the transmetallation step.  When the hydrozirconation product of 213 was quenched with an 
excess of CD3OD, a ratio of 1.5:1 (H:D) of the alkenyl product was observed by 1H NMR 
(Scheme 2.26).   
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Scheme 2.25.  Synthesis of 217. 
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Scheme 2.26.  Deuterium quenching studies. 
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Unfortunately, the low yield in the alkenylzirconocene/zinc addition as a consequence of 
the inability to inhibit the formation of the diene byproduct 219 did not enable the use of our 
methodology as a viable approach to this fragment.   
2.5.3 Suzuki Approach  
OTBS
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18
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Scheme 2.27.  Pd-mediated approach to the C(14)-C(29) segment. 
 
The requisite bond formation at C(17)-C(18) could conceivably be derived from a Suzuki 
reaction  between vinyl iodide 216 and alkenyl borane intermediate 221 (Scheme 2.27). Addition 
of the lithium anion of TMS-acetylene to decyl aldehyde gave the corresponding alcohol 223 in 
78% yield (Scheme 2.28).154  The resulting alcohol was protected with TBSCl, and subsequent 
hydrolysis of the TMS group provided 225 in 99% yield.155   
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Scheme 2.28.  Synthesis of propargyl alcohol 225. 
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Hydroboration of 225 using pinacolborane in the presence of 10 mol% Cp2ZrHCl and 10 
mol% Et3N gave exclusively the (E)-vinylboronic ester (Scheme 2.29).156 In hydroboration 
reactions of alkynes containing oxygen atoms, it is speculated that intramolecular chelation 
between zirconium and oxygen favors the formation of the pseudo-(Z)-intermediate, which in 
turn leads to the (Z)-vinylboronic esters.157  However, the equilibrium can be shifted with the use 
of a catalytic amount of Et3N.  Et3N acts to distrupt the intramolecular Zr-O interaction, yielding 
the (E)-vinylboronic ester (Figure 2.4).  
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Scheme 2.29.  Hydroboration of propargyl alcohol 225. 
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Figure 2.5.  Stereoselectivity of the initial hydrozirconation in the presence of Et3N and 
temperature. 
 
With the (E)-vinylboronic ester in hand, the requisite vinyl iodide coupling partner 216 
was synthesized as mentioned above. The (E)-vinylboronic ester was coupled via a Suzuki 
reaction158 with vinyl iodide 216 in the presence of thallium ethoxide and Pd(PPh3)4 to furnish 
the conjugated diene 226 in 66% yield over 2 steps (Scheme 2.30).  TlOEt is an alternative base 
to TlOH, and has been shown by Kishi et al. to significantly enhance rates of Suzuki 
reactions.159  TlOEt has the advantages over TlOH in terms of commercial availability, stability, 
and ease of use.160  Deprotection of the primary alcohol using TBAF while maintaining the 
temperature between 5 ºC and 15 ºC resulted in a 83% yield of 227 (Table 2.6, entry 3).  
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Scheme 2.30.  Synthesis of fragment 226. 
 
Table 2.6.  Deprotection of 226.   
OTBS
OTBS
226
7
OH
OTBS
227
7
Conditions
 
Entry Conditions Yield (%) of 227 
1 TBAF, 0 ºC, 1.5 h 66% conversiona
2 TBAF, rt, 2.5 h 37% 
3 TBAF, rt, 20 h 37% +bisdeprotection 
4 TBAF, 5 ºC to 15 ºC, 2.5 h 83% 
5 HF/pyridine, 0 ºC to rt, 12 h 45% + bisdeprotection 
aconversion of 226 measured by 1H NMR. 
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 A variety of conditions for oxidation of the homoallylic alcohol, 227, were investigated 
to complete the synthesis of this fragment (Table 2.7).  Disappointingly, attempts at oxidation via 
a two-step sequence or a one-step procedure directly to the acid led to none of the desired acid 
229.  It is conceivable that 228 and 229 are unstable while isomerization of the diene into 
conjugation with the newly formed carbonyl group can occur. Partial or total migration of the 
double bond to the corresponding more stable α,β-unsaturated aldehyde has been reported in the 
oxidation of β,γ-unsaturated alcohols.161
 
Table 2.7.  Oxidation of 227. 
OH
OTBS
227
7
CHO
OTBS
228
7
+
COOH
OTBS
229
7
Conditions
 
Entry Conditions Resulta
1 PDC, DMF162 no reaction 
2 DMP, pyridine163 many aldehyde peaks 
3 TEMPO, PIDA164 aldehyde, messy 
4 NaClO2, NaOCl, TEMPO165 sm 
5 CrO3 (1.2 mol%), H5IO6, wet CH3CN166 messy 
6 CrO3, H2SO4, acetone167 decomposition 
7 
trichloroisocyanuric acid, TEMPO (0.01 equiv), 
NaBr (0.05 equiv)168
many aldehyde peaks 
aby 1H NMR of crude material 
 
It is, however, possible to take a slightly different approach in order to circumvent the 
problematic oxidation.  Initial oxidation of the alcohol 229 to the aldehyde 230 using Dess-
Martin reagent followed by subsequent oxidation resulted in formation of the desired acid 231 
(Scheme 2.31).   
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Scheme 2.31.  2-Step oxidation of 229.  
2.6 Fragment Coupling 
2.6.1 Coupling of Segments 156 and 157 
Preparation of the trienic acid segement 164 for peptide coupling necessitated a 
deprotection of the TBS-ether in the presence of the TIPS-ester.169  Conditions were examined 
using mild acid (Table 2.8).  In the presence of 5 equivalents of PPTS, facile deprotection of both 
TBS-ether along with the TIPS-ester occurred (entry 3).  Lowering the amount of PPTS to 2 
equivalents and carrying out the reaction at room temperature led to a facile deprotection of the 
TIPS-ester to give 233 in 75% yield. Use of Cs2CO3 and BiBr3 also resulted in cleavage of the 
TIPS-ester (entry 5 and 6).  These results are indicative of the higher lability of the TIPS-ester in 
comparison to the TBS-ether under acid conditions. 
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 Table 2.8.  Deprotection of TBS-ether in the presence of TIPS-ester of 164. 
 
TIPSO OTBS
O
TIPSO OH
O
Conditions
232
HO OTBS
O
233
HO OH
O
234
164
 
 
Entry Conditions Products and Isolated Yields 
1 PPTS (2 equiv), EtOH, 0 ºC, 3h SM  + 232 
2 PPTS (2 equiv), EtOH,  rt,  4.5h 233; 75% 
3 PPTS (5 equiv), EtOH, rt, 2.5h170 234; 82% 
4 HOAc (1 equiv), THF, H2O, μW, 125 ºC, 5 min.171 234; 84% 
5 Cs2CO3, DMF:H2O (10:1)172 233; 71% 
6 BiBr3, CH3CN, H2O173 233; 78% 
 
Alternatively, conversion of the TBS-ester to the alkyl bromide was examined as a 
possible solution to this problem.174  Treatment of 164 with Ph3PBr2 resulted in the formation of 
the desired product 235 along with acid 236.   
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 Table 2.9.  Conversion of TBS-ether to the bromide in the presence of TIPS-ester of 164. 
TIPSO OTBS
O
TIPSO Br
O
Conditions
HO Br
O
235
236  
Entry Conditions Products and Isolated Yields 
1 Ph3PBr2 (1.1 equiv), rt, 10 min 235(10%) + 236(24%) 
2 Ph3PBr2 (1.1 equiv), 0 °C, 10 min 235 + sm 
3 Ph3PBr2 (1.1 equiv), 0 °C, 5 h 235 + sm 
4 236(57%) + 235(5%) Ph3PBr2 (3.1 equiv), 0 °C, 30 min 
 
2.7 Conclusions 
In summary, the synthesis of the 3 major fragments of pseudotrienic acid A was achieved.  The 
trienic acid fragment was synthesized via a cationic zirconocene addition followed by a base 
induced 1,4-elimination.  The synthesis of the γ-amino-β-hydroxy acid segment was 
accomplished via a Frater-Seebach alkylation.  The C(17)-C(18) bond was readily made utilizing 
a Suzuki coupling reaction.  Coupling of these fragments remains to be investigated and might 
ultimately lead to the synthesis of pseudotrienic acid A.  Further investigation must also focus on 
formation of the C(20) hydroxy moiety in an enantioselective fashion.   
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2.8 Experimental  
General:  All moisture-sensitive reactions were performed under an atmosphere of N2. 
Glassware was dried in an oven at 140 ºC prior to use.  THF and Et2O were dried by distillation 
over Na/benzophenone.  CH2Cl2 was purified by filtration through activated alumina. Me2Zn was 
purchased from the Aldrich Chemical Company and Cp2ZrHCl was prepared according to a 
modification of a literature protocol.175  Unless otherwise stated, solvents and reagents were used 
as received.  Analytical thin layer choromatography was performed on pre-coated silica gel 60 F-
254 plates (particle size 0.040-0.055 mm, 230-400 mesh) and visualization was accomplished 
with a 254 nm UV light or by staining with an anisaldehyde solution (7.5 mL of p-anisaldehyde, 
25 mL  of concentrated H2SO4 and 7.5 mL  of glacial acetic acid in 675 mL  of 95% ethanol) or a 
KMnO4 solution (1.5 g of KMnO4, 10 g of potassium carbonate and 2.5 mL of 5% aqueous 
NaOH in 150 mL of H2O).  Flash chromatography on SiO2 was used to separate and purify the 
crude reaction mixtures. IR spectra obtained on a Nicolet AVATAR 360 FT-IR E.S.P. 
Spectrometer.  NMR spectra were recorded at 300 MHz/75 MHz (1H NMR/13C NMR) at 21 ºC 
in CDCl3 unless otherwise noted. Chemical shifts (δ) are reported as follows:  chemical shift, 
multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, p=pentet, sx=sextet, sp=septet, o=octet, 
dt=doublet of triplet, dq=doublet of quartet, m=multiplet, b=broad), integration, and coupling 
constants.  Mass spectra were obtained on a double focusing instrument. 
 
 
OTBS
166  
tert-Butylbut-3-ynyloxydimethylsilane (166).176  To a solution of 1.00 g (14.3 mmol) of 3-
butyn-1-ol, 2.39 mL (17.1 mmol) of Et3N, and 174 mg (1.43 mmol) of DMAP in 45 mL of 
CH2Cl2 was added 2.36 g (15.7 mmol) of TBSCl.  The reaction mixture was stirred under N2 for 
3 h, diluted with Et2O, and extracted with NH4Cl. The combined organic layers were dried 
(MgSO4), filtered, and concentrated in vacuo.  The resulting crude residue was purified by 
chromatography on SiO2 (10% EtOAc/Hexanes) to yield 2.66 g (99%) of 166 as a colorless oil: 
1H NMR δ 3.74 (t, 2 H, J = 7.2 Hz), 2.39 (td, 2 H, J = 2.4, 6.9 Hz), 1.95 (t, 1 H, J = 2.4 Hz), 0.90 
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(s, 9 H), 0.07 (s, 6 H); 13C NMR δ 81.45, 69.28, 61.72, 25.86, 22.83, 18.30, -5.33; MS (EI) m/z 
(rel intensity) 127 ([M-C4H9]+, 13), 84 (8), 74 (62), 59 (100). 
 
HO OTBS
167  
5-(tert-Butyl-dimethyl-silanyloxy)-pent-2-yn-1-ol (167).176  A solution of 3.37 mL (5.40 mmol) 
of n-BuLi (1.6  M in hexanes) was added dropwise to a solution of 1.00 g (5.40 mmol) of 166 in 
11 mL of THF at –40 ºC.  The resulting mixure was stirred for 15 min and then added to a 
solution of 486 mg (16.2 mmol) of paraformaldehyde in 6 mL of THF at –45 ºC.  The reaction 
mixture was further stirred at –45 ºC for 1 h followed by 1 h at room temperature, diluted with 
H2O, washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude 
residue was purified by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 913 mg (79%) 
of 167 as a colorless oil: 1H NMR δ 4.25 (dt, 2H, J = 2.1, 6.0 Hz), 3.73 (t, 2 H, J = 7.2 Hz), 2.44 
(tt, 2 H, J = 2.1, 7.2 Hz), 1.58 (t, 1 H, J = 6.3 Hz), 0.91 (s, 9 H), 0.08 (s, 6 H), 0.88 (d, 3 H, J = 
6.6 Hz); 13C NMR δ 83.4, 79.5, 61.8, 51.3, 25.9, 23.1, 18.3, -5.3; MS (EI) m/z (rel intensity) 157 
([M-C4H9]+, 29), 139 (37), 125 (15), 105 (87), 89 (21), 75 (100), 59 (10); HRMS (EI) Calcd for 
C11H22OSi-C4H9 157.0684, found 157.0678. 
 
 
HO OTBS
168  
5-(tert-Butyldimethylsilanyloxy)-pent-2-en-1-ol (168).177  To a solution of 4.31 g (20.1 mmol) 
of 167 in 175 mL of Et2O at 0 ºC was added 12.5 mL (40.2 mmol) of Red-Al (65 wt%).  The 
resulting reaction mixture was stirred for 4 h and quenched with NH4Cl at 0 ºC.  The layers were 
extracted with EtOAc, washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. 
The resulting crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 
3.25 g (75%) of 168 as a colorless oil:  IR (neat) 3352, 1675, 835 cm-1; 1H NMR δ 5.71-5.65 (m, 
2 H), 4.12-4.05 (m, 2 H), 3.65 (t, 2 H, J = 6.6 Hz), 2.26 (qd, 2 H, J = 1.2, 4.2 Hz), 1.65 (t, 2 H, J 
= 5.7 Hz), 0.89 (s, 9 H), 0.05 (s, 6 H); 13C NMR δ 130.9, 129.3, 63.6, 62.8, 35.8, 25.9, 18.3, -5.3; 
MS (EI) m/z (rel intensity) 215 (M+, 15), 199 (13), 159 (18), 145 (22), 129 (10), 115 (27), 105 
(100); HRMS (EI) Calcd for C11H23OSi 199.1518, found 199.1515. 
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 OTBS
160
H
O
 
5-(tert-Butyldimethylsilanyloxy)-pent-2-enal (160).177  To a suspension of 63.9 g (734 mmol) 
of MnO2 in 150 mL of CH2Cl2 was added 3.18 g (14.7 mmol) of 168 in 50 mL of CH2Cl2.  The 
solution was stirred at rt for 4 h, filtered through celite, and concentrated in vacuo. The resulting 
crude residue was purified by chromatography on SiO2 (5% EtOAc/Hexanes) to yield 2.29 g 
(73%) of 160 as a colorless oil: 1H NMR δ 9.52 (d, 1 H, J = 7.9 Hz), 6.90 (dt, 1 H, J = 6.9, 15.7 
Hz), 6.18 (qt, 1 H, J = 1.4, 7.9 Hz), 3.80 (t, 2 H, J = 6.2 Hz), 2.55 (qd, 2 H, J = 1.4, 6.2 Hz), 0.90 
(s, 9H), 0.07 (s, 6 H); 13C NMR δ 193.9, 155.5, 134.2, 61.1, 36.0, 25.8, 18.2, -5.4; MS (EI) m/z 
(rel intensity) 214 (M+, 25), 212 (20), 172 (45), 155 (33), 125 (40), 103 (55), 73 (100).   
 
 
159a
HO
O
 
But-3-ynoic acid (159a).120  To a solution of 14.0 g (139 mmol) of CrO3 and 96 mL of H2SO4 in 
360 mL of distilled H2O was added via addition funnel a solution of 5.00 g (71.3 mmol) of 3-
butyn-1-ol in 70 mL of acetone over a period of 1.5 h.  The reaction mixture was stirred for 3.5 h 
at 0 ºC, extracted with Et2O (6x), washed with H2O, dried (MgSO4), filtered, and concentrated in 
vacuo to give 3.41 g (57%) of 159a as an off-white solid: 1H NMR δ 3.39 (t, 1 H, J = 2.6 Hz), 
3.39 (d, 2 H, J = 2.7 Hz); MS (EI) m/z (rel intensity) 122 (7), 121 (50), 91 (9), 84 (M+, 33), 74 
(62), 59 (100). 
 
TIPSO
O
159  
Triisopropylsilyl 3-butynoate (159).120 To a solution of 223 mg (2.65 mmol) of 159a and 0.56 
mL (2.65 mmol) of TIPSCl in 13 mL of CH2Cl2 at rt was added 180 mg (2.65 mmol) of 
imidazole.  The resulting reaction mixture was stirred for 1.5 h and diluted with H2O and 
CH2Cl2.  The organic layer was washed with H2O and NaCl, dried (MgSO4), filtered, and 
concentrated in vacuo to give 636 mg (100%) of 159 as a colorless oil: 1H NMR δ 3.27 (d, 2 H, J 
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= 2.7 Hz), 2.15 (t, 2 H, J = 2.7 Hz), 1.37-1.19 (m, 3 H), 1.05 (d, 18 H, J = 7.5 Hz), MS (EI) m/z 
(rel intensity) 197 ([M-C3H7]+, 100); 157 (126), 153 (64), 125 (22), 111 (60), 97 (23), 83 (63), 75 
(53), 61 (47), 59 (45). 
 
TIPSO OTBS
O
164  
9-(tert-Butyldimethylsilanyloxy)-nona-2E,4E,6E-trienoic acid triisopropylsilylester (164).  
To a solution of 241 mg (0.93 mmol) of Cp2ZrHCl in 3 mL of CH2Cl2 was added 224 mg (0.93 
mmol) of 159 in 1 mL of CH2Cl2.  The mixture was stirred for 15 min followed by the addition 
of 100 mg (0.46 mmol) of 160 in 1 mL of CH2Cl2 and 9.6 mg (0.046 mmol) of AgClO4.  The 
reaction mixture was stirred for 30 min, filtered through florisil, and washed with EtOAc.  The 
filtrate was concentrated in vacuo to give 169 as an orange oil which was used without further 
purification. 
To a  –10 ºC solution of 169 in 5 mL of THF was added 0.16 mL (1.40 mmol) of 1-
(trifluoroacteyl)imidazole followed by 0.13 mL (1.63 mmol) of pyridine.  The mixture was 
allowed to warm to 5 ºC over 1 h, treated with 0.41 mL (2.33 mmol) of DIEA, and allowed to 
warm to 15 ºC over 3.5 h.  The solution was poured into a separatory funnel containing H2O and 
Et2O.  The layers were separated and the organic layer was washed with NH4Cl, H2O, and NaCl.  
The organic layer was dried (MgSO4), filtered, and concentrated in vacuo. The crude material 
was titurated with hexanes and the soluble material was used for chromatography.  The resulting 
crude residue was purified by chromatography on SiO2 (100% Hexanes) to yield 122 mg (60%) 
over 2 steps of 164 as a colorless oil: IR (neat) 2930, 1695, 1620, 1006, 976, 835 cm-1; 1H NMR 
δ 7.27 (dd, 1 H, J = 11.5, 15.1 Hz), 6.53 (dd, 1 H, J = 10.3, 14.9 Hz), 6.23 (dd, 1 H, J = 10.8 Hz), 
6.17 (d, 1 H, J = 15 Hz), 6.00-5.82 (m, 2 H), 3.68 (t, 2 H, J = 6.5 Hz), 2.37 (q, 2 H, J = 6.6 Hz), 
1.42-1.23 (m, 3 H), 1.09 (d, 18 H, J = 7.3 Hz), 0.09 (s, 9 H), 0.06 (s, 6 H); 13C NMR δ 166.7, 
145.1, 140.7, 136.4, 131.6, 128.3, 122.2. 62.5, 36.6, 25.9, 18.3, 17.8, 12.1, -5.3; MS (EI) m/z (rel 
intensity) 395 ([M-C3H7]+,100), 381 (17), 169 (13), 133 (7), 115 (13), 89 (26), 73 (49), 59 (20); 
HRMS (EI) Calcd for C24H47O3Si2 439.3064, found 439.3060. 
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 EtO2C CO2Et
OTBDPS
172  
3-((tert-Butyldiphenylsilyl)oxy)pentanedioic acid, diethylester (172).178  To a solution of 16.7 
mL (245 mmol) of imidazole in 250 mL of CH2Cl2 was added 30.2 mL (116 mmol) of 
TBDPSCl.  After stirring for 10 min at rt, a solution of 25.0 g (122 mmol) of diethyl 3-
hydroxyglutarate in 100 mL of CH2Cl2 was added.  The reaction mixture was stirred at rt for 16 h 
and diluted with H2O and Et2O.  The combined organic layers were washed with NaCl.  The 
aqueous layers were combined and re-extracted with Et2O.  The organic layer was dried 
(MgSO4), filtered, and concentrated in vacuo to yield 51.0 g (99%) of 172 as a yellow solid:  Mp 
44-46 °C; 1H NMR δ 7.72-7.63 (m, 4 H), 7.43-7.26 (m, 6 H), 4.55 (p, 1 H, J = 6.0 Hz), 4.10-3.93 
(m, 4 H), 2.58 (A of ABX, 2 H, J = 6.3, 15.0 Hz), 2.57 (B of ABX, 2 H, J = 6.0, 15.0 Hz), 1.19 
(t, 6 H, J = 6.9 Hz), 1.03 (s, 9 H); MS (EI) m/z (rel intensity) 467 (10), 466 (30), 465 ([M-Na]+, 
74); HRMS (EI) Calcd for C25H34O5Si (M+Na) 465.2073, found 465.2083. 
 
161
O
OTBDPS
O O
 
3-[(tert-Butyldiphenylsilyl)oxy)]pentanedioic anhydride (161).178  To a solution of 8.85 g 
(20.0 mmol) of 172 in 30 mL of MeOH was added 2.00 g (50.5 mmol) of NaOH pellets and the 
mixture was stirred at rt for 36 h.  The resulting suspension was concentrated in vacuo.  The 
crude residue was crushed into fine particles and suspended in 40 mL of benzene and 30 mL of 
Ac2O.  The mixture was heated at reflux for 1.5 h, quenched with NaCl, and extracted with 
CHCl3.  The organic layers were washed with NaHCO3, dried (MgSO4), filtered, and 
concentrated in vacuo. The resulting crude residue was purified by chromatography on SiO2 
(100% Hexanes containing 1% Ac2O to 20% EtOAc/Hexanes containing 1% Ac2O) to yield 3.79 
g (61%) of 161 as peach-colored oil: 1H NMR δ 7.71-7.52 (m, 4 H), 7.51-7.31 (m, 6 H), 4.30-
4.70 (m, 1 H), 2.83 (A of ABX, 2 H, J = 3.6, 16.2 Hz), 2.60 (B of ABX, 2 H, J = 2.7, 16.0 Hz), 
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1.05 (s, 9 H); MS (EI) m/z (rel intensity) 311 ([M-C4H9]+, 74), 291 (21), 240 (17), 225 (74), 199 
(100), 183 (27), 105 (8), 78 (31). 
 
MeO2C CO2H
OTBDPS
170  
(S)-((3-tert-Butyldiphenylsilyl)oxy)pentanedioic acid, monomethylester (170).178  To a 
solution of 1.09 g (2.96 mmol) of 161 in 100 mL of Et2O at –40 ºC was added 760 mg (0.887 
mmol) of (DHQD)2AQN.  The mixture was stirred for 20 min, treated with 1.20 mL (29.6 mmol) 
of MeOH and stirred for 72 h at –40 ºC. The reaction mixture was quenched with 10% aq. HCl at 
–40 ºC, warmed to rt, and extracted with EtOAc.  The aqueous layer was reextracted with 
EtOAc.  The combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo to 
yield 865 mg (73%) of 170 as a colorless oil: 1H NMR δ 7.75-7.60 (m, 4 H), 7.50-7.35 (m, 6 H), 
4.51 (p, 1 H, J = 6.3 Hz), 3.56 (s, 3 H), 2.71-2.50 (m, 4 H), 1.03 (s, 9H); MS (EI) m/z (rel 
intensity) 357 ([M-CO2H]+, 5), 343 (58), 265 (66), 225 (15), 199 (100), 179 (32), 78 (30). 
 
MeO2C NHCbz
OTBDPS
174  
(R)-4-Benzyloxycarbonylamino-3-(tert-butyldiphenylsilyloxy)-butyric acid methyl ester 
(174).  To 600 mg (1.50 mmol) of 170 in 10 mL of toluene was added 0.39 mL (1.80 mmol) of 
DPPA and 0.25 mL (1.80 mmol) of Et3N.  The solution was stirred at rt for 30 min and further 
heated at reflux for 3.5 h.  At rt, 0.47 mL (4.50 mmol) of BnOH was added.  The resulting 
reaction mixture was heated at reflux for 18 h, quenched with NaHCO3, extracted with Et2O, 
dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was purified by 
chromatography on SiO2 (3% EtOAc/Hexanes) to yield 596 mg (80%) of 174 a colorless oil: IR 
(neat) 3004, 2866, 1745, 1645, 1525, 1260, 993 cm-1; 1H NMR δ 7.62 (t, 5 H, J = 7.0 Hz), 7.42-
7.23 (m, 10 H), 4.97 (s, 2 H), 4.84 (t, 1 H, J = 5.2 Hz), 3.49 (s, 3 H), 3.30-3.15 (m, 2 H), 2.54-
2.36 (m, 2 H), 1.00 (s, 9 H); 13C NMR δ 171.0, 156.2, 136.4, 135.7, 135.6,133.3, 133.0, 129.9, 
129.8, 128.4, 128.0, 127.9, 127.7, 127.6, 127.7, 69.2, 66.5, 51.5, 46.1, 39.6, 26.8, 19.2; MS (EI) 
m/z (rel intensity) 449 (M+, 6), 448 (15), 340 (10), 319 (13), 283 (6), 236 (10), 199 (14), 135 
(11), 105 (8), 91 (100); HRMS (EI) Calcd for C25H26NOSi 448.1580, found 448.1580. 
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 MeO
NHCbz
OHO
176  
(R)-4-Benzyloxycarbonylamino-3-hydroxybutyric acid methyl ester (176). To a solution of 
50 mg (0.10 mmol) of 174 in 2 mL THF in a polyethylene vial at rt was added 0.13 mL (4.94 
mmol) of 70% HF.pyr.  The reaction mixture was stirred for 4 d, quenched with NaHCO3, 
extracted with Et2O, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude 
residue was purified by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 20 mg (80%) of 
176 a colorless oil: 1H NMR δ 7.43-7.29 (m, 5 H), 5.20 (bs, 1 H), 5.12 (s, 2 H), 4.20-4.10 (m, 1 
H, J = 3.5 Hz), 3.72 (s, 3 H), 3.47-3.35 (m, 1 H, J = 3.5 Hz), 3.27-3.12 (m, 1 H, J = 1.3 Hz), 
2.59-2.42 (m, 2 H); MS (EI) m/z (rel intensity) 267 (M+, 25), 263 (4), 249 (5), 236 (6), 165 (5), 
108 (11), 104 (15), 91 (100); HRMS (EI) Calcd for C13H17NO5 267.1096, found 267.1107. 
 
 
N(Boc)2
184  
Bis-tert-butoxycarbonyl allylamine (184).179  To 0.75 mL (10 mmol) of allyl amine and 12 mg 
(0.1 mmol) of DMAP in 25 mL of CH3CN was added 2.18 g (10 mmol) of Boc2O in 20 mL of 
CH3CN.  The reaction mixture was stirred at rt for 6 h, diluted with 10 mL of toluene and 
concentrated in vacuo.  The resulting solid was redissolved in 25 mL of CH3CN followed by 
addition of 12 mg (0.1 mmol) of DMAP and 2.18 g (10 mmol) of Boc2O.  The solution was 
heated to 60 ºC for 14 h and concentrated in vacuo.  The resulting oil was washed with NaHCO3, 
extracted with CH2Cl2, washed with NaCl, dried (MgSO4), and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (5% EtOAc/Hexanes) to yield 
1.03 g (40%) of 184 a white solid: Mp 43-44 ° C (EtOAc/Hexanes); lit. 43-44 ° C; 1H NMR δ 
5.92-5.78 (m, 1 H), 5.16 (dq, 1 H, J = 1.5, 26.8 Hz), 5.15-5.12 (m, 1 H), 4.18 (dt, 2 H, J = 1.5, 
5.5 Hz), 1.51 (s, 9 H); MS (EI) m/z (rel intensity) 280 (M+, 82), 224 (53), 168 (100), 140 (13), 
124 (90). 
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OH
N(Boc)2
186  
1-(Bis-tert-butoxycarbonyl amino)-2-ethanal (186). To solution of 1.66 g (6.45 mmol) of 184 
in 70 mL of CH2Cl2 at –78 ºC was introduced O3 for 30 min until blue color persisted.  The 
reaction mixture was purged with N2 for 30 min followed by quenching with 4 mL of DMS and 
stirred for 16 h at rt.  The reaction mixture was poured into dilute NaCl, extracted with CH2Cl2, 
dried (MgSO4), and concentrated in vacuo. The resulting crude residue was purified by 
chromatography on SiO2 (5% EtOAc/Hexanes) to yield 1.67 g (59%) of 186 a colorless oil: 1H 
NMR δ 9.54 (s, 1 H), 4.37 (s, 2 H), 9.54 (s, 1 H); 13C NMR 196.7, 151.8, 83.4, 55.2, 27.9; 
HRMS (EI) Calcd for C12H21NO5 282.1317, found 282.1311. 
 
O
O
N
Boc
Boc
182  
(R)-4-(Dicarbamic acid-t-butylester)-oxetane-2-one (39). To a solution of 20 mg (0.05 mmol) 
of TMSQ and 160 mg (1.5 mmol) of LiClO4 in 0.5 mL of diethyl ether was added 1.0 mL of 
CH2Cl2. The reaction mixture was cooled to –78 ºC, and treated with 0.21 ml (1.3 mmol) of N,N-
diisopropylethylamine followed by the addition of 130 mg (0.5 mmol) of 186.  A solution of 72 
μL (0.5 mmol) of acetyl chloride in 0.3 mL CH2Cl2 was then added over 1 h by syringe pump.  
The reaction mixture was stirred for 16 h at –78 ºC and was quenched at –78 ºC by adding 5 mL 
of Et2O, filtered through silica gel, washed with Et2O, and concentrated in vacuo.  The crude 
material was triturated with hexanes to remove impurities to yield 100 mg (66%) of 182 as a 
white solid: 1H NMR δ 4.71 (p, 1 H, J = 5.5 Hz), 4.07 (A of AB, 1 H, J = 5.5, 14.9 Hz), 4.01 (B 
of AB, 1 H, J = 5.4, 14.9), 3.52 (A of AB, 1 H, J = 5.9, 16.5 Hz), 3.34 (B of AB, 1 H, J = 4.3, 
16.6 Hz), 1.52 (s, 18 H). 
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O
OEt
OH
O
202  
(R)-Diethyl malate (202).180 To a solution of 5.00 g (37.3 g) of (D)-malic acid in 32 mL of 
EtOH was added 120 μL of HCl.  The resulting solution was stirred at reflux for 15 h, 
concentrated in vacuo, purified by chromatography on SiO2 (20% EtOAc/Hexanes) to yield 5.68 
g (80%) of 202 as a colorless oil: 1H NMR δ 4.48 (q, 1 H, J = 5.7 Hz), 4.28 (qd, 2 H, J = 1.2, 7.2 
Hz), 4.18 (q, 2 H, J = 7.2 Hz), 3.21 (d, 2 H, J = 5.4 Hz), 2.83 (A of ABX, 1 H, J = 4.5, 16.2 Hz), 
2.82 (B of ABX, 1 H, J = 6.0, 16.2 Hz), 1.31 (t, 3 H, J = 6.9 Hz), 1.28 (t, 3 H, J = 7.2 Hz); 13C 
NMR δ 173.1, 170.3, 67.0, 61.6, 60.6, 38.5, 13.8.  
 
 
EtO
O
OEt
OH
O
203  
Diethyl (2R, 3S)-3-methylmalate (203).180  To a solution of 6.38 mL (45.8 mmol) of 
diisopropylamine in 21 mL of THF was added 26.3 mL (42.1 mmol) of n-BuLi dropwise via an 
addition funnel at 0 ºC.  The solution was stirred at 0 ºC for 30 min and further cooled to -78 ºC.  
A solution of 3.48 g (18.3 mmol) of 202 in 5 mL of THF was added slowly to the LDA solution.  
The resulting solution was stirred for 50 min at -78 ºC, warmed to -20 ºC over 2 h, stirred at -20 
ºC for 20 min, and recooled to -78 ºC.  At -78 ºC, 1.71 mL (27.5 mmol) of MeI was added, and 
the mixture was stirred for 30 min and warmed to -30 ºC over 1 h.  After 1 h at 0 ºC, the reaction 
mixture was warmed to rt during a 1 h period and stirred at rt for 1 h.  The mixture was quenched 
with 1.0 M citric acid and extracted with EtOAc. The combined organic layers were dried 
(MgSO4) and concentrated in vacuo. The resulting residue was purified by chromatography on 
SiO2 (5% EtOAc/Hexanes) to yield 2.40 g (64%) of 203 as a yellow oil in a 6:1 ratio of 
diastereomers based on integration of 1H NMR signals at 3.03 ppm (major) and 2.92 ppm 
(minor): 1H NMR δ 4.36-4.21 (m, 3 H), 4.15 (qd, 2 H, J = 1.5, 7.2 Hz), 3.14 (bd, 1 H, J = 5.4 
Hz), 3.03 (qd, 1 H, J = 3.6, 7.2 Hz), 1.32 (d, 3 H, J = 7.2 Hz), 1.31 (t, 3 H, J = 6.9 Hz), 1.26 (t, 3 
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H, J = 7.2 Hz); Major isomer: 13C NMR δ 173.0, 172.6, 72.2, 61.7, 60.7, 42.9, 13.9, 12.6, 10.4. 
Minor isomer: 13C NMR δ 173.0, 172.6, 71.2, 61.6, 60.6, 42.8, 13.8, 12.6, 10.4.  
 
EtO
O
OTs
OH
204  
(2S,3R)-3-Hydroxy-2-methyl-4-(toluene-4-sulfonyloxy)-butyric acid ethyl ester (204).180  To 
a solution of 400 mg (1.96 mmol) of 203 in 4 mL of THF was added 1.01 mL (2.20 mmol) of 
BH3.DMS over 15 min.  The resulting solution was stirred for 20 min at rt and cooled to 0 ºC.  At 
0 oC, 3.7 mg (0.098 mmol) of NaBH4 was added.  The mixture was stirred for 2 h, quenched with 
1 mL of EtOH and 18.6 mg of p-TsOH, stirred for 30 min at rt, and concentrated in vacuo.  The 
resulting residue was dissolved in 4 mL of 1:1 mixture of EtOH: benzene and concentrated in 
vacuo (repeated three times).  The crude 204a was used in the next step without further 
purification.   
To a solution of crude 204a in 6 mL of CH2Cl2 at rt was added 25 mg (0.099 mmol) of 
dibutyltin oxide, 0.27 mL (1.96 mmol) of Et3N, and 374 mg (1.96 mmol) of TsCl.  The reaction 
mixture was stirred for 15 h at rt, filtered, and concentrated in vacuo. The resulting residue was 
purified by chromatography on SiO2 (25% EtOAc/Hexanes) to yield 348 mg (56% over 2 steps) 
of 204 as a colorless oil: 1H NMR δ 7.80 (d, 2 H, J = 8.4 Hz), 7.36 (d, 2 H, J = 8.1 Hz), 4.15 (q, 
2 H, J = 7.2 Hz), 4.09 (d, 2 H, J = 4.8 Hz), 3.89 (q, 1 H, J = 5.7 Hz), 2.69 (p, 1 H, J = 6.6 Hz), 
2.46 (s, 3 H), 2.09 (s, 1 H), 1.26 (t, 3 H, J = 7.2 Hz), 1.21 (d, 3 H, J = 7.2 Hz). 
 
EtO
O
N3
OH
205  
(2S,3R)-4-Azido-3-hydroxy-2-methylbutyric acid ethyl ester (205).180  To 110 mg (0.35 
mmol) of 204 in 2 mL of DMF was added 45 mg (0.70 mmol) of NaN3.  The reaction mixture 
was heated at reflux for 5.5 h, cooled to rt, and diluted with EtOAc.  The solution was washed 
with H2O and NaCl, dried (MgSO4), filtered, and concentrated in vacuo to yield 39 mg of 204 
(65%) as a colorless oil: 1H NMR δ 4.16 (q, 2 H, J = 7.2 Hz), 3.85 (ddd, 1 H, J = 6.3, 10.2, 12.6 
  164
Hz), 3.38 (A of ABX, 1 H, J = 3.6, 12.6 Hz), 3.36 (B of ABX, 1 H, J = 6.0, 12.3 Hz), 3.30 (d, 1 
H, J = 6.3 Hz), 2.65 (p, 1 H, J = 7.2 Hz), 1.26 (t, 3 H, J = 11.1 Hz), 1.19 (d, 3 H, J = 7.2 Hz); 13C 
NMR δ 175.2, 72.5, 60.9, 54.3, 42.6, 14.0, 13.9; Major isomer: 13C NMR δ 175.2, 72.5, 60.9, 
54.3, 42.6, 14.0, 13.9. Minor isomer: 13C NMR δ 175.2, 70.5, 60.9, 54.0, 42.4, 14.0, 13.9. 
 
CO2Me
TMS
209
 
3-Methyl-5-(trimethyl-silanyl)-pent-2-en-4-ynoic acid methyl ester (209).145 A solution of 
132 mg (0.30 mmol) of TDMPP and 136 mg (0.30 mmol) of Pd(OAc)2 in 10 mL of THF was 
stirred for 15 min, followed by the addition of 1.00 mL (10 mmol) of 3-methylbutynoate.  The 
resulting solution was stirred for 5 min, followed by the addition of 1.41 mL (10 mmol) of 
trimethylsilylacetylene.  The reaction mixture was stirred for 75 min at rt and concentrated in 
vacuo. The resulting residue was purified by chromatography on SiO2 (100% Hexanes) to yield 
1.51 g (77%) of 209 as an orange oil: 1H NMR δ 6.07 (s, 1 H), 3.69 (s, 3 H), 2.26 (s, 3 H), 0.18 
(s, 9 H); 13C NMR δ 166.4, 137.8, 124.4, 106.4, 99.3, 51.1, 19.6, -0.4; MS (EI) m/z (rel intensity) 
196 (M+, 20), 181 (100), 165 (27), 151 (60), 122 (100), 113 (47); HRMS (EI) Calcd for 
C10H16NO2Si 196.0920, found 196.0914. 
 
TMS
OH
210
 
3-Methyl-5-(trimethyl-silanyl)-pent-2-en-4-yn-1-ol (210). To a solution of 1.80 g (9.18 mmol) 
of 209 in 48 mL of CH2Cl2 at –78 ºC was added 20.2 mL (20.2 mmol) of diisobutylaluminum 
hydride (1 M in hexanes).  The resulting reaction mixture was stirred for 1 h, quenched with 
aqueous sodium potassium tartrate, and stirred for 2 h at rt.  The mixture was diluted with 
CH2Cl2, washed with NaCl, dried (MgSO4), and concentrated in vacuo. The resulting residue 
was purified by chromatography on SiO2 (25% EtOAc/Hexanes) to yield 1.30 g (84%) of 210 as 
an orange oil: IR (neat) 3345, 2959, 2900, 2144, 1680, 1250 cm-1; 1H NMR δ 6.01 (td, 1 H, J = 
1.2, 6.6 Hz), 4.21 (dd, 2 H, J = 0.6, 6.6 Hz), 1.82 (s, 3 H), 1.60 (s, 1 H), 0.18 (s, 9 H); 13C NMR 
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δ 136.5, 120.7, 107.3, 92.1, 59.1, 17.4, -0.1; MS (EI) m/z (rel intensity) 181 (7), 168 (M+, 14), 
153 (28), 141 (20), 125 (48), 109 (16), 99 (27), 83 (55), 75 (84), 73 (100); HRMS (EI) Calcd for 
C9H16NOSi 168.0970, found 198.0964. 
 
H
SMe
SMe
SMe
206  
3-Methyl-6,6,6-trismethylsulfanyl-hex-3-en-1-ynyl (206). To a solution of 1.90 g (11.3 mmol) 
of 210 and 2.67 mL (19.2 mmol) of Et3N in 40 mL of CH2Cl2 at –10 ºC was added 0.95 mL 
(12.4 mmol) of methanesulfonylchloride.  The reaction mixture was stirred for 30 min at –10 ºC, 
1 h at 0 ºC, and 15 h at rt.  The mixture was washed with cold H2O, 10% HCl, NaHCO3, NaCl, 
dried (MgSO4), and concentrated in vacuo to yield the mesylate.  The mesylate was immediately 
used in the next step without further purification. 
To 2.53 mL (19.0 mmol) of tris(methylthio)methane in 40 mL of THF at –78 ºC was 
added 12.3 mL (18.4 mmol) of n-BuLi (1.5 M/Hexanes).  The resulting solution was stirred at –
78 ºC for 15 min followed by the addition of the above prepared mesylate in 5 mL of THF.  The 
reaction mixture was stirred at –78 ºC for 1 h, warmed to –40 ºC and quenched with ether.  The 
organic layer was washed with NaHCO3, NaCl, dried (MgSO4), and concentrated in vacuo. The 
resulting residue was purified by chromatography on SiO2 (100% hexanes) to yield 3.27 g of 
206a and excess tris(methylthio)methane as an yellow/orange oil.  This material was used in the 
next step.   
To a solution of 3.27 g (10.7 mmol) of 206a in 40 mL of distilled MeOH at rt was added 
1.63 g (11.8 mmol) of K2CO3.  The reaction mixture was stirred at rt for 15 h, quenched with 
NH4Cl, washed with H2O, extracted with CH2Cl2, washed with NaCl, dried (MgSO4), and 
concentrated in vacuo. The resulting residue was purified by chromatography on SiO2 (100% 
Hexanes) to yield 1.27 g (51% over 3 steps) of 206 as a yellow oil: IR (neat) 3287, 2982, 2916, 
2093, 1403, 962, 754 cm-1; 1H NMR δ 6.29-6.20 (m, 1 H), 2.83 (s, 1 H), 2.83 (s, 1 H), 2.74 (d, 2 
H, J = 6.7 Hz), 2.12 (s, 9 H), 1.85 (s, 3 H); 13C NMR δ 133.2, 118.8, 86.1, 74.6, 69.5, 37.2, 17.6, 
13.0; MS (EI) m/z (rel intensity) 249 (10), 217 (67), 201 (15), 184 ([M-SMe]+, 100), 153 (50), 
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138 (30), 123 (30), 112 (28); HRMS (EI) Calcd for C9H13S2 (M-SCH3) 185.0459, found 
185.0456. 
 
OH
MeS
SMe
211
SMe
 
4-Methyl-1,1,1-trismethylsulfanylhexadeca-3,5-dien-7-ol (211). To a suspension of 126 mg 
(0.49 mmol) of zirconocene hydrochloride in 2 mL of CH2Cl2 under N2 was added 100 mg (0.43 
mmol) of 206 at room temperature. The reaction mixture was stirred for 15 min, cooled to -65 
ºC, and was treated with 0.21 mL (0.43 mmol) of Me2Zn (2.0 M solution in toluene).  After 5 
min, the mixture was warmed to 0 ºC, stirred for 30 min, treated with 74 µL (0.39 mmol) of 
decylaldehyde, stirred for 3 h at 0 ºC, quenched by addition of NaHCO3 solution, filtered through 
a plug of florisil and extracted with EtOAc.  The combined organic layers were washed with 
brine, dried (MgSO4), filtered, and concentrated in vacuo.  The resulting residue was purified by 
chromatography on SiO2 (10% EtOAc/Hexanes) to yield 62 mg (41%) of 211 as a colorless oil:  
1H NMR (CD3OD) δ 6.14 (d, 1 H, J = 15.7 Hz), 5.66 (t, 1 H, J = 6.9 Hz), 5.49 (dd, 1 H, J = 7.0, 
15.7 Hz), 3.96 (q, 1 H, J = 6.7 Hz), 2.70 (d, 2 H, J = 6.8 Hz), 1.99 (s, 9 H), 1.69 (s, 3 H), 1.50-
1.30 (m, 2 H), 1.30-1.20 (bs, 14 H), 0.80 (t, 3 H, J = 7.0 Hz); 13C NMR (CD3OD) δ 136.1, 135.8, 
131.8, 127.5, 73.8, 71.5, 38.6, 38.0, 33.1, 30.8, 30.7, 30.7, 30.5, 26.7, 23.8, 14.5, 13.4, 13.2; MS 
(EI) m/z (rel intensity) 803 (38), 621 (22), 524 (38), 413 ([M+Na]+, 100), 381 (28), 325 (23); 
HRMS (EI) Calcd for C20H38OS3Na 413.1983, found 413.2002. 
 
OTBS
I
Me
216  
tert-Butyl-(4-iodopent-3-enyloxy)dimethylsilane (216).181 To a solution of 448 mg (5 mmol) 
of CuCN in 10 mL of a 1:1 solution of THF:ether at –40 ºC was added 7.1 mL (10 mmol) of n-
BuLi (1.4M/hexanes).  After 5 min, the solution was stirred at rt for 15 min, cooled to –40 ºC, 
treated with 2.69 mL (10 mmol) of Bu3SnH, and stirred for 70 min at –40 ºC.  In a separate flask, 
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to a solution of 0.38 mL (5 mmol) of 2,3-dihydrofuran in 5 mL of THF was added 7.06 mL (12 
mmol) of t-BuLi (1.7 M/Hexanes).  The mixture was stirred at –60 ºC for 10 min and at 0 ºC for 
55 min before it was added via cannula to the above reaction mixture.  The resulting solution was 
then stirred at 0 ºC for 1.5 h, treated with 2.18 mL (35 mmol) of MeI, allowed to warm to rt 
during a period of 1 h and stirred at rt for another 3 h.  The mixture was poured into an aqueous 
mixture of NH4Cl and NH3-H2O at 0 ºC and stirred for 30 min.   The aqueous layer was extracted 
with ether, dried (MgSO4), filtered, and concentrated in vacuo.   
To a solution of the resulting oil in 45 mL of CH2Cl2 at 0 ºC was added a solution of 1.4 
g (5 mmol) of I2 in CH2Cl2 until the brown color persisted.  The mixture was treated with 1.0 g 
(15 mmol) of imidazole followed by the addition of 2.23 g (15 mmol) of TBSCl.  The resulting 
reaction mixture was stirred at 0 ºC for 20 min, quenched with aqueous solution of Na2S2O3, 
extracted with Et2O, dried (MgSO4), and concentrated in vacuo. The crude residue was purified 
by chromatography on SiO2 (100% Hexanes) to yield 1.22 g (76%) of 216 a colorless oil:  1H 
NMR δ 6.17 (td, 1 H, J = 1.5, 7.8 Hz), 3.62 (t, 2 H, J = 6.6 Hz), 2.39 (s, 3 H), 2.24 (q, 2 H, J = 
6.9 Hz), 0.90 (s, 9 H), 0.06 (s, 6 H); 13C NMR δ 137.7, 95.3, 61.7, 34.2, 27.7, 25.9, 18.3, -5.3; 
MS (EI) m/z (rel intensity) 325 (M+, 10), 311 (33), 269 (100), 215 (5), 185 (20), 141 (6); HRMS 
(EI) Calcd for C11H23OSiI (M-CH3) 311.0328, found 311.0313. 
 
Me
OTBS
213  
tert-Butyldimethyl-(4-methylhex-3-en-5-ynyloxy)silane (213). To a solution of 199 mg (0.02 
mmol) of Pd(PPh3)4 in 6 mL of THF was added at rt 1.12 g (3.44 mmol) of 216 and 10.3 mL 
(5.15 mmol) of ethynylmagnesium chloride.  The reaction mixture was stirred for 2 h and 
quenched with NH4Cl, extracted with pentane, dried (MgSO4), and concentrated in vacuo. The 
resulting crude residue was purified by chromatography on SiO2 (100% pet. Et2O) to yield 550 
mg (71%) of 213 a colorless oil: IR (neat) 3351, 2899, 2144, 1250, 1677, 1014, 844 cm-1; 1H 
NMR δ 5.96 (t, 1 H, J = 7.2 Hz), 3.64 (t, 2 H, J = 6.9 Hz), 2.77 (s, 1 H), 2.33 (q, 2 H, J = 7.2 
Hz), 1.82 (s, 3 H), 0.90 (s, 9 H), 0.06 (s, 6 H); 13C NMR δ 135.9, 118.5, 86.7, 73.3, 62.0, 32.3, 
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25.9, 18.3, 17.2, -5.3; MS (EI) m/z (rel intensity) 167 ([M-t-Bu]+, 73), 132 (12), 89 (43); HRMS 
(EI) Calcd for C13H24OSi (M-CH3) 209.1369, found 209.1362. 
 
OTBS
OH 217
7
 
1-(tert-Butyldimethylsilanyloxy)-4-methylhexadeca-3,5-dien-7-ol (217).  To a suspension of 
125 mg (0.49 mmol) of zirconocene hydrochloride in 2 mL of CH2Cl2 under N2 was added 100 
mg (0.45 mmol) of 213 at room temperature.  The reaction mixture was stirred for 10 min, 
cooled to -65 ºC, and treated with 0.21 mL (0.43 mmol) of Me2Zn (2.0 M solution in toluene). 
After 5 min, the mixture was warmed to 0 ºC, stirred for 30 min, treated with 74 µL (0.41 mmol) 
of decylaldehyde, and stirred for 4 h at 0 ºC.  The solution was quenched by addition of sat. 
NaHCO3 solution, filtered through a plug of florisil and extracted with EtOAc.  The combined 
organic layers were washed with brine, dried (MgSO4), filtered, and concentrated in vacuo.  The 
resulting residue was purified by chromatography on SiO2 (10% EtOAc/Hexanes) to yield 35 mg 
(23%) of 217 as a colorless oil: IR (neat) 3312, 2928, 1682, 1005, 1361, 938, 776 cm-1; 1H NMR 
δ 6.23 (d, 1 H, J = 15.6 Hz), 5.58 (dd, 1 H, J = 7.3, 15.7 Hz), 5.40 (t, 1 H, J = 7.4 Hz), 4.10-4.25 
(m, 1 H), 3.64 (t, 2 H, J = 6.9 Hz) 2.38 (q, 2 H, J = 7.1 Hz), 1.84 (s, 3 H), 1.49-1.42 (m, 2 H), 
1.40-1.20 (bs, 14 H), 0.95-0.83 (t, 3 H), 0.91 (s, 9 H), 0.07 (s, 6 H). 
 
OH
8
TMS
223  
1-(Trimethylsilanyl)dodec-1-yn-3-ol (223). To a solution of 1.41 mL (10 mmol) of 
trimethylsilylacetylene in 4 mL of THF at –12  ºC was added 6.67 mL (10 mmol) of n-BuLi (1.5 
M/hexanes).  After stirring for 1 h at –12 ºC, a pre-cooled solution of 1.88 mL (10 mmol) of 
decylaldehyde in 4 mL of THF was added.  The reaction mixture was stirred at –78 ºC for 30 
min, and at -12 ºC for 1 h, quenched with NH4Cl and extracted with Et2O.  The combined 
organic layers were washed with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The 
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resulting crude residue was purified by chromatography on SiO2 (10% EtoAc/Hexanes) to yield 
1.98 g (78%) of 223 as a colorless oil: 1H NMR δ 4.36 (bs, 1 H), 1.80-1.60 (m, 2 H), 1.57 (s, 1 
H), 1.50-1.40 (m, 2 H), 1.28 (bs, 12 H), 0.89 (t, 3 H, J = 6.3 Hz), 0.17 (s, 9 H); 13C NMR δ 
107.0, 89.3, 62.9, 37.7, 31.9, 29.5, 29.3, 29.2, 25.1, 22.7, 14.1, -0.1; MS (EI) m/z (rel intensity) 
275 ([M+Na]+, 5), 249 (28), 239 (7), 221 (8), 181 (25), 153 (12), 127 (95), 99 (91), 78 (65), 72 
(100); HRMS (EI) Calcd for C15H30OSi (M-CH3) 239.1831, found 239.1841. 
 
OTBS
8
TMS
224  
3-(tert-Butyldimethylsilanyloxy)-1-(trimethylsilanyl)dodec-1-yne (224).  To a solution of 1.98 
g (7.78 mmol) of 224 in 21 mL of CH2Cl2 at 0 ºC was added 1.59 g (23.3 mmol) of imidazole 
and 1.76 g (11.7 mmol) of TBSCl.  The resulting reaction mixture was stirred at rt for 20 h, 
quenched with sat. NH4Cl, and extracted with Et2O.  The combined organic layers were washed 
with NaCl, dried (MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was 
purified by chromatography on SiO2 (100% Hexanes) to yield 2.47 g (86%) of 224 a colorless 
oil: IR (neat) 3333, 2925, 2855, 2171, 1464, 1250, 1017, 844 cm-1; 1H NMR δ 4.32 (t, 1 H, J = 
6.3 Hz), 1.72-1.60 (m, 2 H), 1.48-1.20 (m, 14 H), 0.92 (s, 9 H), 0.93-0.82 (m, 3 H), 0.16 (s, 9 H), 
0.13 (d, 6 H, J = 6.3 Hz); 13C NMR δ 108.1, 88.3, 63.4, 38.5, 31.9, 29.5, 29.3, 29.2, 25.9, 25.3, 
22.7, 18.3, 14.1, -0.1, -4.4, -4.9; MS (EI) m/z (rel intensity) 354 ([M-CH3]+,13), 353 (35), 311 
(100), 241 (76), 213 (72), 185 (78), 155 (98), 147 (89), 133 (77), 109 (57); HRMS (EI) Calcd for 
C21H44OSi2 (M-CH3) 353.2696, found 353.27. 
 
OTBS
8
H
225  
3-(tert-Butyldimethylsilanyloxy)-1-(trimethylsilanyl)dodec-1-yne (225). To a solution of 2.74 
g (7.43 mmol) of 224 in 30 mL of dry MeOH was added 1.13 g (8.17 mmol) of K2CO3.  The 
reaction mixture was stirred for 16 h at rt, quenched with NH4Cl, extracted with CH2Cl2, dried 
(MgSO4), filtered, and concentrated in vacuo. The resulting crude residue was purified by 
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chromatography on SiO2 (100% Hexanes) to yield 2.20 g (99%) of 225 a colorless oil: IR (neat) 
3312, 2927, 2856, 1713, 1466, 1254, 1095, 838 778 cm-1; 1H NMR δ 4.34 (td, 1 H, J = 1.8, 6.6 
Hz), 2.37 (d, 1 H, J = 1.8 Hz), 1.72-1.62 (m, 2 H), 1.50-1.22 (m, 14 H), 0.92 (s, 9 H), 0.90 (t, 3 
H, J = 7.2 Hz), 0.13 (d, 6 H, J = 7.2 Hz); 13C NMR δ 85.5, 71.8, 62.8, 38.6, 31.9, 29.6, 29.3, 
29.3, 25.8, 25.1, 22.7, 18.2, 14.1, -4.6, -5.1; MS (EI) m/z (rel intensity) 296 (M+, 10), 239 (38), 
221 (24), 169 (27), 113 (100); HRMS (EI) Calcd for C18H36OSi 296.56, found 296.25. 
 
OTBS
OTBS
226
7
 
1,7-Bis-(tert-butyldimethylsilanyloxy)-4-methylhexadeca-3,5-diene (216).  To a mixture of 
500 mg (1.69 mmol) of 225 and 0.26 mL (1.77 mmol) of 4,4,5,5-tetramethyl-
[1,3,2]dioxaborolane was added 44 mg (0.169 mmol) of Cp2ZrHCl and 24 μL (0.169 mmol) of 
Et3N.  The resulting mixture was heated for 16 h and diluted with EtOAc.  The resulting 
precipitate was filtered through a plug of celite and washed with EtOAc.  The filtrate was 
concentrated in vacuo to yield 756 mg of 221 as a light yellow oil that was used in the next step 
without further purification. 
A solution of the crude boronic ester (717 mg, 1.69 mmol) prepared above and 799 mg 
(2.45 mmol) of 216 in THF-H2O (32 mL:15 mL) was degassed using freeze-pump-thaw(3x),  
treated with 195 mg (0.169 mmol) of Pd(PPh3)4 and stirred for 5 min in the dark.  The resulting 
mixture was treated with 0.181 mL (2.54 mmol) of TlOEt, stirred for 20 h in the dark, filtered 
through a plug of celite and separated from the aqueous layer.  The organic layer was dried 
(MgSO4) and concentrated in vacuo. The resulting residue was purified by chromatography on 
SiO2 (100% Hexanes) to yield 551 mg (66% over 2 steps) of 226 as a yellow oil: IR (neat) 3011, 
2985, 1683, 1245, 1003, 910, 845 cm-1; 1H NMR δ 6.11 (d, 1 H, J = 15.6 Hz), 5.52 (dd, 1 H, J = 
6.9, 15.9 Hz), 5.43 (t, 1 H, J = 6.9 Hz), 4.12 (q, 1 H, J = 6.0 Hz), 3.64 (t, 2 H, J = 7.2 Hz), 2.36 
(q, 2 H, J = 6.9 Hz), 1.74 (s, 3 H), 1.56-1.36 (m, 2 H), 1.26 (s, 14 H), 0.89 (s, 18 H), 0.88 (t, 3 
H), 0.05 (s, 6 H), 0.04 (d, 6 H, J = 8.1 Hz); 13C NMR δ 134.8, 133.8, 130.9, 127.8, 73.9, 62.8, 
38.7, 32.1, 31.9, 29.6, 29.6, 29.3, 26.0, 25.4, 22.7, 18.4, 18.3, 14.1, 12.6, -4.2, -4.7, -5.3; MS (EI) 
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m/z (rel intensity) 497 (M+, 50), 439 (40), 369 (40), 307 (87), 271 (10), 237 (65), 89 (29), 75 
(100); HRMS (EI) Calcd for C29H60O2Si2 496.957, found 496.4124. 
 
OH
OTBS
227
7
 
7-(tert-Butyldimethylsilanyloxy)-4-methylhexadeca-3,5-dien-1-ol (227). To a solution of 551 
mg (1.11 mmol) of 226 in 10 mL of THF was added 0 ºC 1.11 mL (1.11 mmol) of TBAF (1 
M/THF).  The reaction mixture was slowly warmed from 0 ºC to 20 ºC over a period of 3.5 h, 
quenched with NH4Cl, extracted with Et2O, dried (MgSO4), filtered, and concentrated in vacuo. 
The resulting crude residue was purified by chromatography on SiO2 (10% EtOAc/Hexanes) to 
yield 354 mg (83%) of 227 a yellow oil: 1H NMR δ 6.17 (d, 1 H, J = 15.7 Hz), 5.56 (dd, 1 H, J = 
6.7, 15.6 Hz), 5.43 (t, 1 H, J = 7.5 Hz), 4.13 (q, 1 H, J = 6.0 Hz), 3.70 (t, 2 H, J = 6.5 Hz), 2.43 
(q, 2 H, J = 6.7 Hz), 1.77 (s, 3 H), 1.52-1.30 (m, 2 H), 1.26 (s, 14 H), 0.92-0.83 (t, 3H), 0.90 (s, 9 
H), 0.04 (d, 6 H, J = 7.9 Hz); 13C NMR δ 135.8, 133.5, 131.3, 127.0, 73.8, 62.2, 38.6, 31.9, 31.8, 
29.6, 29.6, 29.3, 25.9, 25.3, 22.7, 18.2, 14.1, 12.7, -4.2, -4.8; MS (EI) m/z (rel  intensity) 382 
(M+, 13), 325 (20), 255 (40), 199 (23), 151 (15), 135 (37), 123 (45), 107 (75), 93 (100); HRMS 
(EI) Calcd for C23H46O2Si  382.3267, found 382.3271. 
 
HO
O
OTBS
233  
9-(tert-Butyldimethylsilanyloxy)-nona-2E,4E,6E-trienoic acid (233).  To a solution of 50 mg 
(0.114 mmol) of 164 in MeOH was added 57 mg (0.228 mmol) of PPTS.  The resulting mixture 
was stirred at rt for 4.5 h and concentrated in vacuo.  The residue was redissolved in EtOAc, 
washed with NaCl, H2O, dried (MgSO4), and concentrated in vacuo. The resulting crude residue 
was purified by chromatography on SiO2 (100% CH2Cl2 to 10% MeOH/CH2Cl2) to yield 32 mg 
(75%) of 233 a white solid: IR (KBr) 3010, 2837, 1634, 1590, 1345 cm-1; 1H NMR δ 7.17 (dd, 1 
H, J = 11.1, 15.0 Hz), 6.49 (dd, 1 H, J = 10.8, 14.4 Hz), 6.17 (td, 2 H, J = 11.4, 15.6 Hz), 5.92-
5.78 (m, 1 H), 5.74 (d, 1 H, J = 15.3 Hz), 3.60 (t, 2 H, J = 6.6 Hz), 2.25 (q, 2 H, J = 6.6 Hz). 
  172
 HO
O
OH
234  
9-Hydroxynona-2E,4E,6E-trienoic acid (234).  To a solution of 50 mg (0.114 mmol) of 164 in 
MeOH was added 142 mg (0.570 mmol) of PPTS.  The resulting mixture was stirred at rt for 4.5 
h and concentrated in vacuo.  The residue was redissolved in EtOAc, washed with NaCl and 
H2O, dried (MgSO4), and concentrated in vacuo. The resulting crude residue was purified by 
chromatography on SiO2 (100% CH2Cl2 to 10% MeOH/CH2Cl2) to yield 30 mg (82%) of 233 a 
white solid: IR (KBr) 3104, 2967, 1620, 1520, 945, 735 cm-1; 1H NMR δ 7.29 (dd, 1 H, J = 11.1, 
15.3 Hz), 6.61 (dd, 1 H, J = 10.8, 15.0 Hz), 6.38-6.21 (m, 2 H), 6.06-5.91 (m, 1 H), 5.84 (d, 1 H, 
J = 15.0 Hz), 3.62 (t, 2 H, J = 6.3 Hz), 2.37 (q, 2 H, J = 6.6 Hz); 13C NMR δ 169.0, 146.8, 142.5, 
137.7, 133.1, 129.7, 121.6, 62.4, 37.4. 
 
TIPSO
O
Br
235  
9-Bromonona-2E,4E,6E-trienoic acid triisopropylsilylester (235).  To a suspension of 126 mg 
(0.30 mmol) of PPh3Br2 in 1 mL of CH2Cl2 was added a solution of 119 mg (0.27 mmol) of 164 
in 0.5 mL of CH2Cl2.  The reaction mixture was stirred for 10 min, diluted with CH2Cl2, washed 
with H2O, dried (MgSO4), and concentrated in vacuo. The resulting crude residue was purified 
by chromatography on SiO2 (100% CH2Cl2 to 10% MeOH/CH2Cl2) to yield 10 mg (10%) of 235 
as a white solid and 25 mg (24%) of 236 as a white solid: IR (KBr) 3082, 2960, 1622, 1301, 
1090, 980, 625 cm-1; 1H NMR δ 7.35-7.20 (m, 1 H), 6.52 (dd, 1 H, J = 14.4 Hz), 6.27 (td, 2 H, J 
= 14.4 Hz), 5.90-5.60 (m, 2 H), 3.43 (t, 2 H, J = 6.9 Hz), 2.73 (q, 2 H, J = 6.6 Hz), 1.50-1.20 (m, 
3 H), 1.07 (d, 9 H, J = 7.5 Hz); 13C NMR δ 166.6, 144.7, 139.9, 135.1, 132.4, 129.5, 122.9, 36.0, 
31.6, 17.8, 12.0. 
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HO
O
Br
236  
9-Bromonona-2E,4E,6E-trienoic acid (236).  1H NMR δ 7.39 (dd, 1 H, J = 11.4, 15.0 Hz), 
7.65-6.50 (m, 1 H), 6.45-6.20 (m, 2 H), 6.05-5.80 (m, 2 H), 3.44 (t, 2 H, J = 6.9 Hz), 2.74 (q, 2 
H, J = 6.6 Hz); 13C NMR δ 172.1, 146.7, 141.2, 136.1, 132.2, 129.1, 119.9, 36.0, 31.4.   
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